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Abstract
Neuronal plasticity, as the capacity of the brain to respond to external
demands or to injury, has emerged as a crucial mechanism to preserve,
at least in part, an adequate behavioral functioning after an injury
and as the process underlying improvements in disability during reha-
bilitation. Brain plasticity can be detected with both structural and
functional magnetic resonance imaging and more and more process-
ing techniques have been developed to better capture the occurring
changes and to better define the potential plasticity. Gait and balance
are affected in patients with multiple sclerosis since the early stages
of the disease with sensory deficits playing a major role in determin-
ing both balance and gait impairment. Moreover, gait disorders are
one of the major causes of disability in patients with Parkinson’s dis-
ease, in particular if suffering from freezing of gait. With this work
we aimed at i) investigating the functional reorganization occurring
in multiple sclerosis at both early and late stages of the disease, ii)
characterizing the functional pattern underlying sensory impairment
in patients with early multiple sclerosis and iii) verifying the neural
correlates of action observation of gait in patients with Parkinson’s
disease. These different studies fit into a larger framework where neu-
roimaging techniques, in particular functional imaging, would support
the clinicians in identifying tailored rehabilitation treatments and the
patients who would better benefit from them. We found that pa-
tients with early multiple sclerosis showed a higher brain functional
flexibility, expressed in terms of blood oxygen level dependent signal
variability, which correlated to clinical disability, representing a possi-
ble compensatory mechanism. In patients with early multiple sclerosis
we also observed subtle position sense deficits, not detectable with a
standard neurological examination, and which affected still standing
balance. Moreover, these deficits were related to a structural damage
at the level of the corpus callosum and to functional activity pat-
terns mainly involving the frontoparietal regions. On the contrary,
patients with multiple sclerosis at the progressive stages presented
with more subtle changes in the resting state functional connectivity
which, nonetheless, were related to clinical disability. Lastly, the pres-
ence of freezing of gait in patients with Parkinson disease influenced
the neural activation underpinning the action observation of walking.
Altogether, these results offer an better insight into the pathophys-
iological mechanisms underlying disability in patients with multiple
sclerosis and constitute a groundwork for the enhancement of rehabili-
tation protocols to improve gait and balance in both multiple sclerosis
and Parkinson’s disease, supporting the embracing of new strategies
such as sensory integration and action observation training.
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1.1 Rationale and objectives
“When an axon of Cell A is near enough to excite a Cell B and repeatedly or
persistently takes part in firing it, some growth process or metabolic change takes
place in one or both cells such that A’s efficiency, as one of the cells firing B, is
increased” [1], with these words, Donald O. Hebb described neural plasticity, at
a synaptic level, in 1949. Defined as the brain capacity to respond to experi-
enced demands with structural changes that alter the behavioral repertoire, the
capacity of the brain to adapt relies on mechanisms involving both the grey and
the white matter and can be detected at a macroscopic level, using neuroimaging
techniques such as diffusion tensor imaging and functional magnetic resonance
imaging. Besides the research made on healthy subjects, the study of neural
plasticity by means of neuroimaging techniques in neurological disorders has re-
ceived more and more attention in the last two decades, resulting in significant
and interesting developments.
The first studies on changes occurring after brain injury focused on stroke, e.g.
after an ischemic damage. Afterwards, research extended to a large number of
1
1. INTRODUCTION
neurological disorders including Parkinson’s disease and multiple sclerosis (MS).
A response to injury is already detectable in the first days after an acute damage,
e.g. stroke, but adaptation occurs over the following weeks and months. While
in the case of an acute damage the course of the response modulation is more
discernible, for chronic diseases or for a disorder such as multiple sclerosis, which
embraces acute events and ongoing degenerative processes at the same time, it is
harder to disentangle the different steps of neural adaptation.
Neural plasticity has also emerged as the mechanism underlying the effects of
rehabilitation in neurological disorders, in particular for gait and balance impair-
ment. In patients with multiple sclerosis, evidence from previous studies suggests
that somatosensory deficits play a major role in determining gait and balance
disorders and rehabilitation protocols for balance including sensory integration
training resulted in a better outcome. Besides, patients with Parkinson’s disease
might benefit from novel rehabilitation strategies to improve gait, including ac-
tion observation training. Despite the progresses in discovering and developing
new drugs for neurological disorders, rehabilitation remains a crucial therapeutic
tool and more and more efforts have been put in the direction of designing per-
sonalized rehabilitation protocols. However, to reach this aim, a comprehensive
understanding of the baseline plastic changes underlying the clinical disability is
necessary.
Against this background, the work described in this thesis aimed at inves-
tigating the functional changes occurring in multiple sclerosis at both the early
and late stages of the disease and the position sense deficits in terms of both
behavioral and neural correlates. A last study on patients with Parkinson disease
aimed at analyzing the functional neural patterns underlying action observation
of walking in presence or absence of freezing of gait.
2
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1.2 Overview of the thesis
• In the chapter 2 an overview of the state of the art of the imaging methods
used to investigate brain plasticity is provided, together with a summary of
the neurophysiology of gait, focusing on the role of position sense. It also
includes a description of multiple sclerosis and Parkinson’s disease.
• In the chapter 3 the first study is presented, investigating the variability of
the BOLD signal, as a measure of the functional flexibility of the brain, in
patients at the early stages of multiple sclerosis.
• In the chapter 4 the main project, aiming at investigating the position sense
in patients at the early stages of multiple sclerosis, is described.
• The chapter 5 illustrates the work exploring functional connectivity in pa-
tients with progressive multiple sclerosis.
• In the chapter 6 is reported the study characterizing the neural correlates of
action observation of gait in patients with Parkinson’s disease in presence
and absence of freezing of gait.
The chapters 3, 4, 5 and 6 contain sections including the background, aims,
methods and discussion specific for each study.
• Lastly, the chapter 7 contains the concluding remarks and future directions







In this chapter a description of the main imaging techniques used in this work as
well as a background for multiple sclerosis and Parkinson’s disease are provided,
emphasizing the studies on gait and balance and on brain plasticity unveiled by
functional neuroimaging.
2.1 Brain plasticity
In neuroscience, the term plasticity is referred to the ability of the brain to change
in response to an internal or external stimuli. This concept have been widely used
and developed through centuries. Between the end of the 19th century and the
beginning of the 20th fundamental discoveries were made in the field of neuro-
physiology. During these decades, Cajal defined the neuron as the basic building
block of the nervous system and Sherrington called synapsis the connection be-
tween two neuronal cells. The term plasticity has been introduced within this
context. Although probably already used by Freud referred to nervous system and
5
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learning, in 1890, it was William James who associated plasticity with behavioral
habits. In the meantime Lugaro, based on the hypothesis of his teacher Eugenio
Tanzi, was the first one linking plasticity to synaptic transmission. The synaptic
theory of learning underwent a strong debate until 1949, when Hebb published
the Organization of Behavior [1]. This essay would lead to a wide acceptance of
synaptic changes as one of the basic mechanisms underlying behavioral changes.
A comprehensive and detailed review of the history of the term plasticity is be-
yond the purposes of this thesis and for further details see [2; 3]. However, a
brief summary was needed to introduce the modern concept of brain plasticity
and the impact it had on the interpretation of changes occurring within the cen-
tral nervous system (CNS). Nowadays, plasticity is a term reserved to reactive
phenomena, reflecting a secondary change in response to a primary change and
authors differentiate it from the existing capacity to optimize brain’s performance
to the occurring demands, which is instead indicated as flexibility. [4].
Mechanisms underlying brain plasticity are multiple and occur at different
levels. At a molecular and cellular levels, changes affect both the white and
grey matter and include neurogenesis, synaptogenesis, changes in neuronal mor-
phology, in the number of axons, in axon diameter, in the density of fibers, in
axonal branching and trajectories, in myelination, in glia cells and angiogenesis
[5]. These changes resonate in modifications at a columnar, cortical map and
systems level, [6] and are detectable by magnetic resonance (MR) imaging. How-
ever, the neuroimaging of plasticity in human brain has drawn the attention only
in the last two decades. The first studies explored differences between individ-
uals that reflected skills or knowledge [7; 8; 9] or, with longitudinal studies, the
learning of a new skill[10]. Both structural and functional imaging can capture
changes due to plasticity and advances have been made in gaining more and more
details of the tissue micro structure and function, i.e. cortical layer functional
6
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Magnetic Resonance Imaging (fMRI) [11]. Plasticity is influenced by genetic and
environmental factors, which would determine a different ability in responding to
a specific stimulus, for each individual. Therefore, both the characteristic of the
demand and the baseline ability to respond to it can determine the amount of
plastic changes.
In neurological diseases, plasticity limits the impact that damage has on be-
havior, thus limiting the clinical disability. In acute neurological diseases, such
as stroke, plasticity investigated by means of fMRI revealed increased functional
activity in areas distant from the lesion early after the stroke and a later relative
normalization [12]. This course mirrors what observed in healthy subjects during
learning, with a decrease in cortical activity specialized in that skill over time,
which occurs in parallel with an increase in effective connectivity [13]. The de-
tection of changes due to plasticity in chronic and spatially diffuse neurological
diseases such as multiple sclerosis is more challenging. However, the understand-
ing of plasticity phenomena occurring in neurological patients in response to
injury is of utmost importance for the development of novel and more effective
rehabilitation strategies [14; 15].
2.2 Functional Magnetic Resonance Imaging
Since 1992, when it was firstly described as an increase in water proton MR
signal in the visual cortex after visual stimulation, on a gradient-echo sequence
[16], brain functional MR imaging has been broadly applied and its results have
been extensively interpreted to better understand the brain function in both
health and disease status. Functional MR imaging, specifically blood-oxygen-
level-dependent (BOLD) fMRI imaging, reflects the interplay between cerebral




According to the classical model, a linear relationship subsists between CBF,
MRO2C, metabolic rate of glucose consumption and brain activity. Although
this is plausible during resting state, when focal neural activation occurs a more
recent theory (feedforward control) states that only MRO2C remains linearly
correlated to neural activity and in particular to synaptic activity [17]. BOLD
signal is considered to arise from a linear coupling between neural activity and
MRO2C and from a more complex coupling with CBF. During focal neural ac-
tivity, CBF increases in excess of MRO2C, thus the rate of oxygen reaching the
cortex exceeds its consumption rate, resulting in an increased ratio of oxygenated
to deoxygenated hemoglobin. Since the former is diamagnetic and the latter
paramagnetic, the higher ratio augments the MR signal, producing the BOLD
response.
Recently, it emerged how astrocytes participate in the neurovascular and neu-
rometabolic coupling. In fact, astrocytes are closely connected to both synapses
and vessels, creating a neurogliovascular unit which has an impact on the neu-
rometabolic coupling. Interestingly, studies on rat brain showed that, even at
resting state, glucose consumption is similar between astrocytes and neurons,
despite the much higher energy demand of the latter, compared to the former.
A possible explanation is that glucose, in astrocytes, is primarily metabolized
through the less efficient pathway, glycolysis, while neurons would use the ox-
idative pathway and tricarboxylic acid cycle, generating more adenosine triphos-
phate, given the same amount of glucose. Moreover, it has been hypothesized
that the lactate produced by glycolysis would be shifted from astrocytes to neu-
rons, and, converted to pyruvate, would enter the tricarboxylic acid cycle as well.
This mechanism, called astrocyte-neuron lactate shuttle, is, in turn, modulated
by synaptic activity and in particular, by glutamate release.
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In the feedforward control hypothesis, focal activity and in particular gluta-
mate also induces an increase in CBF through both a neuronal and an astrocytic
pathway which induce vasodilation, using different cascades and mediators. The
neurovascular coupling is modulated by the balance between the two pathways
and other regional and central processes. This complex modulation underlies the
variable and non-linear coupling between synaptic activity and CBF. However it
does not explain the disproportionate rise in CBF relative to MRO2C, the con-
ditio sine qua non to have BOLD signal. A possible explanation for the increase
in CBF to be much higher than what apparently needed would be to constitute
a reserve in case of activity-related hypoxia.
The complex relationship between neural activity and metabolic or vascular
processes suggests that the BOLD signal is causally better correlated with the
integrated synaptic input activity rather than with the spike output activity
and in a complex way, depending on the afferent input, on the target neuronal
subpopulation and on the vascular response. However, correlation between BOLD
signal and spike output activity has been also reported.
BOLD signal is measured using a T2*-weighted sequence. When a radiofre-
quency pulse is applied, a transverse magnetization is obtained which rotates in
the transverse plane at the Larmor frequency and induces an MR signal in the
radiofrequency coil. The decay of the transverse magnetization (or relaxation)
starts as protons begin going out of phase. The characteristic time represent-
ing the decay of the signal by 1/e is called T2 relaxation time and 1/T2 is the
transverse relaxation rate. Transverse relaxation is mainly related to intrinsic
field caused by adjacent protons and thus reflects the interactions at atomic and
molecular levels. Additional dephasing fields arise from local field inhomogeneities
and its characteristic time is the T2* relaxation. In gradient echo sequences the
latter is a combination of T2 relaxation and relaxation caused by local magnetic
9
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= γ∆Binhom, ∆Binhom is the magnetic field inhomogeneity across a
voxel and lambda is the gyromagnetic ratio.
Deoxyhemoglobin is paramagnetic thus perturbing the surrounding magnetic
field, while oxyhemoglobin, containing unpaired electrons, is diamagnetic with
no perturbation effects. Briefly, the magnitude of the resulting local field pertur-
bations is proportional to intravascular oxygen saturation and to the strength of
the external field:
∆Bz ∝ [dHb]xB0
After a radiofrequency excitation, the signal decay occurs faster with higher
levels of deoxyhemoglobin. As aforementioned, the level of deoxyhemoglobin is
affected by CBF, MRO2C and CBV. During brain activation, the increase in CBF
is much higher than the increase of MRO2C and the effect of CBV is relatively
small. Therefore, the result is a net decrease in the level of deoxyemoglobin, in
turn resulting in a slower rate of T2* relaxation and a higher T2*-weighted signal.
The relative signal change between the baseline and the activation condition
















·TE − 1 = e
−∆R∗2 ·TE − 1 ≈ −∆R∗2 · TE
where S0 and Sa are the signals in the baseline and activated conditions,
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respectively, R∗2,(0) and R
∗
2,(a) are the baseline and activated relaxation rates, re-
spectively, ∆R∗2 = R
∗
2,(a) − R∗2,(0) and the (linear) approximation applies because
∆R∗2 is small.
Therefore, the fractional change in T ∗2 -weighted signal is proportional to the
absolute change in T ∗2 relaxation rate. In fact, in the total transverse relaxation
rate R∗2, the intrinsic T2 relaxation is fixed and the change in R
∗
2 depends only
on the perivascular field perturbations. Relaxation due to spatial magnetic field
perturbation is, in turn, proportional to the magnitude of such perturbation ∆Bz
and to the vascular volume fraction




the relaxation rate is directly proportional to the deoxyhemoglobin concentration,
the vascular volume fraction and the magnetic field strength is given by:
R′2 ∝ [dHb]B0V
.
However, by including the diffusion effect (for which each spin samples a
wide range of fields around vessels modifying its phase history) and the effect of
intravascular spins, the model is described now by:
R′2 ∝ ([dHb]B0)βV
Assuming that the arterial oxygenation saturation is 100 % and thus that the
11
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fractional deoxygenation is equal to the oxygen extraction fraction (E):



























where m and f are the MRO2C and CBF normalized to their baseline val-
ues. Similarly, as the normalized blood volume v = Va
V0
, substituting it into the










M = k · TE · V0 · (B0[Hb]E0)β
.
The constant M: 1) sets a ceiling on BOLD effect e.g. the limiting case in
which CBF increases so much compared to MRO2C and CBV that the baseline
deoxyhemoglobin is all washed out, 2) is dependent on vessel geometry, total
baseline deoxyhemoglobin content and MR parameters (TE and B0). At 1.5 T,
M values have been found to be 0.08, thus giving a theoretic maximal BOLD
12
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effect of 8%. Lastly, the Davis model includes an empiric power law relationship
between CBF and CBV, resulting in:
∆S
S0
= M [1− fα−βmβ]
.
In conclusion, with an empirical value of M=8%, n=2-3 and an increase in
CBF of 50%, the model predicts a BOLD signal change of 0.8-1.5%.
The BOLD response after a neural impulse is dispersed over seconds and this
accounts for the poor temporal resolution of the fMRI. The function describing
it, the hemodynamic response function (HRF), presents an initial dip in the curve
which reflects an initial increase in deoxyemoglobin and has been inconsistently
observed. Then, CBF rises and so does the BOLD signal, reaching the peak in
about 5-6 seconds and then decreasing towards baseline at about 10 seconds and
lastly falling below baseline with an undershoot whose origin is uncertain. A
general linear model (GLM) is applied to the statistical analysis of fMRI data,
decomposing the signal y (vector of voxel signal measurements at the sampled
time points) into the model estimate y = βX and the residual error e, resulting
in:
y = βX + e
where y (y1...yn) are the observed time series for each voxel, X is the design
matrix, containing the exploratory variables and η are the residuals. [17]
2.2.1 Task functional MR imaging
Task-based fMRI is used to evaluate the variation in the BOLD signal during a
task condition compared to a control condition. There are two different designs
used: block design and the event-related design. In the block design activation
13
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and control conditions alternate, each lasting a time interval of about 15-30 sec-
onds, called block. During the activation block the subjects perform an action
(generally a motor or cognitive task) continuously. Advantages are the simplicity
and the power for detection of the activation response. In fact, the hemody-
namic response over each activation block is summed, resulting in a relatively
high BOLD signal-to-noise ratio.
2.2.2 Resting state functional MR imaging
Functional MR imaging at rest, in absence of external stimuli, is referred to as
resting state fMRI. At baseline, neural activity accounts already for the 20% of
body energy consumption and activation induces only a small increase in this
consumption, e.g. for stimulation of the visual cortex it is estimated between
the 5% [18] and 15% [19], depending on the task. Moreover, thalamo-cortical
synapses represent only a small fraction of all synapses, the majority consisting
of ones between non-primary areas neurons which support the activity at rest.
A correlation between time courses of low frequency fluctuations in different
brain regions was found by Biswal et al. in 1995 [20]. Since then, resting state
fMRI (rs-fMRI) has been widely used and applied to study brain activity at rest,
with a continuous development of different methods of analysis.
The advantages of rs-fMRI, in particular when applied to patients with neuro-
logical or psychiatric conditions, is its independence on the ability of the patient
to understand the instructions and perform a specific task. The most used rs-
fMRI design consists in asking the subjects to keep their eyes closed, not to think
about anything in particular and not to fall asleep.
Resting state fMRI activity can be measured, in specific areas, with the am-
plitude of low frequency fluctuations (ALFF) or with the regional homogeneity
(ReHo). Instead, the resting state functional connectivity (rs-FC) between dif-
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ferent areas of the brain can be measured using the functional connectivity den-
sity analysis, the seed-based functional connectivity, the independent component
analysis method or the graph analysis[21]. In the latter, brain connectivity is
intended as networks of brain regions connected by functional associations [22].
Consistent functional resting state networks are observed in studies on healthy
subjects [23].
Differences in rs-FC between task and rest can be subtle but still detectable.
Cole et al. showed that up to 38% of connections differ significantly between
rest and task. However, compared to rest, the task condition differs in sev-
eral ways: within-network connectivity decreases during task periods; changes
in across-network connectivity is observed during task in both an increased and
reduced direction; reorganization of the hubs during task; the contribution of
frequencies within the 0.01-0.1 Hz changes, with a more balanced contribution of
all frequencies during task; ReHo, reflecting local rs-FC, is reduced during task;
moment-to-moment fluctuations in rs-FC are more stable during task than rest;
the variability of the dynamics of inter-network connectivity increases with age
at rest while during task is higher in younger subjects; a higher global integration
state is observed during task. [24].
2.2.3 Functional MR imaging preprocessing
The fMRI preprocessing includes multiple steps which can be performed using
different software available or automated preprocessing pipelines that have been
implemented, although the use of different pipelines and the order of the prepro-
cessing steps have been showed to affect the results. Here are reported the main
steps: [25].
• Initial stabilization: when the sequence acquisition starts, the scanner takes
some seconds to completely stabilize its gradients and the tissues require
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few seconds to reach the necessary excitation. For this reason, usually the
first volumes acquired are discarded from the analysis.
• Slice timing correction: since the fMRI is a 2D sequence there is a delay
between the acquisition of the first and last slice, which depends on the
TR. The slice timing correction adjusts the time course at each voxel level,
interpolating the information in each slice to match the one of the reference
slice (usually the first or the mean one).
• Motion correction: head motion is a major issue in fMRI data and it has
been addressed with several methods. A classic one is to realign each volume
to a reference one using a rigid body transformation. It has been suggested
to discard volumes which present a motion range greater than a single
voxel dimension. Other methods to reduce motion artifacts are: expansion
to 24 or 36 motion parameters regression, independent component analysis
denoising and scrubbing, the latter based on framewise displacement.
• Spatial transformation: consists in the alignment of the functional data to
another sequence, usually to the anatomical one or to a standard space.
Linear and nonlinear transformations or surface registration techniques are
available.
• Spatial smoothing: in this step data points are averaged with the neighbors,
increasing the signal to noise ratio but reducing the actual spatial resolu-
tion. The spatial smoothing is achieved by convolving the fMRI signal to a
Gaussian function of a specific width. Typical smoothing values range from
5 to 8 mm.
• Temporal Filtering: consists in removing the effect of confounding signals
with known or expected frequencies, fMRI data are usually filtered using a
16
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high pass filter (0.008-0.01 Hz) for task fMRI and band pass filter (usually
0.01-0.08 Hz) for rs-fMRI.
2.2.4 BOLD signal variability
Brain activity has been showed to vary from moment to moment. This variabil-
ity has been detected at different level, from a single neuron level to networks
oscillations. The interpretation and biological meaning of variability in brain
function is still unknown. It has been typically regarded as noise but recently its
role in better unveiling brain functioning has emerged [26]. An hypothesis is that
brain variability could derive from coherent spontaneous oscillations throughout
the cortex [27] and therefore BOLD signal variability may reflect functional con-
nectivity between brain regions and in particular the dynamic range of FC, with
a greater dynamic range allowing a better adaptability and efficiency of neural
systems.
Temporal signal variability reflects the magnitude of moment-to-moment vari-
ability in a fMRI time series. It can be measured as variance, standard deviation
and mean square successive differences.
A higher variability of brain signals has been associated with a better be-
havioral performance, it’s low during resting state, increases during internally
focused tasks and is highest during externally focused tasks [28]. BOLD signal
variability has been shown to change across lifespan but results are divergent
with some studies finding a u-shaped lifespan developmental curve, increasing
from infancy to young adulthood and then decreasing to elderly [29] while others
differentiating the course based on the brain regions, with most of the networks
showing a decrease of variability across the lifespan [30]. Brain signal variability
has been applied to neurological and psychiatric disorders with discordant results
on schizophrenia and Alzheimer disease but more consistent results in other dis-
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eases such as traumatic brain injury and autism, pointing towards a decreased
variability in patients compared to healthy subjects.
2.2.5 Dynamic functional connectivity
Functional connectivity has been showed to vary over time, with fluctuations
occurring within time scales of seconds to months [31; 32; 33]. However, the
ones that received more attention are changes happening over seconds and there-
fore detectable within a standard rs-fMRI acquisition. Numerous approaches
have been recently proposed to better capture FC dynamic. The classic sliding
window method is based on the choice of a temporal window to segment the
timecourses and on the comparison of the FC obtained within single windows.
The sliding window approach has some of limitations, such as the appropriate
choice of the window length and the different measures to assess the FC within
the window. Moving from a sliding window analysis towards an observation of
single frames and retaining only the significant time points, e.g. over a certain
threshold, a point process analysis (PPA) [34] was developed, according to the
hypothesis that meaningful information could be retrieved from short periods
of time. Similarly, co-activation-patterns (CAP) [35] select the time points only
within the seed while maintaining the non-thresholded timecourses at the selected
timepoints for temporal clustering. A further step involved the computation of
whole-brain co-activation patterns based on transients in fMRI signal, rather
than using peaks, leading to innovation-driven co-activation-patterns (iCAPs)
[36]. The latter, compared to CAPs, indicate brain regions which simultaneously
activate or deactivate, but without information about the direction [37].
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2.3 Diffusion Tensor MR Imaging
Diffusion MR imaging of the brain has been applied since the early 1990s, with
striking consequences on the early diagnosis of stroke and, in 1994, the use of
diffusion tensor for MR imaging was proposed by Basser [38]. Diffusion ten-
sor imaging is sensitive to cellular structure, measuring the diffusion of water
molecules. Brownian motion is the constant random molecular motion due to
heat. At a fixed temperature the diffusion rate can be described by:
< r2 >= 6Dt
where < r2 > refers to the mean squared displacement of the molecules, t is the
diffusion time, and D is the diffusion coefficient, a constant of proportionality for
the particular substance being measured. Among the several methods for mod-
elling diffusion in biological systems, the simplest one would be to assume free
diffusion. However, the diffusivity measured in clinical setting depends on ex-
perimental parameters (in particular the diffusion time that for clinical diffusion-
weighted imaging is 10-50 ms) and on the sample, therefore the term apparent
diffusion coefficient (ADC) has been introduced [39]. The diffusion measured in
tissues is not the same in all directions (anisotropic) and reflects the microscopic
tissue heterogeneity [38].
A diffusion-weighted pulse sequence is built adding a pair of diffusion-sensitizing
gradients, known as motion-probing gradients, to a T2-weighted spin-echo se-
quence. The gradients are applied along the same directional axis before and
after the 180◦ refocusing pulse, a procedure known as the Stejskal-Tanner diffu-
sion encoding [40]. The MR signal (S) depends on the diffusion coefficient (D),
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repetition time (TR) and echo time (TE) according to the following equation [41]:
S = PD(1− e−TR/T1)e−TE/T2e−bD
where PD is the proton density, T1 and T2 the signal relaxation times after ex-
citation which are related to the tissue properties and b is the diffusion-weighting
parameter. The b factor depends on the strength, duration and temporal spacing
of the diffusion-sensitizing gradients, according to:
b = γ2G2δ2(∆− δ/3)
where λ is a constant (gyromagnetic ratio), G the amplitude of diffusion gradi-
ent, delta is the duration of each diffusion gradient, Delta is the interval between
the onset of the of the diffusion gradient before the refocusing pulse and that
after the refocusing pulse. Typical b values used in clinical applications range
from 600 to 1500 seconds/square millimeter. The increase in b values determines
an increase in the degree of diffusion-weighting, as well as an increase of G and








where S0 is the signal intensity in the absence of diffusion-sensitizing gradient,
derived from an image acquired at b=0 s/mm3. ADC maps can be thus derived
using a set of diffusion-weighted images acquired at high b factor and a second
set acquired at a lower b factor. Applying the two diffusion-sensitizing gradients,
S1 can be calculated by:




T2 e−b1D) = S0e
−b1D
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The first pulse causes the water molecules to resonate and when it ends the
molecules will be out of phase. The second pulse causes a phase refocusing and if,
in the meantime, the molecules have moved, the phase refocusing would fail caus-
ing a signal loss. The refocusing process is linked to the strength of the gradient
pulse and to the interval between the two pulses. Pure water at body tempera-
ture shows an isotropic diffusion and in human brain an isotropic diffusion can be
found at the CSF level. Instead white matter is characterized by tightly packed
coherently oriented fiber bundles thus hindering water displacement perpendicu-
lar to the direction of the fibers, resulting in higher ADCi values parallel to the
fibers than perpendicular to them. It’s noteworthy that diffusion measurements
detect water motion only along the applied gradient axis. Combining the gradi-
ents along the three axes ADC can be measured along any orientation. However,
measurements along the X, Y and Z axes are not enough because fiber orienta-
tion is almost always oblique to the axes, so theoretically measurements along
thousand of axes should be made. To simplify this the concept of diffusion tensor
was introduced, fitting the measurements along different axes to a 3D ellipsoid
[41]. The properties of this ellipsoid, e.g. the length of the longest, middle and
shortest axes (eigenvalues lambda 1 2 3) and their orientation (eigenvectors) can
be defined by 6 parameters. The measurements of ADC along 6 axes are enough
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to obtain the ellipsoid. In this way the degree of diffusion anisotropy can be
obtained by:
(λ1 − λ2)2 + (λ1 − λ3)2 + (λ2 − λ3)2
and if diffusion is isotropic e.g. [(λ1 = λ2 = λ3)] this measure becomes 0 while
large numbers indicate high diffusione anisotropy. One of the most used metrics














A decrease in FA value is associated with white matter disruption.
2.4 Gait and balance
Locomotion is one of the most important sensori-motor behaviors in humans.
The act of standing and walking requires coordination of the limbs and muscles,
a multi-sensory integration, and robust control mechanisms.
The start of the alternating muscle activity and the locomotor rhythm are
produced by spinal neural networks called central pattern generators (CPGs)
[42], even in absence of afferent or descending projections. However, a complex
sensori-motor dynamic interaction is needed during walking and the CPGs are
controlled by both central commands and proprioceptive feedback [43; 44]. This
dynamic sensori-motor interaction is recognized as fundamental in shaping the
CPG function, particularly in guiding post-lesional plasticity mechanisms [45].
Components of this interaction system include: 1) cutaneous inputs which have a
role in facilitating or inhibiting locomotion but, in particular, are involved in the
correct positioning of the limb during normal locomotion or after perturbations;
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2) muscle afferents to modulate the timing of the step cycle, the duration of the
subsequent phases of the cycle and the amplitude of muscle activation during
each phase; 3) joint afferents (discharge at knee level has been showed by Loeb
et al. during movement and stance [46]); 4) the mesencephalic and diencephalic
locomotor region, which are sites of sensori-motor integration, and other parts of
the brainstem including vestibular nuclei, medial longitudinal fascicle, reticular
pathways; 5) cerebral cortex and cerebellum [47].
The musculoskeletal and biochemical mechanisms involved in gait are well
studied and used in rehabilitation protocols; however the underlying neural con-
trol organization, necessary for a stable gait, in particular at the supraspinal level,
is less clear in humans. The difficulty in studying supraspinal control mechanisms
during gait relies in the assessment of the neuronal processes during movement.
Cortical activity during gait has been recorded with functional near infrared
spectroscopy (fNIRS) [48], electroencephalography (EEG)[49] and single photon
emission tomography [50], showing an increased activation in the primary sen-
sorimotor regions (M1/S1) and in the supplementary motor area (SMA), the
involvement of a fronto-posterior cortical network and of sub-cortical structures.
Further, it was demonstrated that bilateral cortical activity in M1/S1, anterior
cingulate cortex (ACC) as well as in the parietal cortex is dependent on the gait
cycle phase [51]. Studies with functional Magnetic Resonance Imaging (fMRI)
have been performed in healthy subjects during the execution of single-joint move-
ment of the lower limbs to mimic walking; they found an involvement of M1/S1,
of the secondary somatosensory cortex (S2), and SMA, cerebellum and the basal
ganglia (i.e., the putamen) [52; 53; 54; 55; 56]. A recent study with a MR com-
patible stepping robot found an activation of several cortical and sub-cortical
areas of the sensorimotor network, with higher relative activation of those areas
during active movement than during passive movement [57].
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During still standing, the position of the center of gravity (COG) or center of
mass (equal in this context) must be maintained vertically over the base of sup-
port. During quiet standing the body center of mass is approximately located at
the level of the sacral vertebrae and positioned in front of the ankles. The upright
posture is unstable due to gravity, breathing, heart rate and intrinsic noise in the
motor and sensory system. The state of someone’s balance is described in terms
of angular displacement of the center of gravity from the gravitational vertical.
The neural processes for determining the center of gravity position and for moving
it are highly integrated but a coarse separation can be made into sensory and mo-
tor processes. When the first is affected, the position of the COG relative to the
base of support is not accurately sensed. Instead, when the motor component is
affected, the automatic movements required to bring the COG to a balanced posi-
tion are not timely or effectively coordinated. In the ”sensory processes” locution
we intend, here, the combination of visual, vestibular and somatosensory (tactile,
deep pressure, position sense and kinesthetic movement sense) input components.
Thus, the integration of somatosensory inputs (providing information on the ori-
entation of the body parts relative to one another and to support surface), the
vestibular inputs (providing gravitational, linear and angular accelerations of the
head in space) and the visual inputs (providing the position and orientation of
the body in relation to surrounding space and objects) is needed to guarantee the
balance ability. Moreover, in case of conflict of sensory inputs, brain must select
the one providing the more accurate information and ignore the misleading ones
[58]. Regarding the motor process, multiple components as the myotatic strech
reflex and both the spinal cord and cortical control of the legs and trunk muscles,
muscle spindles and tendons are involved. Different biomechanical models have
been proposed to describe the complex integrated process that allows postural
control, among them the inverted pendulum model [59]. In neurological disease,
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balance disorders can derive from motor weakness, altered muscular tone, sen-
sory loss, perceptual deficits and altered spatial cognition with reference to the
postural body scheme. Focusing on the somatosensory cues contributing to bal-
ance, inputs derive from muscles, joints and skin receptors. In particular, muscle
length and velocity are encoded by primary and secondary afferents innervating
muscle spindles, the active muscle force production is recorded and provided by
the Golgi tendon organs; lastly the dynamic skin deformation and skin vibration
are encoded by fibers innervating the Meissner and Pacinian corpuscles, respec-
tively, while the skin indentation and static skin stretch information are provided
by afferents originating from Merkel and Ruffini cells, respectively. [60] Lower
limbs somatosensory information is the most sensitive, among sensory inputs, in
detecting whole body sway. [61]
2.4.1 Proprioception at the lower limbs
In 1906, the English neurophysiologist Sir Charles Sherrington coined the term
“proprioception” to give a term for the sensory information derived from receptors
embedded in joints, muscles and tendons that enable a person to know where parts
of the body are located at any time. He defined it as “the perception of joint and
body movement as well as position of the body, or body segments, in space” [62].
Proprioception is classically comprised of both static (i.e. joint position sense)
and dynamic (i.e. kinesthetic movement sense) components. Following the early
observations of Sherrington (1906), the proprioceptive feedback has been found
to derive from muscle spindles, mediating the conscious perception of movement
and limb position; moreover cutaneous and joint mechanoreceptors are also im-
portant for determining the position of distal body segments and/or signaling
extremes in range of motion.[63] For the execution of functional movements in
daily activities, exercise, and sports, central processing receives proprioceptive
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information from a variety of mechanoreceptors, which need to be integrated. To
examine proprioceptive mechanisms, three main testing techniques are reported
in the literature: threshold to detection of passive motion (TTDPM), joint po-
sition reproduction (JPR), also known as joint position matching, and active
movement extent discrimination assessment (AMEDA). [64] Differences in these
tests exist since they have been developed from different concepts, are conducted
under different testing conditions, and assess different aspects of proprioceptive
modalities.
These three techniques to assess proprioception refer to three classical meth-
ods used in psychophysical experiments: the method of adjustment, the method
of limits and the method of constant stimuli. In the method of adjustment, also
known as the method of average error, the participant is required to control the
level of the stimulus, starting with a level that is clearly less or greater than a
reference stimulus, and then to adjust the level until they feel that the level of the
stimulus is the same as the level of the reference stimulus. The difference between
the adjustable stimulus and the reference one is recorded as the participant’s er-
ror, and the average error is calculated as the measure of sensitivity. The current
JPR proprioception test protocol is one form of the method of adjustment, where
participants are usually asked to match or reproduce the previously experienced
reference joint positions, using their ipsilateral or the contralateral limb.[64]
The JPR testing method is conducted under either passive or active condi-
tions for criterion and reproduction movements. There are three types of JPR
tasks described in the assessment of proprioception: ipsilateral JPR; and two
contralateral JPR approaches. For the ipsilateral testing, a predetermined target
joint position is passively or actively presented to the participant for a few sec-
onds; then, the joint is returned to the initial start position, either passively by
the experimenter or actively by the participant. Participants are then required
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to reproduce the target joint position previously experienced by either indicating
the target position by pressing a stop-button when the joint is passively moved
into the same range, or by actively moving the joint to the target position. There-
fore, in the ipsilateral test, participants need to remember the target position and
reproduce the position using the same limb. In the contralateral tests, one pro-
cedure is identical to the method for ipsilateral testing in terms of experiencing
the target joint position, but differs in that the participant is asked to reproduce
the joint position by using the contralateral limb; in this case, participants need
to remember the target joint position and use the opposite limb to reproduce the
position. The second contralateral test differs in that once one joint is moved to
the target position, it remains in that position and the contralateral limb is re-
quired to reproduce the target joint position; this test does not require a memory
of the target position, but participants can use the information in the position
task to help them to replicate the position on the contralateral side.
The ipsilateral and contralateral tests differ since participants use also other
networks for central processing. In fact, in the ipsilateral matching tasks, where
the same arm serves to establish both the reference and matching locations, it
is inherently necessary to use memory in order to accurately match the target
position; in this situation, when the test is used in clinical practice, the error
in performing the task could reflect cognitive or memory deficits, rather than
any decrease in proprioception itself. In the contralateral matching tasks on the
other hand the reference joint angle is available throughout the task from the
opposing limb and the use of memory is not required. However, contralateral
position matching tasks are subject to other limitations: due to the involvement
of both arms in the task, it is difficult to ascertain whether the measured error
arises from the reference arm, the matching arm, or both; additionally, based
on the anatomical pathways involved in the transmission of peripheral proprio-
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ceptive input to the brain, it is almost certain that matching using the opposite
limb requires greater interhemispheric communication compared with ipsilateral
matching. Bilateral matching tasks have shown higher matching error magnitude
with respect to unilateral task both for the upper [65; 66] and lower limbs [67].
Goble et al. found that the non-dominant arm has an advantage in propriocep-
tive position matching tasks. In a study where both left-handed and right-handed
healthy subjects performed an elbow position matching task, they showed that
matching was more accurate by the non-preferred arm and that the magnitude
of arm asymmetry favoring the non-preferred arm also was relatively increased
with greater cognitive demands. Specifically, although preferred arm errors were
progressively larger when comparing the contralateral condition with the ipsilat-
eral and contralateral remembered conditions, non-preferred arm matching errors
were similar in magnitude across all tasks. In a follow-up study involving also
visual matching, it was shown that non-preferred arm position matching advan-
tages were evident only in the proprioceptive version of the matching experiment
[65; 68; 69].
There is currently evidence in the literature that enhanced non-preferred left
arm matching is linked to a right hemisphere specialization for the processing of
proprioceptive inputs.[70; 71] Besides the studies by Naito, also Ben-Shabat et
al. showed the activation of the right supramarginal gyrus during matching tasks
with both non-dominant and dominant wrist and suggested a right hemisphere
dominance for upper limb proprioception [72]. The proprioceptive asymmetry in
the upper limb is associated with differences in performance and control strategies
between the two arms [73; 74].
The different limb specialization in everyday life activities could either induce
or reinforce different brain activation patterns in the two hemispheres during both
motor and proprioceptive tasks [75; 76]. Some studies suggested that foot later-
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alization may be a better indicator than handedness to study brain lateralization
since the feet were less biased by use-dependent motor behavior than the upper
limbs [77; 78].
A clear relationship exists also between the target amplitude and the magni-
tude of matching error, with further targets inducing greater matching errors; in
fact, participants make smaller errors when matching a reference position that
is established through their own active movement, rather than the same target
position determined passively by the experimenter [79]. This effect is thought
to be the consequence of 2 movement-related features: 1) the sensitivity of mus-
cle spindles (key proprioceptors) is enhanced during active movements via the
gamma motor system 2) an “efferent copy” of the motor command used to get
to the target position may be called upon to inform subsequent matching move-
ments. Another point of concern for clinical researchers is the “tau effect.” The
tau effect manifests as a strong interdependence between time and space, such
that movements of longer duration are perceived as traveling farther than those
of shorter duration. For position matching experiments, this finding implies that,
if during the establishment of the target joint angle an experimenter takes a long
versus a short amount of time, the participants will perceive the target as being
further from the starting joint angle than it actually is [66].
Despite the impact of lower limb position sense on everyday life activities
such as posture control and gait the neural correlates of proprioception have
received little attention. To date, two studies have investigated the neural ba-
sis of lower limbs proprioception by focusing on proprioceptive-related activity
elicited by vibro-tactile stimulation; authors found cluster of neural activity, in
response to muscle-spindle stimulation, in the bilateral inferior parietal cortex,
inferior frontal gyrus, supplementary motor area, anterior insula, basal ganglia
and thalamus; right hemisphere-specific activations were seen in ventral premotor
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area, orbital frontal cortex, dorsolateral prefrontal cortex (BA 9/46), and dorsal
anterior cingulate [80; 81]. Although muscle spindle vibration could induce a
proprioceptive illusion [82], no studies focused on the cortical activation induced
by specific position sense tasks.
2.4.2 The role of the ankle
The analysis of ankle dorsiflexion has been suggested as a potentially practical
way to assess the integrated cortical, subcortical, and spinal sensori-motor net-
work involved with gains in skillful walking [83].
In fact, an appropriate control of the ankle joint is necessary for maintaining
the standing posture,[84] for the foot clearance during the swing phase and the
push-off at the terminal stance of gait.
Moreover the ankle dorsi-flexion has been used to assess the supraspinal
sensori-motor network and to evaluate the effects of rehabilitation training also
in neurological diseases, as stroke.[52] Previous fMRI studies showed that during
active (i.e., movement generated by the participant) or passive (i.e., movement
generated by an experimenter or an actuated external device) single-joint move-
ments of the ankle an activation of M1/S1, secondary somatosensory cortex (S2),
and SMA is observed. Subcortical activations were seen in the cerebellum and
the basal ganglia (i.e., the putamen). Generally, it has been found that passive
movements, when compared to active ones, elicit weaker peak activations in the
subcortico-cortical sensori-motor network and increased activation in the ACC,
in the precuneus and in the right premotor cortex [52; 55; 56; 83]. In the study
of Dobkin et al. the motor learning related to active ankle dorsi-flexion in both a
healthy subjects and a small group of stroke patients during a course of locomotor
rehabilitation was assessed. The stroke patients had fewer activated voxels in the
contralateral sensori-motor cortex for active ankle dorsi-flexion compared with
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the healthy group, potentially indicating fewer available cortical motor neurons
for the task. After 2–6 weeks of rehabilitative therapy the number of activated
voxels during active task was shown to increase within the contralateral sensori-
motor and cingulate motor cortex, with this increase being correlated with motor
performance [52]. In patients with MS recent studies found that a reduced push-
off due to insufficient ankle plantar-flexion force production strongly contributes
to gait disturbances [85; 86].
The behavioral aspects of proprioception at the level of the ankle has been
studied [87], showing that the accuracy and precision of ankle joint position sense
decrease with aging [88] and fatigue [89].
2.5 Multiple sclerosis
Multiple sclerosis (MS) is defined as a chronic immune-mediated, demyelinating
disease of the central nervous system.
2.5.1 Classification
The most common form is relapsing-remitting multiple sclerosis and affects about
85% of patients; the onset, in this case, is characterized by an acute episode of
neurological deficit (clinically isolated syndrome (CIS)) lasting at least 24 hours
and in most cases interesting the optic nerve, brainstem, spinal cord or cerebel-
lum, followed by a remission period of clinical recovery. The clinical course of
relapsing remitting (RR) MS is typically marked by recurring relapses and remis-
sions; relapses are characterized by focal inflammation and demyelination in the
CNS. Approximately 15-30% of these patients develop secondary progressive (SP)
MS, over a long-term follow-up. About 10-15% of patients with MS are diagnosed
with primary progressive (PP) disease, which is characterized by a progressive
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disability from the outset and the absence of relapses. A new phenotype descrip-
tion has been introduced, for the three forms (RR, PP and SP), which further
subdivide them according to disease activity and progression.[90]
2.5.2 Epidemiology
Multiple sclerosis is the most common demyelinating disease seen in high-income
countries, and the main cause of non-traumatic chronic disability in young adults,
with the average age at diagnosis being 30 years [91].
Prevalence and incidence. The global prevalence of MS has been esti-
mated, in 2016, as 30.1 cases per 100000 population. Age-standardised prevalence
has increased from 1990 to 2016, in particular in east Asia and Canada. The
highest estimates have been registered in high-income North America (164.6),
western Europe (127.0) and Australasia (91.1) while the lowest in eastern and
central sub-Saharan Africa (3.3 and 2.8, respectively) and Oceania (2.0). In a
recent systematic analysis, a significant association was found between prevalence
and both latitude and the socio-demographic index [92]. The constant increase
in MS prevalence [92] [93] is probably due to concomitant factors: the higher rate
in survival, the higher incidence and the improvements in the diagnosis, with an
easier access to medical facilities and the revisions of McDonald Criteria. [93]
The global median incidence of MS is 2.5 per 100000 [94], with higher rates in
Europe (3.8), Eastern Mediterranean (2), Americas (1.5), Western Pacific and
Africa. Early epidemiological studies and reviews reported a north to south and
a high- to low-income gradient in MS prevalence. However, despite the differ-
ences among continents, the traditional view of a latitudinal gradient has been
questioned, in particular in Europe and North America, where, when considering
the incidence instead of prevalence, no correlation is found with latitude.[95]
Gender ratio. At the beginning of the last century MS was considered a
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disease affecting predominantly males. However, in the last decades the gender
ratio (female:male) showed an increase in both Europe and Canada, where it
changed from 1.9 between 1936 and 1940 to 3.2 for patients born between 1976
and 1980 [96]. Gender ratio negatively correlates with latitude but increases with
incidence and time [95]. Reasons to explain the increase in gender ratio over time
could be the improvements in access to healthcare and the fact that there are
more benign cases of MS in women, which are now being identified more quickly
with the use of MR imaging and new diagnostic criteria.
Mortality. According to one published series [97], 70–88% of patients are
still alive 25 years after clinical onset, and the median time from onset to death
ranges from 24 years to over 45 years. The age-standardised mortality decreased
from 1990 to 2016 by 11.5%, at a global level [92]. Factors associated with a
better vital prognosis include a relapsing–remitting phenotype, MS clinical onset
before 25 or 30 years of age, initial symptoms such as optic neuritis and sensory
problems, a low level of disability during the first years of the disease, and a long
time lag between the first and second neurological episode [98].
2.5.3 Risk factors
Multiple sclerosis does not have a single cause, with both genetic susceptibility
and environmental exposure playing a role in the disease development.
Environmental risk factors. Multiple environmental factors have been
associated with MS. In their umbrella review, Belbasis et al. examined the
meta-analyses of observational studies, concluded that three risk factors showed
a strong, consistent evidence of an association with MS with no suggestion of
bias: immunoglobulin G (IgG) seropositivity to Epstein Barr virus (EBV) nu-
clear antigen; infectious mononucleosis; smoking. The association between the
following risk factors and MS was found to be null or to have very small effect:
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several vaccinations (tetanus, diphtheria, influenza, BCG, mumps, measles and
rubella, poliomyelitis, hepatitis B virus, and typhoid fever), biochemical factors,
presence of dental amalgam, past surgeries and traumatic events (tonsillectomy,
adenoidectomy, and traumatic injury), and presence of allergies, eczema, and
chronic cerebrospinal venous insufficiency. The authors also concluded that the
evidence for low 25 − (OH) − D levels to be a risk factor for MS is weak and
deserves further studies [99].
Environmental factors could contribute to the disease development through
different mechanisms such as molecular mimicry, generation of new autoantigens,
release of segregated CNS autoantigens in the periphery or determining a pro-
inflammatory environment. Two main mechanisms have been hypothesized to
explain the role EBV could have in determining MS: according to the first one a
reactivation of the virus within the CNS would activate B cells, while the second
one implies a general dysregulation of the immune response.[100]
Genetics. Genetic factors play a main role in causing MS, as evidenced by
the higher concordance for MS in monozygotic twin pairs (25.9%), compared to
dizygotic ones (2.3%) [101]. The association between MS and variations in the
genes encoding human leukocyte antigens (HLAs) within the major histocom-
patibility complex was first observed several decades ago. The HLA-DRB1 gene,
and in particular the HLA-DRB1*15:01 allele common in European population,
showed to have the strongest association with MS with an average odds ratio of
about 3 for this allele [102]. MS patients carrying the DRB1*15:01 haplotype are
more likely to be female and an earlier disease onset but it’s not associated to
disease severity or progression. Moreover, this haplotype is associated with pres-
ence of oligoclonal bands and IgG levels in the cerebrospinal fluid of MS patients.
Instead, alleles which have a protective effect include class I HLA-A*02:01 and
class II DRB1*14:01 [102]. More than 150 single nucleotide polymorphisms have
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been associated with MS, in genes including the ones encoding for the α-chains of
interleukin-7 and interleukin-2 receptors [100]. Probably, both central tolerance
mechanisms and changes in the threshold of peripheral immune cell activation
contribute to this genetically determined pathogenetic pathways. Recently, dif-
ferences in the expression of genes involved in inflammatory and immunological
pathways have been found between patients with mild relapsing-remitting MS
and patients with primary progressive MS, further underlining the gap between
these two clinical phenotypes of MS [103].
2.5.4 Pathogenesis
MS is considered, in the traditional way, an autoimmune inflammatory disorder
affecting the CNS. The hallmark of the disease are focal inflammatory lesions,
mostly perivenular [104], caused by the disruption of the blood-brain barrier, re-
sulting in an infiltrate of lymphocytes, microglia activation, demyelination, axonal
damage and, ultimately, alteration of the neuronal signaling.
In broad terms, MS develops in genetically susceptible subjects who occur
to be exposed to environmental risk factors, triggering an autoimmune response
against the CNS. The primum movens is still uncertain and disentangling the
role inflammatory cells have in triggering or sustaining the pathological process
is difficult. Two different models implicate that the immune response initiates in
the periphery or in the CNS itself. In the former one, autoreactive T cells are
activated in peripheral sites and then move to the CNS with activated B cells
and monocytes. On the contrary, in the “CNS-intrinsic” model, events (i.e. viral
infection or neurodegeneration) occurring within the CNS trigger the immune
response, releasing CNS antigens in the periphery which secondly attracts au-
toreactive lymphocytes. Within this “central” model frame, some authors claim
that MS is primarily a degenerative disorder and that inflammation is secondary
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to neurodegeneration [105]. Observations supporting this hypothesis are, among
others, the lack of effect of the available disease modifying drugs (DMD) on the
primary progressive clinical phenotypes of the disease and the independence of
the inflammatory relapse activity and the degeneration, as they were driven by
two different processes [106]. According to this hypothesis, PP MS would be
the primary disease and RR and SP phenotypes would represent variants with
an abnormal inflammatory response. Instead, traditionally, neurodegeneration
is considered as secondary to the both acute and chronic inflammation phase of
the disease and PP MS a clinical variant with a feebler inflammatory compo-
nent. In both cases, whether the process starts in the periphery or within the
CNS, antigens released from the CNS reach the periphery and activate a further
immune response and the invasion of CNS by lymphocytes. Microglia activa-
tion contributes to the initiation of tissue damage and to the protraction of the
disease.
Inflammation is present at all stages of MS, but it is more pronounced in
acute phases than in chronic phases. Perivenular inflammatory lesions are the
ones characterizing the disease, showing an infiltrate of macrophages and CD8+
T cells, and a lower number of CD4+ T cells, B cells and plasma cells. Oligo-
dendrocyte and demyelination occur as result of inflammation. In the progressive
phase of the disease, the immune response is more confined to the CNS and tissue
damage consist in diffuse demyelination, axonal injury, microglia activation and
cortical involvement with the formation of tertiary lymphoid structures. This
results in a more pronounced atrophy of the grey and white matter. Axonal and
neuronal loss are the main responsible of the permanent clinical disability, axonal
damage occurring both in the acute and later stages while neuronal loss is mainly




The focal lesions are characterized by primary demyelination and astrocytic scar-
ing, but also by axonal and neuronal injury and they affect not only in the
white matter but also the grey matter, deep nuclei, brainstem and spinal cord.
Remyelination to variable extent is present in focal lesions. Focal lesions can be
distinguished in classical active lesions, chronic active or slowly expanding lesions
with a low degree of demyelination and no major BBB damage and representing
about 30% of lesions in patients in the progressive phase, inactive lesions and
remyelinated shadow plaques.
Cortical lesions have been recently recognized as a major substrate of MS
pathology but, in vivo, only the 10-15% of cortical lesions can be identified by
MR imaging. Most lesions involve the cortex and the subcortical white matter
(cortico-subcortical lesions) but also intracortical and subpial lesions have been
identified. Subpial lesions are associated with meningeal inflammation and ter-
tiary lymph follicles can be observed, especially in patients with SP MS and PP
MS with rapid disease progression. Active cortical demyelination starts on surface
with an outside-in gradient and is associated with a severe axonal and neuronal
degeneration. Focal grey matter lesion and a diffuse neuronal loss interest also
the deep gray matter nuclei since the early stages of the disease and their number
and size only moderately increases over time.
Diffuse injury is found in the “normal appearing” white and grey matter, in
particular in the progressive stage of the disease. In the white matter the in-
jury consists of small perivascular inflammatory infiltrates, diffuse axonal injury,
astrocytic scaring and microglia activation. However, the extent of the cortical
demyelination is even more severe in the progressive stage, characterized by neu-





Clinical onset and symptoms from relapses broadly vary, based on the spatial
dissemination of lesions within the CNS and the degenerative process over time.
Common clinically isolated syndrome presentations include acute unilateral
optic neuritis, a partial myelitis, or a brainstem syndrome.[107] On the con-
trary, the onset of primary progressive MS by contrast is characterized by slowly
progressive symptoms, most often an asymmetric paraparesis that evolves over
months or years or, less commonly, a progressive hemiparesis or cerebellar ataxia
or very rarely, visual failure or dementia.
However, the symptomatology and the clinical course of the disease are very
heterogeneous and a univocal pathogenetic and pathophysiological corresponding
pattern to each of the clinical phenotypes is still lacking. Prognosis, in terms of
disability accumulation, depends on age at diagnosis, gender, higher disability at
baseline and brain atrophy.
2.5.7 Diagnosis
A definite diagnosis of MS is not provided by a single test, including tissue biopsy.
Therefore, the diagnosis is based over the integration of clinical, imaging and lab-
oratory features and on the demonstration of dissemination of the disease in space
(DIS) and time (DIT). The reference criteria for MS diagnosis are the McDonald
criteria which are periodically revised. The current diagnostic criteria for MS
are the revised McDonald criteria of 2017 [108]. The diagnosis of MS requires
objective evidence of CNS lesions disseminated in time and space, that there is
no better explanation for the clinical presentation and that alternative diagnoses
are considered and excluded. Using the McDonald 2017 criteria, a diagnosis of
MS can still be made on clinical grounds alone. However, MR imaging role has
become more and more important in the disease diagnosis since criteria for both
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DIS and DIT include the presence of new lesions in specific brain and spinal
cord areas and the simultaneous presence of a gadolinium enhancing and non-
enhancing lesions, respectively. Additionally, MR imaging has a complementary
main contribute in the exclusion of alternative diagnoses that can mimic MS
[108; 109; 110].
In most patients with typical clinical and MR imaging findings, examination
of cerebrospinal fluid (CSF) is not usually necessary but can provide supportive
evidence of MS and its importance has been highlighted in the last 2017 Mc-
Donald criteria, where the presence of CSF oligoclonal bands can represent DIT,
thus allowing the diagnosis if also DIS criteria is satisfied. CSF findings include a
normal or mildly raised white cell count (< 25 cells per cm3; predominantly lym-
phocytes) and protein (usually < 1 g/L), a raised IgG index, and IgG oligoclonal
bands not present in serum.
Neurophysiological testing of evoked potentials in visual, sensory, or auditory
pathways can also provide supportive evidence of MS through identification of
a clinically silent lesion in the CNS, indicating dissemination in space and the
urgency for studies validating the visual evoked potentials as a tool to fulfil DIS
has been stressed in the last revision.
2.5.8 Treatment
In the last five years, several drugs have been approved for patients with RR MS.
Their main target is the inflammatory component of the disease, with limited
effects on the neurodegenerative component and thus on the progressive forms of
MS. The disease-modifying drugs for MS (DMD) currently approved for use in
the EU for the treatment of RR MS include interferon-beta (IFN−β), glatiramer
acetate (GA), teriflunomide, dimethyl fumarate (DMF), fingolimod, natalizumab,
alemtuzumab, cladribine and ocrelizumab.
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The latter drug has been approved also for PP MS patients, showing an effect
of slowing progression. Two main strategies are used in choosing and prescribing
the more appropriate drug: an escalation and an induction strategy, the first
consisting in starting with a first-line treatment and then changing in case of no
response, the second providing an higher effective drug as first choice to obtain a
fast disease remission, mostly used in patients with a disease characterized by high
activity since the beginning. Autologous haemopoietic stem cell transplantation
has been used in patients not responding to DMD. Guidelines to help in the
choice of the most appropriate drugs have been recently published [111].
Rehabilitation has been used since the first phases of the disease. In order
to make rehabilitation protocols more efficient and tailored to the single patient,
further studies investigating the mechanisms of cortical plasticity and the way
the rehabilitative treatments modulate the neural plasticity are needed [15].
2.5.9 Structural and functional MR imaging studies in
multiple sclerosis
As previously mentioned, the hallmark of MS are focal inflammatory lesions
which, on MR imaging, appear as hyperintense lesions on T2-weighted and hy-
pointense on T1-weighted sequences, interesting mainly the periventricular, jux-
tacortical and infratentorial regions. The lesion load on T2-weighted sequences
has been found to correlate with the global clinical disability (expressed in terms
of the expanded Disability Status Scale (EDSS)). Lesions affecting the spinal cord
are detectable in 80-90% of patients with established MS and in up to 50% of
patients with CIS [112]. Despite the relationship between lesion load and global
clinical disability, still MR imaging features do not extensively explain disability
in MS, resulting in the clinico-radiological paradox of MS.
Guidelines have been released to optimize the MR imaging clinical protocol
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for MS in order to increase the diagnosis accuracy and to monitor the disease, in
terms of relapses and progression [113].
Besides a standardized protocol for brain and spinal cord MR imaging [114],
other more innovative MR imaging techniques have been applied to better char-
acterize the pathophysiological mechanisms underlying the onset and progression
of the disease. The lymphoid follicles and leptomeningeal inflammation can be
visualized in 25-50% of cases of MS, using a delayed high resolution post-contrast
T2 fluid-attenuated-inversion-recovery sequence (FLAIR) sequence and in 90% of
patients, at ultra-high field MR imaging, using a postgadolinium magnetization
prepared FLAIR.
The demyelination, occurring non only at the level of the focal lesion, but
diffusively in the white matter and affecting also the grey matter and the deep
grey matter nuclei, can be detected using the magnetization transfer ratio (MTR)
maps, although they reflect also the inflammation, edema and axonal loss. To-
gether with MTR, the myelin water fraction and the computation of MR imaging
ration maps of T1 and T2 weighted images, have been showed to reflect myelin
content and thus could be valuable markers of demyelination.
The concentration of N-acetyl-aspartate, obtained using spectroscopy MR,
and the total sodium concentration, by means of sodium MR imaging (or 23Na-
MR imaging) have been used to detect neurodegeneration, in terms of neuro-
axonal loss and cellular metabolic dysfunction/irreversible damage, respectively.
An indirect indicator of neurodegeneration is the tissue atrophy, which has emerged
as a mechanism taking place since the early stages of the disease and interesting
also the deep grey mater nuclei that, in particular, correlates with disability [115].
Brain and spinal cord atrophy can be measured using 3D T1-weighted images.
However, the estimation of brain tissue loss is affected by concurrent pathophys-
iological states such as hydration, inflammation and the concurrent therapies, by
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technical factors such as MR imaging contrast quality, signal-to-noise ratio, field
inhomogeneity and by the reliability of the post-processing algorithms used [116].
Resting state fMRI has been widely applied to MS patients. A comprehensive
review of fMRI studies in MS is beyond the aim of this thesis. However, I’ll try to
summarize the major findings in this field, examining the multiple studies based
on the stage of the disease they have been applied to.
Studies on functional connectivity in patients at the early stages of the dis-
ease, in particular patients with CIS, showed an increased synchronization (using
a variance-normalized time-series) in CIS patients compared to healthy subjects
(HS) in the executive function network, the attention network, and the sensori-
motor network and also in CIS patients compared to RR MS in attention, default
mode and frontoparietal networks [117]. In a more recent studies on CIS, using
graph properties, no differences were observed in the functional network metrics
between CIS patients and HS, while, at 1 year follow-up, the betweennes centrality
was significantly increased in CIS patients but no region survived after multiple
comparison correction for nodal-level comparison. Since authors found differ-
ences in structural network properties at the baseline and a structural-functional
decoupling they suggested that structural abnormalities precede functional reor-
ganization [118]. In another study on both CIS and MS patients, Liu et al., after
detecting the modules of functional connectome, found no differences between
HS and CIS but a decreased inter-module efficiency between sensori-motor and
frontoparietal network and between visual and frontoparietal netweork in RR MS
patients compared to both HS and CIS [119]. Instead, examining the structural
connectivity of the same networks, changes in structural inter-module efficiency
was detected already in CIS patients. Similarly, Shu et al found alterations in
structural connectome but not in functional connectome in CIS patients, func-
tional changes becoming evident only in the definite stage of the disease [120; 121].
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Further evidence of the interdependence between structural damage and func-
tional connectivity derives also from a study by Patel et al. where, using a com-
putational model, they demonstrated that structural disconnection contributes
to the observed increase in functional connectivity. Authors also commented how
the results from previous studies, indicating an early increase in FC, followed by
a pseudonormalization and an eventual reduction in later stages, could be ex-
plained by the accumulation of subcortical pathology [122]. In another modeling
study authors simulated both grey and white matter damage and for each simu-
lation quantified functional connectivity. They found that cortical and thalamic
damage induced an increase in FC, while the white matter damage resulted in
an early increase and subsequent decrease in FC and that both white and grey
matter damage resulted in a reduced network integration [123].
A recent study on a large sample of patients including RR and SP MS, re-
vealed that disability had a direct linear relation with frontal FC but a non linear
one with cerebello-temporal and cerebello-frontal FC. Moreover, applying math-
ematical modeling to find the best describing EDSS vs functional or structural
measures they found that, in cortical regions, FC increased together with struc-
tural model for EDSS scores < 3 and decreased for higher values of the disability
scale, suggesting an exhaustion of compensatory mechanisms at more advanced
disability stages [124]. Lastly, Pinter and co-authors, on a large sample including
CIS, RR MS and SP MS patients, found out that the connectivity in the central
area of the sensori-motor network was related to focal damage but not to global
atrophy [125]. Studies on RR MS, besides the results above mentioned, are the
majority, the RR MS phenotype being the most represented among MS forms.
However, studies on rs-fMRI, in particular the early ones, gave discordant results,
some finding and increase FC compared to HS, while others finding a reduced
FC. Although RR MS is the most frequent form, it is also very heterogeneous,
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with patients varying in severity of clinical disability and severity of traditional
imaging features such as lesion load and atrophy. Therefore, this could at least
partially account for the incongruous results when exploring rs-fMRI. Hawellek
et al., including CIS and RR MS patients, found an increased functional con-
nectivity in patients compared to control despite a disruption in white matter
integrity [126]. An increase in FC in RR MS patients was also observed by Faivre
et al. in most of the functional networks found by means of independent com-
ponent analysis, negatively correlated with clinical disability [127]. Furthermore,
the analysis of functional activity, by means of exploring the differences in the
ALFF between RR MS and HS patients showed an increase of ALFF in bilateral
thalami, right insula and right superior temporal gyrus, the latter two correlating
with EDSS [128].On the contrary, Rocca et al., in RR MS patients, found both an
increase and a decrease in FC, depending on the network regions examined, with
salience, executive control, working memory, sensori-motor, and DMN showing
a reduced FC correlating with disability and lesion load on T2-weighted images
and an increase of FC in other regions of executive control and auditory networks
[129]. Focusing on specific networks such as the sensori-motor and the default
mode network (DMN) an increase in FC was found in patients, including RR and
SP MS, compared to HS and in RR MS compared to SP MS in the sensori-motor
network while the opposite, SP MS greater than RR MS, was observed for DMN
regions [130]. Lastly, DMN has been showed to have a reduced intrinsic FC in pa-
tients compared to HS, with the reduction in the PCC being worse in cognitively
impaired patients [131].
Even results of fMRI studies using graph properties showed different re-
sults in MS patients. Available studies included both RR and SP MS patients.
Schoonheim et al did not find any differences in clustering coefficient values be-
tween patients and controls, the only difference being in the network efficiency
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when the analysis was restricted to male patients and controls [132]. In a subse-
quent study the eigenvector centrality mapping values were increased in patients
in the thalami and PCC and decreased in the sensori-motor and ventral stream
areas [133]. Instead, Rocca et al. found reduced global graph properties values,
in particular degree, global efficiency and hierarchy and a higher path length and
assortativity in MS patients compared to HS and an altered distribution of hubs
between the two groups and between different MS phenotypes (RR and SP MS)
[134]. In a 1-year longitudinal study, an increase in local graph properties, such as
modularity, clustering coefficient, local efficiency and transitivity, was observed
in patients with RR MS but not in HS and beyond detectable atrophy [135].
The same authors, in another study, suggested that the increase in modularity
in patients, indicating an increase in local connectivity and a reduced strength of
long range connections and suggested that concomitant beneficial and detrimental
changes in FC occurs in close proximity in MS [136].
The relationship between functional connectivity and cognitive status has
been considerably explored in patients with MS. A study exploring functional
networks related to cognitive function revealed a decrease in functional connec-
tivity in RR MS patients compared to HS [137]. Similarly, on a larger sample
of MS patients, a reduced functional connectivity was found in the default mode
network, fronto-parietal and salience network in cognitive impaired patients com-
pared to both cognitively reserved patients and HS [138]. Using, as a measure of
preservation of functional connectivity, the z-scored connectivity matrices (based
on a sample of age and sex matched HS) Fuchs et al., found that a preserved
functional connectivity reduced the impact of white matter damage on cognitive
performance [139]. Longitudinal changes in FC within cognitive related networks
were also showed to predict cognitive performance after cognitive rehabilitation.
Studies on rs-FC in patients at the progressive stages of the disease are more lim-
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ited. In a early study Rocca et al., focusing on the relation between functional
activity in the DMN and cognitive status, found a reduced activity in both PP and
SP MS patients compared to HS, but the reduction concerned different cortical
areas (pre-central gyrus and medial prefrontal cortex for PP and SP MS, respec-
tively); moreover, the activity in the anterior cingulate cortex was increased in SP
MS compared to PP MS but reduced in cognitively impaired patients compared
to cognitively preserved. Functional activity in the medial prefrontal cortex cor-
related also with cognitive test scores [140] A study using BOLD signal variability
and functional connectivity measures in cognitively impaired and cognitively pre-
served patients with PP MS found an increased variability in patients, compared
to HS and in cognitively impaired vs cognitively preserved patients; in the same
study variability correlated with cortical lesion load at the level of the cingulate
and superior frontal gyrus [141]. Altogether, these studies point out the following
hypothesis: white matter damage drives changes in functional connectivity in the
early stages of the disease and these functional changes are compensatory and
occur until a threshold of damage, thereafter getting insufficient or maladaptive.
Task fMRI in patients with MS has been used to explore mainly the functional
neural correlates underlying cognitive or motor impairment. In a cross-sectional
study on patients at different stages of the disease, Rocca and co-authors found a
progressively altered functional recruitment, with patients at the late stage of the
disease presenting larger and bilateral activation [142]. In another study includ-
ing CIS, RR MS and SP MS, using a Go/No-go discrimination task, Loitfelder
and colleagues found that the task-related activation pattern changed more in the
late stages of the disease, e.g. in SP MS. In particular, they did not observe any
significant differences between CIS and HS, but both RR MS and SP MS patients
showed an increase activation in several cortical areas, compared to CIS. These
results were interpreted as an adaptive functional reorganization to, at least par-
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tially, compensate and guarantee a normal clinical performance [143]. Task fMRI
has also been applied to evaluate the occurrence of brain plasticity after motor or
cognitive rehabilitation in patients wit MS. A first study by Rasova and colleagues
using a thumb and index flexion task before and after a motor rehabilitation pro-
gram found no differences between patients and HS and no relationship between
changes in motor performance and functional activation [144]. On the contrary,
Tomassini et al. found a reduction in task-related activation at the level of occip-
ital and parietal cortices in patients after long term training of a visuomotor task
while in HS the reduction was observed only a the level of the occipital cortex
[145]. Plasticity after cognitive rehabilitation has been investigated even more
widely. Altogether, results point towards an increase in functional connectivity,
explored with task fMRI, after cognitive rehabilitation, in regions including the
cingulate cortex, frontal and parietal areas and cerebellum [146].
Dynamic FC approach has been recently used to investigate functional reorga-
nization occurring in patients with MS, in particular in relation to their cognitive
status. In a study including 29 patients with MS and 18 age- and gender-matched
HS performing both rs-fMRI and cognitive task fMRI authors did not find any
differences between the two groups but, in MS group, the variance in the cognitive
performance was predicted by the cortical volume and by the difference between
dynamic FC of the DMN during rest and during task, the latter accounting for
an increase of the 26% of the explained variance [147]. In a cross-sectional study,
cognitively impaired RR MS patients, compared to cognitively preserved patients
showed slower inter-network connectivity and authors suggested this could con-
tribute to cognitive dysfunction [148]. In a longitudinal study, CIS patients
showed an increase in dynamic functional network connectivity, which became
significant after 2-years of follow-up, interesting mainly the DMN [149]. Lastly,
in a study involving rehabilitation using action observation training (AOT) pa-
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tients presented with reduced dynamic rs-FC at baseline, compared to HS, but an
increase in dynamic FC after training involved the sensori-motor and cognitive
networks in patients and not in HS [150].
2.5.10 Gait and balance in multiple sclerosis
Dysfunction of gait is present in MS since the early stages, also in patients with
minimal disability. The ability to walk is a feature which mainly contribute to
assigning a disability score,according to the most used scale (EDSS), in particular
in the more advanced stages [151]. Patients with MS walk more slowly, with a
shorter step and stride length, reduced cadence, increased double support time
and increased swing phase time, compared to healthy subjects [152]. Lastly,
patients with MS walk more slowly and present more timing variability also when
walking while performing a cognitive task, compared to healthy controls [153].
The disturbances of gait in MS can result can rely on the damage in one of the
CNS areas involved in sensory, motor, coordination functions and it is probably
a main contributor to the risk of falls. However, evidence suggests that gait
impairment are most likely the result of sensory and particularly proprioceptive
impairments and/or central processing deficits rather than deficits in strength,
vision, or other neurologic functions affected by MS.[154; 155; 156].
Ankle motion is affected since the earliest stages of the disease although often
underestimated due to the limited sensitivity and reproducibility of the conven-
tional clinical measures. Moreover Benedetti et al. found an enhanced degree of
EMG coactivation resulting from premature recruitment and/or late relaxation
of ankle antagonist muscles, and supposed that stiffening of the ankle joints may
serve as a nonspecific superimposed protective mechanisms acting whenever the
perceived reliability of balance control is lowered [157].
Balance deficits occur in 50-80% of patients with MS, being present through-
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out the course of the disease but detected since the early stages even in patients
with minimal or no disability detected with clinical scales [158]. As a preserved
balance is the result of the integration of several brain functions such as coordina-
tion, vestibular function, proprioception, sight, cognition and muscular strength,
there is no a single brain structure responsible of balance dysfunction in patients
with MS. In fact, as the whole neuraxis can be affected by focal lesions or dif-
fuse damage in MS, all the different areas concurring to preserve balance can be
damaged as well as the integration between them. Although balance has been
extensively studied in patients with MS it is still not known which component,
among the cerebellar, vestibular, proprioceptive and visual, plays a main role or
how their interaction is affected [151].
Balance dysfunction can result in a decreased ability to mantain position, a
limited and slowed movement towards limits of stability and a delayed response to
postural displacement and perturbations. The first has been studied by means of
dynamic posturography or more simply during standing still with several studies
showing that patients with MS sway more compared to healthy controls and
maintain standing for less time with a reduced base of support [159; 160]. Patients
with MS also move less far and less quickly when trying to reach or step from
a standing position, they have a worse trunk control [161] and delayed postural
responses when the support surface moves. While the latter deficit has been
correlated with delays in spinal somatosensory conduction, cerebellar dysfunction
seems to have a minor contribution to the delays in postural responses in patients
with MS [151].
Taken together, these observations suggest that the sensori-motor impairment
at the level of the ankle may be a primary factor that determines mobility and
balance impairments in people with MS. Previous fMRI studies during the exe-
cution of active and passive ankle movements [56; 162] have shown greater fMRI
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activation in MS patients than controls in the superior temporal gyrus, rolandic
operculum, and putamen. However, no studies focused on the neural correlates
of proprioception in patients with MS.
Once again, rehabilitation and exercise are of utmost importance in improving
both gait and balance and reducing the risk of falls, in particular in the progres-
sive stage of the disease. Identifying the role proprioception has in the gait and
balance impairment would help in the selection of the most appropriate rehabil-
itation strategy. In line with these observation, rehabilitation strategy aimed at
improving the central integration of the sensory inputs resulted in greater im-
provement in balance and risk of falls, compared to a standard rehabilitation
protocol [163].
2.6 Parkinson’s disease
Parkinson’s disease (PD) is a neurodegenerative disease of the nervous system
characterized by the loss of dopaminergic neurons I the pars compacta of the
substantia nigra. The classical clinical features are represented by bradykinesia,
tremor, rigidity and postural and gait impairment [164]. Among gait disorders,
the freezing of gait has a high disabling impact, affecting the quality of life and
increasing the risk of falls [165].
2.6.1 Epidemiology
Parkinson’s disease is the second most frequent neurodegenerative disease diag-
nosed. Annual incidence in the high-income countries is about 14 per 100000,
increasing to 160 per 100000 if the population aged 65 years or over is considered
[166]. The lifetime risk is slightly higher for men (2% than for women (1.3%) in
individuals aged 40 years. From 1999 to 2009 a decrease in the incidence of PD
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disease diagnosis was reported, interpreted as an improved diagnosis of different
parkinsonian syndromes [167]. After 50 years the incidence increase rapidly until
a peak at around 80 years. In elderly the incidence decrease is probably due to
an increasing prevalence of dementia which is an exclusion diagnostic criteria for
PD. The male:female ratio is reported to vary from 1.3 to 2.[168]
2.6.2 Risk Factors
Both genetic and environmental factor contribute to PD pathogenesis. Mono-
genic forms of the disease result in both autosomal dominant (genes involved:
SNCA, LRRK2, VPS35, EIF4G1, DNAJC13,CHCHD2) and autosomal recessive
types (genes involved: Parkin, PINK1, DJ-1) [164]. Moreover, subjects with a
family history of PD or tremor present an increased risk and, so far, a muta-
tion in the β-glucocerebrosidase is the greatest genetic risk factor for develop-
ing the disease and recently 24 genetic loci have been associated with disease
risk [169]. Environmental risk factors include the consumption of dairy prod-
ucts, the exposure to pesticides (in particular the 1,1’-dimethyl-4,4’-bipyridinium
dichloride),metamphetamine, previous traumatic brain injuries. on the contrary,
smoking, the consumption of coffee and physical activity have been indicated as
protective factors. [168]
2.6.3 Pathology and pathogenesis
The main neuropathological features of PD are the loss of dopaminergic neurons
in the pars compacta of the substantia nigra and the presence of Lewy bodies
(abnormal aggregates of α-synuclein) in the surviving nigral neurons. Lewy bod-
ies have been showed to spread from enteric and autonomous nervous system
to brainstem and to higher part of the neuraxis [170]. Nonetheless the clinical
features seem to be more correlated to neuronal loss than to the extent of Lewy
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bodies pathology. The presence of the Lewy bodies in the neocortex has been
associated with midiline motor symptoms (postural instability and difficulty of
gait) and with more severe bradykinesia [171]. Lastly, also the severity of freezing
of gait (FOG) was related to the density of Lewy bodies containing neurons in
the cortex [172].
Other pathological features include neuroinflammation, the neuronal loss in
many other brain regions (locus ceruleus, nucleus basalis of Meynert, pedunculo-
pontine nucleus, raphe nucleus, dorsal motor nucleus od the vagus, amygdala ans
hypothalamus) and the presence of other protein aggregates such as β-amyloid
plaques and tau neurofibrillary tangles. With the discovery of monogenic forms
of PD, the clinical features of PD have been found to occur also in absebce of
Lewy pathology [164; 173].
Several pathogenetic mechanisms have been proposed, from the toxicity of
protein aggregates, mitochondrial dysfunction, synaptic dysfunction, neuroin-
flammation and prion-like transmission of α-synuclein.
2.6.4 Clinical features
Parkinson’s disease is characterized by motor symptoms including bradykinesia,
muscular rigidity, rest tremor, postural and gait impairment. Empirical clinical
observations suggest two major forms, a tremor-dominant and a non-tremor-
dominant. The former is usually associated with a slower rate of progression and
less functional disability [164]. Other non-motor features include olfactory dys-
function, cognitive impairment, psychiatric symptoms, sleep disorders, autonomic
dysfunction, late dementia. In particular, some of them are characteristic of the
prodromal phase of the disease characterized by impaired olfaction, constipation,
depression, excessive daytime sleepiness and rapid eye movement sleep behavior
disorder. Falls, impaired gait and postural instability are frequent in patients with
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PD. Freezing of gait is present in up to 80% of patients with PD after about 17
years of the disease [174] and this condition has been associated with extranigral
pathology, including cortical cholinergic denervation and beta-amyloid deposition
2.6.5 Diagnosis
The diagnosis is based on the clinical motor features after the exclusion of red
flags who would suggest a different cause of parkinsonism [175]. although the
gold standard is the neruopathological assessement there re no generally accepted
standard pathological diagnostic criteria [176]. Genetic testing is recommended in
monogenic forms but most of them do not show a complete penetrance making a
definite diagnosis in asymptomatic subjects not possible[164]. Positron emission
topography and single photon emission tomography can help in the differential
diagnosis with other causes of parkinsonism.
2.6.6 Treatment
The symptoms of the disease are treated with drugs that increase intracere-
bral dopamine concentrations or stimulating dopamine receptors and include lev-
odopa, dopamine agonists, monoamine oxidase type B inhibitors, catecholOmethyl-
transferase inhibitors and amantadine. A surgical treatment, with deep brain
stimulation, is considered when the motor fluctuations and dyskinesia become
disabling [164].
However disease modifying drugs are not available yet and the physical activity
and rehabilitation, aimed in particular at reducing the risk of fall and improving
balance and gait, play a major therapeutic role [173; 177].
53
2. BACKGROUND
2.6.7 Action observation in Parkinson’s disease
Motor imagery and Action observation (AO) has been proposed as a rehabilitation
strategy to improve freezing of gait in patients with PD. These two approaches
rely on different, although partially overlapping, neural substrates [178]. While
Motor Imagery ability has been showed to be substantially preserved in patients
with Parkinson’s disease, this is not the case for AO. AO training is based on
the finding that during the observation of an action a similar pattern of brain
activity is observed as during the actual execution of the same action. The
neurophysiological basis of AO relies in the mirror neuron system which is defined
as the brain areas containing mirror neurons, e.g. neurons that discharge during
both the execution of a goal-directed action and the observation of other subjects
performing the same action [179; 180].
A previous study on PD patients with FOG showed that after physical AO
training patients significantly reduced the number of episodes of FOG and an
overall improvement in motor performance and quality of life when compared to
a control group without AO training [181]. Nonetheless, the integrity of the MNS
in patients with PD is still a matter of discussion, and the neural correlates of AO
in these patients have not been investigated yet. Moreover, the neural correlates
of gait and of AO could be of aid in the choice of a specific or even personalized
rehabilitation protocols [182]).
2.6.8 Functional MR imaging studies in Parkinson’s dis-
ease
MR imaging had a secondary role in the diagnosis and prognosis of Parkinson’s
disease but with the advent of sequences that better capture the functional and
structural brain organization more and more studies are emerging. Altered func-
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tioning in the cortico-striatal network and a reduced functional connectivity be-
tween the striatum and other brain regions such as thalamus, midbrain pons and
cerebellum have been found [183; 184]. Reduced cortico-subcortical sensori-motor
connectivity and dysfunction of the cognitive networks have also been observed
[185; 186] as well as a disruption in the functional networks with altered global
graph metrics correlating with cognitive symptoms and local ones with motor
features [187]. A recent study using dynamic functional connectivity revealed an
abnormal global integration and a reduction in the functional segregation among
networks, which was correlated with the clinical severity [188].
Patients with FOG presented a reduced functional connectivity between the
basal ganglia network and the cognitive control network during a virtual reality
gait task and this reduction was associated to the frequency of freezing behaviors
[189].
Gait and gait alterations have been studied in patients with Parkinson’s dis-
ease by means of single photon emission tomography with results showing a re-
duction of brain activity in the medial frontal motor area [190] and of positron
emission tomography. The latter study in particular revealed that, during a gait
mental imagery task, premotor-parietal and brainstem area where activated in
patients in the off(-medication) phase, while a brain activity pattern more similar
to the healthy controls’ one was observed in the on(-medication) phase [191].
A task fMRI study using motor imagery of gait in patients with and without
freezing of gait showed that patients with FOG had an increased activity at the
level of mesencephalic regions but decreased at the level of fronto-parietal regions,
compared to FOG- patients. [192]. Altogether these studies point out towards a
compensatory functional activation of brainstem regions and an altered brain re-
sponse at the level of the fronto-parietal areas in patients either in off-medication





BOLD signal variability in early
multiple sclerosis
Summary
Here are presented the rationale and methods of the study of BOLD signal vari-
ability in patients with Multiple Sclerosis at the early stage of the disease, the
results and their interpretation.
3.1 Introduction
Resting state fMRI (rs-fMRI) analysis has been classically based on the study
of temporal coherence of the blood oxygenation level dependent (BOLD) signal
between different areas of the brain, resulting in measures of resting state func-
tional connectivity (rs-FC) [20]. It is now widely accepted that a disruption of
resting state functional networks and a subsequent functional reorganization oc-
cur in patients with multiple sclerosis (MS) as a consequence, albeit in part, of
structural damage [193]. However, the clinical impact and the precise role of the
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rs-fMRI connectivity changes remain a matter of debate [194].
Variability of the BOLD signal is emerging as an index of the complexity and
efficiency of neuronal networks [27]. This measure can be quantified in different
ways such as multiscale entropy or as the amplitude of low frequency fluctua-
tions (ALFF). In this work it will be defined as the standard deviation (SD) of
the temporal fluctuation of the BOLD signal [26]. Initially discarded as “noise”,
temporal variability has recently received greater attention and has been showed
to characterize both physiological and pathological conditions, such as systemic
inflammation, bipolar disorder and progressive multiple sclerosis [141; 195]. In
particular, low-frequency oscillations have been shown to be consistent within cor-
tical regions [196]; moreover, fluctuations within sub-bands of the low-frequency
spectrum of 0.01-0.1 Hz, i.e. Slow-4 (0.027-0.073 Hz) and Slow-5 (0.01-0.027 Hz),
have also been shown to be more restricted to the gray matter (GM) compared
to the white matter (WM)[197; 198]. Lastly, the amplitude of low-frequency
fluctuations correlated with cognitive symptoms in previous rs-fMRI studies on
patients with neurological diseases [199].
Neuronal variability has been investigated in patients with progressive MS,
showing increased values within areas of the attention and executive control net-
work especially in cognitive impaired patients [141]. Nonetheless, it is still un-
known whether variability is altered in patients at the very early stages of the
disease. The MS onset is, in most cases, characterized by a neurological event,
referred as clinically isolated syndrome (CIS). In up to 82% of cases, patients
with a CIS develop a clinically defined relapsing-remitting MS (RR-MS) [200].
While no previous studies have explored the change in neuronal variability in
these two populations of patients, studies on rs-FC alterations in patients with
CIS or RR-MS have reported different results, controversial in terms of both the
comparison between patients and healthy subjects (HS) and between CIS and
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RR-MS [117; 128].
Therefore, the aims of our study were: a) to investigate the presence and
extent of neuronal variability changes as function of disease severity in patients
with CIS and RR-MS; b) to assess the relationship between variability changes
and rs-FC; c) to explore the clinical relevance of variability changes.
3.2 Materials and methods
Participants. Thirty-seven outpatients (17 with CIS and 20 RR-MS) were con-
secutively recruited. Twenty-seven HS with no history of neurological or psy-
chiatric disorders were included as control group. CIS patients were defined as
subjects presenting with a first neurological event, suggestive of a demyelinating
disease. The diagnosis was made upon clinical examination, and supported by
radiological and cerebrospinal fluid (CSF) findings, according to McDonald’s cri-
teria 2010 [201]. Patients were excluded if they presented pregnancy, an active
major organ disease or any other neurological or psychiatric disorder. RR-MS
patients had to be free from clinical relapses in the three months preceding the
scan.
On the same day, all subjects underwent MRI and symbol-digit-modality test
(SDMT) while CIS and RR-MS patients additionally underwent a neurological
assessment, including Expanded Disability Status Scale (EDSS).
The study conforms to the standard of the declaration of Helsinki and was
approved by the institutional ethical committee. All subjects provided written
informed consent prior to participation into the study.
MRI acquisition. All subjects underwent MRI at 1.5T (SignaHDxt scan-
ner, GE MEDICAL Systems), using a 8-channel brain array coil. The protocol
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included the following sequences: 1) axial PD-T2-weighted (TR/TE1/TE2 =
2340/102/38.25 ms; FA = 90◦; voxelsize = 0.94x0.94x4 mm3); 2) sagittal
3D-T1-weighted fast-spoiled-gradient-echo (TR/TE/TI = 11.56/5.048/500 ms;
FA = 8◦, voxelsize = 1x1x1 mm3); 3) gradient-echo Echo Planar Imaging (EPI)
sensitive to BOLD signal with 150 volumes for resting-state fMRI (TR/TE =
3000/60 ms; FA = 90◦, voxelsize = 3.3x3.3x3.3 mm3). During rs-fMRI, partici-
pants were explicitly instructed to keep their eyes closed and to relax.
Structural MRI analysis. WM T2 and T1 lesion volumes (LV) were mea-
sured on the PD-T2-weighted and the 3D-T1-weighted images respectively, us-
ing a semi-automated technique (Jim version 7; Xinapse Systems, http://www.
xinapse.com). A lesion mask obtained on the 3D-T1-weighted images was ob-
tained for each patient and used to fill-in the T1-hypointense lesions [202].
Statistical analysis of demographic, clinical and structural MRI
data. Chi-square test was used to assess significant differences in terms of gen-
der among the three groups. The normality of distributions and homogeneity of
variances for age, disease duration, SDMT, T2LV and T1LV were checked with
Shapiro-Wilk test and Levene’s Test, respectively. Since the two conditions were
not satisfied, Mann-Whitney U test and Kruskal-Wallis 1-way analysis of variance
(ANOVA) were used to compare the above-mentioned variables between RR-MS
and CIS or among RR-MS, CIS and HS, respectively.
Resting state fMRI preprocessing. All pre-processing steps were imple-
mented in Analysis of Functional NeuroImages (AFNI version 17.0.13) (http:
//afni.nimh.nih.gov/afni) if not otherwise specified. The first 3 volumes of
each time-series were discarded. Subsequently, the remaining volumes underwent
despiking and slice-timing correction. Head motion estimation along six dimen-
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sions (three rotational axes and three translational axes) was then performed. All
subjects showed head motion < 2mm (translation) and < 2◦ (rotation) (mean
values and range of the six motion parameters per each group are reported in
Table 3.1). T1 images were registered to the standard space (Talairach, using the
TT N27 space, i.e. the “talairached” version of the Colin N27 atlas). rs-fMRI
data were thus normalized to standard space and spatially smoothed (6mm). The
filled T1-weighted images were segmented using FAST (FSL version 5.0.9) and
WM and CSF masks, thresholded at 0.99 and binarized (using Fslutils, part of
FSL), were registered to the standard space; subsequently, the nuisance signal
from the WM and CSF was obtained. Linear interpolation was used for all the
transformations to the standard space, performed in AFNI. The estimated 6 head
motion parameters and the mean time series from CSF and WM were used as
covariates in the correlation computation. Data were subsequently filtered be-
tween 0.01 and 0.1 Hz, obtaining the standard frequency band (SFB). Moreover,
we analyzed two separate bands within the standard range: Slow-4 (0.027-0.073
Hz) and Slow-5 (0.01-0.027 Hz).
Variability analysis. Variability of the BOLD signal was measured by calcu-
lating the SD of the time-series amplitude, in each frequency band (SFB, Slow-4
and Slow-5). However, as the fractional amplitude of the fluctuations of BOLD
signal at low frequencies (fALFF) has been found to be more robust, with a
higher sensitivity and specificity for the neuronal signal compared to the ALFF
[203], also fractional SD (fSD), a normalized index of SD, is more specific and
reliable to variations of the neuronal activity. Therefore, fSD was obtained as
the ratio of SD for each frequency band and SD in the entire range (0-0.167 Hz),
for the SFB and for both the Slow-4 and Slow-5 bands [195]. Whole-brain vari-
ability was obtained extracting the fSD values using a GM mask. The GM mask
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RR-MS (N=20) CIS (N=17) HS (N=27)
Roll 0.0421 0.0374 0.0055
(-0.539; 1.5571) (-0.298; 0.5564) (-0.851; 0.513)
Pitch -0.006 0.0318 -0.056
(-0.801; 1.0829) (-0.909; 1.0793) (-0.728; 0.6589)
Yaw -0.019 0.0063 0.0123
(-0.644; 0.3828) (-0.244; 0.2005) (-0.398; 0.4599)
DispSup 0.0597 0.0719 0.1273
(-0.844; 1.0892) (-0.352; 0.7036) (-0.856; 1.2101)
DispLeft 0.0203 0.0204 -0.013
(-0.302; 0.9746) (-0.196; 0.626) (-0.758; 0.3371)
DispPost -0.006 -0.012 0.0006
(-0.237; 0.2913) (-0.231; 0.1305) (-0.194; 0.2195)
Table 3.1: Mean and range of the 6 motion parameters per each group.
Roll, pitch and yaw are expressed in degrees CCW. DispSup, DispLeft and Disp-
Post are expressed in mm. The average value and the range of values are reported
for each group.
DispSup= displacement in the superior direction
DispLeft= displacement in the left direction
DispPost= displacement in the posterior direction
was obtained by averaging the partial volume estimates of GM (output of FAST,
part of FSL) for each subject and then thresholded at 0.2. To test differences in
variability at a whole-brain level, voxel-wise statistics were performed in AFNI,
using ANOVA (among RR-MS, CIS and HS) in SFB, Slow-4 and Slow-5, with
age, gender and the estimated head motion parameters as covariates. The results
were thresholded at a corrected p-value=0.05 an alpha=0.05 using a Montecarlo
simulation via 3dClustSim in AFNI, with the autocorrelation function. Whole-
brain variability analysis revealed significant differences between HS and CIS at
the level of left intraparietal sulcus within Slow-5 and between HS and RR-MS
patients at the level of the posterior cingulate cortex (PCC) within Slow-5 (see
Results and Fig.1).
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Post hoc analysis
Based on whole-brain variability results we chose to:
1. perform subsequent analyses focusing on the default mode network (DMN)
and the dorsal attentional network (DAN) within Slow-5 and SFB. These
two networks were chosed because intraparietal sulcus and PCC are part
of the DAN and DMN, respectively. Moreover, since the differences were
found only within Slow-5, analysis within Slow-4 was discarded, while the
analysis within SFB was kept in order to compare results with previous
findings in literature.
2. validate the results of the variability analysis at a whole-brain level, per-
forming the analysis at a network level. Therefore, using AFNI, the fSD
values in Slow-5 and SFB were extracted from the nodes of DMN (as de-
fined by [204] e.g. including the PCC, precuneus, ventral anterior cingulate
cortex (vACC), medial prefrontal cortex (MPFC), right and left inferior
parietal lobule (r-IPL and l-IPL, respectively), left middle frontal gyrus
(l-MFG) and left and right middle temporal gyrus (l-MTG and r-MTG re-
spectively)) and of the DAN (as defined by [205] e.g. left and right frontal
eye field (l-FEF and r-FEF respectively), left and right posterior intrapari-
etal sulcus (lp-IPS and rp-IPS), left and right anterior intraparietal sulcus
(la-IPS and ra-IPS), r-MTG and l-MTG); then, the values for each network
were compared among the three groups with ANOVA (using SPSS, version
22.0). Prior to ANOVA analysis, the normality of distributions and homo-
geneity of variances were verified with Shapiro-Wilk test and Levene’s Test,
respectively. The Sidak correction was applied when evaluating factors in-
teractions
3. Correlations between variability values extracted from the two networks
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and T2LV, EDSS or SDMT scores were tested using partial nonparametric
correlation, adding age and gender as covariates. The statistical analysis
was performed with SPSS (version 22.0)
4. Lastly, the consistency of the signal variability within the two networks was
evaluated in HS, CIS and RR-MS patients [197]. A Pearson correlation
analysis between the variability values of each different regions of inter-
est (ROI) of the networks was performed and r values were represented
on a correlation matrix plot. Moreover, Pearson correlation values were
transformed to z-scores using Fisher’s r-to-z transformation and significant
differences between HS and both RR-MS or CIS were assessed.
The time-series obtained from the ventral anterior cingulate cortex (vACC) (ROI
of the DMN) were discarded from all subsequent analysis because signal drop was
detected in 11 out of 64 subjects.
rs-FC analysis For the rs-FC a seed-based analysis was used, considering
the DMN and DAN, based on the results from the variability analysis at whole-
brain level. Spheres of 6 mm radius were used as ROI in the nodes of the DMN
and of the DAN, as previously defined. Mean time-series for each seed-ROI were
calculated by averaging the time-series of all voxels within the sphere. Correlation
analysis was performed between each seed-ROI and all other brain voxels for the
SFB and Slow-5. Fisher’s r-to-z transform was used to obtain spatial z-maps with
each voxel’s intensity representing its correlation strength with the seed-ROI.
To test differences in rs-FC at a whole-brain level, voxel-wise statistics were
performed in AFNI, using ANOVA (among RR-MS, CIS and HS) in SFB and
Slow-5, with age, gender and the estimated head motion parameters as covariates.
In RR-MS and CIS patients, voxel-wise correlations between rs-FC and both
1) variability values extracted from DAN and DMN (in the respective frequency
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ranges) and 2) T2LV, were performed in AFNI, with age, gender and the es-
timated head motion parameters as covariates. The results were thresholded
at a corrected p-value=0.01 an alpha=0.05 (using a Montecarlo simulation via
3dClustSim in AFNI, with the autocorrelation function). Talaraich altas in AFNI
was used to anatomically label the results.
3.3 Results
Demographics, clinical and conventional MRI data of RR-MS, CIS and HS, are
summarized in Table 3.2.
RR-MS(N=20) CIS(N=17) HS(N=27) p
Age◦ 39.10± 9.45 35.53± 8.16 32.41± 7.7 0.013
Gender† 11 F; 9 M 10 F; 7 M 15 F; 12 M 0.969
Disease duration
(months)‡
27.80± 15.45 14.12± 8.20 - 0.022
EDSS
(median; range)‡
1.5; 1.0-3.5 1.0; 0.0-2.0 - 0.008
SDMT◦ 54.20± 15.02 58.94± 10.74 60.46± 11.00 0.136
T2LV (mL)‡ 7.45± 8.03 1.81± 1.75 - 0.005
T1LV (mL)‡ 3.07± 3.68 0.45± 0.50 - 0.005
Table 3.2: Demographic and clinical data of the RR-MS, CIS and HS groups.
Results are reported as average±standard deviation unless otherwise specified.
◦Kruskal Wallis test was used: χ2(2) = 8, 76 p = 0.01 and χ2(2) = 3, 99 p = 0.14
for age and SDMT respectively. Post hoc pairwise comparison revealed a signifi-
cant different for age between HS and RR-MS (p = 0.02)
† Chi square test was used. χ2(2) = 0.064.
‡ Mann Whiney U test was used.
Abbreviations: EDSS expanded disability status scale; SDMT: symbol digit
modalities test;T2 LV: T2 lesion volume; T1 LV: T1 lesion volume.
Whole brain variability within SFB, Slow-4 and Slow-5
When compared to HS, CIS patients showed one cluster of significant increased
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variability at the level of the left parietal region (peak in x= 26, y= 68, z= 36,
Talaraich coordinates), while RR-MS patients presented increased variability at
the level of the PCC (peak in x= 7, y= 50, z=12, Talaraich coordinates), both
within Slow-5 (Figure 3.1). No statistically significant differences were found
when CIS and RR-MS patients were compared in any of the frequency bands.
Based on these results a subsequent analysis focusing on the DAN and DMN was
performed.
Figure 3.1: Results of the comparisons among the three groups within Slow-5 at
the whole-brain level. When compared to HS, CIS patients showed one cluster
of significant increased variability at the level of the left parietal region (peak in
x= 26, y= 68, z= 36, Talaraich coordinates), while RR-MS patients presented




Variability within DAN and DMN in Slow-5 and SFB
Based on the results from the whole brain analysis we chose to focus on the fSD
values extracted from DAN and DMN ROI in Slow-5.
With regard to the DAN, ANOVA analysis revealed a significant difference
for the l-FEF (F(2,59)=5.57, p¡0.01), l-MTG (F(2,59)=3.41, p=0.04) and r-MTG
(F(2,59)=3.96, p=0.02) and the whole network (F(2,59)=4.03, p=0.02. Post-hoc
pairwise comparisons revealed a significant difference for l-FEF between both
RR-MS (p<0.01) and CIS (p=0.048) when compared to HS, for l-MTG between
RR-MS and HS (p=0.04) and for r-MTG between CIS and HS (p=0.02). Finally,
the whole DAN significantly differed between CIS and HS (p=0.04) with a trend
between RR-MS and HS (p=0.07).
With regard to the DMN, only the fSD values extracted from the PCC seed,
were significantly higher in RR-MS compared to HS (F(2,59)=3.71, p<0.05, post-
hoc analysis p=0.04). In all cases both groups of patients showed higher fSD
compared to HS.
No significant differences were found among fSD values extracted from both
DAN and DMN regions within SFB.
Correlations between variability and clinical parameters
The following significant correlations were found between clinical measures and
fSD values within Slow-5 in the MS patients (results are reported in Table 3.3):
• The SDMT positively correlated with the whole DAN, l-FEF, r-FEF, rp-
IPS, la-IPS and ra-IPS in the RR-MS group and with l-MTG in the CIS
group. No significant correlations were found between DAN and EDSS in
both groups.
• Regarding the DMN, SDMT negatively correlated with variability values
within the precuneus in CIS but positively with the whole network, r-IPL
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and l-IPL and l-MTG in the RR-MS group. Moreover, the EDSS negatively
correlated with the whole network, r-IPL and l-IPL in the RR-MS group.
No correlations were found between both SDMT and EDSS with fSD values of
DAN or DMN regions within SFB, except for l-FEF and SDMT in RR-MS group
(r=0.619, p=0.006). No correlations were found between SDMT and fSD values
of the DAN or DMN regions in HS.
SDMT
RRMS CIS
DAN r=0.491, p=0.039 -
l-FEF r=0.641, p=0.004 -
r-FEF r=0.569, p=0.014 -
rp-IPS r=0.502, p=0.034 -
la-IPS r=0.561, p=0.015 -
ra-IPS r=0.569, p=0.014 -
l-MTG - r= 0.539, p=0.038
DMN r=0.511, p=0.30 -
Precuneus - r= -0.683, p=0.005
r-IPL - r=0.566, p=0.014
l-IPL - r=0.601, p=0.008
l-MTG - r=0.475, p=0.046
EDSS
RRMS CIS
DMN r= -0.475, p=0.046 -
r-IPL r= -0.511, p=0.030 -
l-IPL r=-0.559, p=0.016 -
Table 3.3: Partial correlations between fSD of the DAN and DMN with SDMT
and EDSS within Slow5.
Abbreviations: l-MTG: left middle temporal gyrus; l-IPL: left inferior posterior
lobule; r-IPL: right inferior posterior lobule; r-FEF: right frontal eye field; l-FEF:
left frontal eye field; rp-IPS: right posterior intraparietal sulcus; ra-IPS: right
anterior intraparietal sulcus; la-IPS: left anterior intraparietal sulcus.
Consistency of the variability signal within each network
HS exhibited a better correlation of the signal variability within different ROI of
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the DMN, compared to CIS and RR-MS patients, in Slow-5 and SFB. Correlation
coefficients resulted significantly different when both RR-MS and HS or CIS and
HS were compared, especially regarding MPFC, parietal and temporal regions,
in both SFB and Slow-5 (Figure 3.2). No significant differences were found for
the DAN.
Figure 3.2: Matrix plots representing the r values of the correlation analysis
between the ROIs of DMN in the three groups in both SFB and Slow5 * p < 0.05
compared to HS ** p < 0.01 compared to HS Abbreviations: PCC: posterior
cingulate cortex; PreC: precuneus; MPFC: medial prefrontal cortex; r-IPL: right
inferior posterior lobule; l-IPL: left inferior posterior lobule; MFG: middle frontal
gyrus; r-MTG: right middle temporal gyrus; l-MTG: left middle temporal gyrus.
Functional connectivity within SFB and Slow-5
RR-MS patients showing reduced rs-FC in the nodes of the DMN (in both SFB
and Slow-5) and DAN (SFB), compared to HS. CIS patients also showed lower
rs-FC when compared to HS, of the posterior, frontal and temporal areas of the
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DMN (SFB and Slow-5). Compared to CIS, RR-MS patients presented reduced
connectivity of regions of the two networks in SFB, with the exception of an
increased connectivity of the frontal areas of the DMN (Table 3.4).




CIS vs HS DMN
Precuneus 334 -55,22,41 r-Postcentral -4.65
MPFC 362 34,6,4 l-Insula -5.12
214 -34,13,20 r-Insula -3.95
r-MTG 249 22,-12,8 l-LN -5.23
l-MTG 157 22,-12,9 l-LN -4.57
RR-MS vs HS DMN
PCC 183 1,73,5 l-Cuneus -4.65
MPFC 366 -1,64,-30 r-Uvula -4.97
r-IPL 697 55,4,11 l-Precentral -5.65
211 -61,-1,17 r-Precentral -5.21
l-IPL 195 37,-1,14 r-Insula -4.72
l-MFG 420 -4,64,-6 r-Culmen -4.31
178 -55,10,8 r-STG -4.00
158 28,16,-12 l-ParaHip -4.38
r-MTG 573 25,1,11 l-LN -5.30
428 7,64,-12 l-Declive -4.53
238 -55,31,20 r-Insula -4.70
181 -31,37,-30 r-CerebTonsil -5.79
l-MTG 279 28,-1,5 l-LN -4.23
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223 -43,46,-24 r-Culmen -5.79
185 10,55,-12 l-Declive -4.46
DAN
r-FEF 169 22,7,2 l-LN -4.03
lp-IPS 392 7,55,-15 l-Culmen -4.77
RR-MS vs CIS DMN
r-IPL 342 52,22,32 l-Postcentral -5.16
l-MFG 329 -43,-22,29 r-MFG* 6.33
DAN
l-FEF 380 49,7,8 l-Precentral -4.58
r-MTG 190 40,4,44 l-Precentral -4.69
Slow5
CIS vs HS DMN
r-MTG 167 -7,46,-15 r-Culmen -4.88
RR-MS vs HS DMN
Precuneus 225 7,91,-3 l-LG -3.97
l-MFG 211 4,73,5 l-LG -4.54
r-MTG 480 25,-1,8 l-LN -5.28
l-MTG 323 30,2,14 l-Insula -4.94
195 -10,46,-18 r-Culmen -4.95
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Table 3.4: Functional connectivity differences among the three groups in SFB
and Slow5.
ANOVA analysis, with age, gender and motion parameters added as covariates.
Both CIS and RR-MS patients showed reduced connectivity, compared to HS, and
RR-MS a reduced connectivity compared to CIS patients from all seed ROIs if not
otherwise specified. Abbreviations: PCC: posterior cingulate cortex; MPFC: me-
dial prefrontal cortex; l-Cuneus: left cuneus; l-MTG: left middle temporal gyrus;
r-MTG: right middle temporal gyrus; l-IPL: left inferior posterior lobule; r-IPL:
right inferior posterior lobule; r-FEF: right frontal eye field; lp-IPS: left posterior
intraparietal sulcus; l-Insula: left insula; r-Insula: right insula; l-MFG: left mid-
dle frontal gyrus; r-MFG: right middle frontal gyrus; l-LN: left lentiform nucleus;
r-Uvula: right cerebellar uvula; l-Precentral: left precentral gyrus; r-Precentral:
right precentral gyrus; l-Postcentral: left postcentral gyrus; r-Postcentral: right
postcentral gyrus r-STG: right superior temporal gyrus; l-ParaHip: left parahip-
pocampal gyrus; l-Declive: left declive; r-CerebTonsil: tight cerebellar tonsil;
l-Culmen: left culmen; r-Culmen: right culmen; l-LG: left lingual gyrus. * clus-
ters showing increased connectivity with the seed regions in RR-MS compared to
CIS patient
Correlation between FC and variability within the DAN and the
DMN in SFB, and Slow-5
Significant inverse correlations between rs-FC and global variability within the
SFB, and Slow-5 were found, in particular within DMN regions, in the RR-MS
group. In the CIS group clusters of positive correlations were found within areas
of the DAN in both SFB and Slow-5 (Table 3.5). Finally, in the HS group no
significant correlations were found between FC and variability in the two networks
in all frequency bands.
Correlation between FC or variability and T2LV in SFB and Slow-5
T2LV correlated negatively with rs-FC of frontal regions of the DAN in CIS and
RR-MS patients and with rs-FC of DMN regions in CIS patients (Table 3.6). No








CIS DAN 178 28,68,29 l-MTG◦ 7.20
RR-MS DMN 533 -53,23,27 r-IPL -7.92
153 50,34,32 l-IPL -4.92
Slow5
CIS DAN 145 32,68,39 l-MTG◦ 5.70
RR-MS DMN 175 -50,34,30 r-IPL -6.08
Table 3.5: Correlations between FC and fSD within the DAN and the DMN in
SFB and Slow5.
Correlations adjusted for age, gender and motion parameters, corrected for mul-
tiple comparisons at p<0.01. Abbreviations: l-MTG: left middle temporal gyrus;
r-MTG: right middle temporal gyrus; l-IPL: left inferior posterior lobule; l-IPL:
right inferior posterior lobule.
◦ clusters showing positive correlation
the DAN or DMN.
3.4 Discussion
To our knowledge this is the first study that characterizes the pattern of variabil-
ity of the BOLD signal in patients with CIS and RR-MS. The results indicate
that patients present increased variability of the BOLD signal within the Slow-
5 band in regions of the DAN and DMN, which is associated with the clinical
performance.
The most novel findings of this study are related to the analysis of BOLD
signal variability, investigated by means of the fSD in the standard- and low-
frequency ranges, in a cohort of CIS and RR-MS patients. We found that CIS
and RR-MS patients exhibited higher variability values, compared to HS, within
the DAN and in the PCC of the DMN respectively, when the Slow-5 frequency
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l-MFG 150 -25,-37,-9 r-MFG -6.21
r-MTG 225 -17,22,59 r-Precentral -8.27
175 -46,34,14 r-STG -5.41
DAN
r-FEF 235 28,88,-9 l-IOG -5.20
Slow5
CIS DAN
r-FEF 181 -43,28,32 r-Postcentral -7.84
RR-MS DAN
ra-IPS 150 31,58,50 l-SPL -4.89
Table 3.6: Correlations between FC and T2LV within SFB and Slow5.
Correlations adjusted for age, gender and motion parameters, corrected for mul-
tiple comparisons at p < 0.01. Abbreviations: l-MFG: left middle frontal gyrus;
r-MFG: right middle frontal gyrus; r-MTG: right middle temporal gyrus; r-
Precentral: right precentral gyrus; r-STG: right superior temporal gyrus; r-FEF:
right frontal eye field; ra-IPS: right anterior intraparietal sulcus; l-IOG: left in-
ferior occipital gyrus; r-Postcentral: right postcentral gyrus; l-SPL: left superior
parietal lobule.
range was considered. As shown in previous studies in HS, the temporal vari-
ability of the BOLD signal within low-frequency range has a higher specificity
and sensitivity in detecting neuronal activity at a grey matter level [197]. The
only previous study on variability in MS, on a cohort of progressive patients,
revealed increased variability in patients compared to HS, in particular at the
level of the frontal and temporal regions of the DAN. Indeed, we found increased
fSD in CIS patients, within the low-frequency band Slow-5, at the level of left
intraparietal sulcus and in the whole DAN, including frontal and temporal areas.
Moreover, higher values of fSD were detected also at the level of the PCC in
RR-MS patients who, interestingly, presented a reduced rs-FC within the DMN
and an inverse correlation, coherent among both SFB and Slow-5, between rs-FC
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of this network and the fSD. Conversely, in CIS patients, a positive relationship
between connectivity and variability was found in the temporal areas of the DAN.
In line with previous studies, a reduced large-networks rs-FC in MS patients
compared to HS was observed [129; 131; 143; 206]. In particular, in this study,
a decreased rs-FC of the areas of DMN in all frequency bands in both groups
of patients was found, and, only in the RR-MS group, a decreased rs-FC of
areas of the DAN in SFB, when compared to the HS group. The trend of a
reduced rs-FC in patients was consistent among SFB and the low-frequency range,
Slow-5, previously not investigated in MS patients at the early stages of disease.
Moreover, FC inversely correlated with the T2 lesion load in particular at the level
of the frontal and parietal areas of the DAN in both CIS and RR-MS patients
and in frontal and temporal areas of DMN in CIS patients.
The interpretation of the relationship between rs-FC and variability is uncer-
tain [207] and whether the differences in the variability affect the connectivity
of two brain regions is still a matter of discussion [5]. Based on our findings,
we could speculate that, in MS patients, a decoupling occurs between fSD and
rs-FC. Whether the increase in variability precedes or is a consequence of the re-
duced connectivity or whether they occur simultaneously is difficult to establish,
especially in a structurally damaged brain. However, the relationships between
FC and T2LV, at the level of the frontal and parietal areas of DAN in Slow-5,
could suggest that the increase in variability could compensate for disruption
of FC caused by structural damage, at least in the very early stages. On the
other hand, in RR-MS patients, the functional disruption affects more deeply the
functional organization and in particular the DMN, possibly interfering with its
interplay with other networks and, at this stage, the compensating mechanisms
could result insufficient.
In this work we also found a reduced consistency of the fSD values within
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the different regions of the DMN in both CIS and RR-MS patients, while HS
exhibited a better correlation between the fSD values within DMN. In particular,
the lower consistency seemed to interest more the temporal regions of the DMN
in Slow-5 in both RR-MS and CIS groups; interestingly the same brain areas
showed a reduced rs-FC in the same group of patients, underlining a further
possible relation between rs-FC and variability.
Another novelty of our study regards the association between variability values
and clinical parameters. In fact, we found that a higher variability in specific
resting-state networks is associated with a better clinical performance, in terms
of SDMT and, regarding RR-MS patients, also EDSS. This is in contrast with
the findings in patients in a progressive and more advanced phase of the disease
[141].
Cognitive impairment is present since the early stages of the disease, and
SDMT has been provided to be a reliable method of assessing the processing speed
in MS [208]. In the MS population of this study, the performance at the SDMT
did not differ compared to the HS group and correlated with increased BOLD
signal variability in both DAN and DMN, especially in RR-MS. The increase in
fSD could reflect the attempt of the brain to respond to the disease, by increasing
the efficiency in specific regions, especially in the very early stages. Interestingly,
the only negative correlation between SDMT and variability was found when the
fSD values of the precuneus were considered. Posterior regions of the DMN have
been already associated with cognitive impairment in MS [131] and a functional
reorganization within DMN regions could be hypothesized, with a compensatory
role of the parietal regions, at least for processing speed.
Altogether these results suggest that increased signal variability could reflect
the capability of the brain to overcome the structural damage in order to allow a
normal functional performance. This, at least in the early stages of MS disease,
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could represent a successful compensatory mechanism, which becomes less effi-
cient in the more advanced phase of the disease, where an increase in variability
does not result in a better clinical performance [141].
This study is not without limitations such as the small sample size and the lack
of analysis of WM microstructural damage. Moreover, in our work we investigated
variability as a measure of the changes of the BOLD signal magnitude over time,
calculated as SD. It is noteworthy that this is only one of the possible methods to
measure variability and results obtained with different procedures and pipelines
should be compared with caution, as suggested also by [209].
However, this is the first study exploring the variability of the BOLD signal
in a group of patients with early MS, revealing the differences with respect to
HS and the relationships with clinical measures. Moreover, the relation with rs-
FC and the finding of a disrupted consistency of the variability within different
areas of the DMN suggest a role for BOLD signal variability in the functional
reorganization occurring in the early stage of MS. Therefore, the investigation
of the variability of the BOLD signal could improve the understanding of the
reorganization subsequent to the structural damage in MS disease, by provid-
ing complementary information about the functional efficiency of different brain
regions.
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Behavioral and neural correlates
of position sense at the lower
limbs in early multiple sclerosis
Summary
Here are presented the rationale and methods of the study of the position sense
in patients with Multiple Sclerosis at the early stage of the disease, the results
and their interpretation.
4.1 Introduction
The ability to identify the position of lower limb in space is critical for ambula-
tion1 and balance control [210; 211]. Since proprioception results from a complex
process of integration of sensory inputs from different peripheral receptors, in-
volving the central nervous system (CNS) at different levels [212], it is likely to
be affected in a spatially disseminated disease such as multiple sclerosis (MS).
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MS is a chronic demyelinating disease of the CNS, causing neurological disability,
especially in young adults [213]. Sensory deficits are predominant in patients with
MS and, among them, proprioceptive impairment is the most common, involving
the lower more than the upper limbs [214; 215]. Moreover, patients with MS
frequently have an impaired control of ankle motion [216], which is necessary for
maintaining standing posture and during gait [156]. Taken all together, these
observations suggest that the sensori-motor impairment at the level of the ankle
may be a primary factor that determines mobility and balance impairment in
people with MS. However, the role of proprioception impairment in determining
disability is often underestimated, due to the limited sensitivity and reproducibil-
ity of the conventional clinical measures [217]. Furthermore, in MS patients, the
investigation of proprioception at the level of the lower limb and specifically at
the level of the ankle joints, has received little attention so far, especially in terms
of neural correlates. Indeed, previous works focused on brain functional activ-
ity during active or passive motor tasks, including both upper limb and ankle
movements [162; 218; 219].
It has been also reported that position sense at the level of the ankle, in
terms of either behavioral outcome or neural activity, correlates with balance
performance, in both healthy subjects (HS) [80; 81] and patients with neurological
diseases [220]. Although balance impairment characterizes MS since its early
stages[221] and it has been extensively investigated[146; 146; 222], none of these
studies explored the specific relationship between the proprioceptive-related brain
activity and the balance ability during quiet standing, in MS patients.
Lastly, both the performance of sensory tasks requiring an inter-hemispheric
transfer of information and the postural control rely on the integrity of the corpus
callosum (CC)[146; 223]. The anterior part and mid-body of the CC connect
higher order sensory and primary/secondary somatosensory areas respectively,
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and CC integrity is required during bimanual coordination movements[224]. The
CC is affected since the early stages of MS23 and its microstructural disruption
has been associated with a poor postural control [225]. However, there are no
studies that examined the relationship between the microstructural integrity of
the CC and the proprioceptive impairment during bilateral sensory tasks with
the lower limbs or during quiet standing, in patients at the early stages of the
disease.
Against this background, we planned this study with three specific aims. The
first aim was to assess the distal lower limb proprioception, in terms of both
behavioral performance and neural activity, in patients with early Relapsing-
Remitting MS (eRR MS). Specifically, we investigated the proprioceptive-related
brain activity using functional MRI (fMRI) during ipsilateral and contralateral
matching tasks [66] performed with the lower limb. The second aim of our study
was to determine whether, in eRR MS subjects, the functional neural correlates
of proprioception and the behavioral performance during the matching tasks were
related to postural control during quiet standing, thus investigating the impact of
proprioceptive deficits on balance. Finally, as a third aim, we tested the hypothe-
sis that the structural damage in the CC could affect the performance during the
proprioceptive matching task requiring bilateral coordination and during quiet
standing, since the early stages of the disease. We focused on matching tasks
for the following reasons: a) they are best suited and extensively employed to
study position sense[66; 226]; b) they have been already employed in subjects
with stroke, [227; 228]R; c) they involve different aspects of sensori-motor control
that can be affected in MS [229].
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4.2 Materials and methods
Participants. Outpatients with eRR MS and gender- and age-matched HS were
prospectively enrolled. The inclusion criteria were: (i) right or mixed foot domi-
nance (Waterloo inventory score > −6 [78]); (ii) no previous history of muscolo-
skeletal injuries at the lower limb level; (iii) no previous intense performance of
sport activities that involved extensively the lower limbs; (iv) no other neuro-
logical or psychiatric disorder. eRR MS subjects were selected according to Mc-
Donald’s criteria 2017 [108] and with the following additional inclusion criteria:
(v) disease duration of less than 5 years and (vi) no relapses in the three months
previous to the examination. We screened 34 eRR MS patients. However, five
patients were excluded because they were left-footed and three of them because
they had suffered a relapse in the three months before the examination. Two out
of the 26 patients were excluded from the analysis: the first one because she did
not complete the MRI scan, the second one because of the poor image quality due
to motion artifacts. Thus, the final sample size of our study included 48 subjects,
24 eRR MS and 24 age and gender matched HS. Patients with eRR MS under-
went clinical evaluation including Expanded Disability Status Scale (EDSS) and
the assessment of the upright standing ability by means of a WII balance board,
within two days of the MRI acquisition. The study conforms to the standard
of the declaration of Helsinki and was approved by the local ethical committee
(CER Liguria, n. 222REG2017). All subjects provided written informed consent
prior to participation in the study.
fMRI experimental setup and protocol. For all subjects the distal lower
limb proprioception inside the MR-environment was evaluated, by using the MR-
compatible setup described in [230] (see Figure 4.1 A-B for further details). Sub-
jects were asked to perform ipsilateral and contralateral matching tasks with the
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right foot during fMRI. In addition, subjects performed ipsilateral and bilateral
active motor tasks involving the same dorsi-plantar flexion movements needed to
perform the matching tasks. In both the active motor tasks and the matching
tasks, we used a block fMRI design with 4 blocks of rest (30 s each) alternated
with 4 blocks of foot movements for the motor task and 6 blocks of rest alter-
nated with 6 blocks of position matching for the proprioceptive task. All subjects
performed the following tasks (Figure 4.1 D ):
• Unilateral and bilateral active motor tasks (ACTIVE-UNILAT and ACTIVE-
BILAT, respectively). Subjects actively moved in the sagittal plane the
right foot, during ACTIVE-UNILAT, or both feet in phase, during ACTIVE-
BILAT, by synchronizing with a metronome set at 1 Hz.
• Ipsilateral matching task with the right dominant foot (IMA-R), consisting
in matching the target position with the same foot (right one); in each
of the six blocks of this task (30 s), the operator presented three target
positions, thus subjects performed 18 ipsilateral matching (3 targets 3× 6
blocks). Each target position was reached at least 4 times and the order
of the targets’ presentation was pseudo-random. The operator passively
moved the foot from the starting position (Figure 4.1 C, BAS) to one of
the four target positions (Figure 4.1 C) and then back to the BAS position.
Subsequently, subjects had to reach the target position with the same foot
and then return to the BAS position.
• Contralateral matching task with the right-dominant foot (CMA-R). An
operator moved the left non-dominant foot to one of the same four posi-
tions as in IMA-R task. The subject had to reach the selected position with
the contralateral right-dominant foot and go back to the BAS location with
both feet. During the matching tasks subjects were required to keep their
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eyes closed. For all the matching tasks, the subjects were asked to perform
the matching trial with a single movement, without corrections while ap-
proaching the target. Once the participants reached the intended matching
position, they were asked them to maintain it for 1 second before coming
back to the baseline position. The order of presentation of the tasks was
balanced across the subject population to minimize potential order effects.
The number of times each target was presented was the same in CMA-R
and IMA-R tasks. To familiarize with the task-fMRI experiment, all sub-
jects performed the motor and matching tasks within 2 days before MRI
acquisition. The entire fMRI experimental session was performed outside
the MR room with the same setup used in the MRI setting. During this
familiarization session, we checked for the absence of voluntary contractions
during the passive movements of the matching tasks by analyzing surface
electromyographic activity.
Foot positions during matching tasks. Subject had to match four different
foot positions spanning the plantar-dorsiflexion range: DF7, REF, PF7, PF14.
These four positions corresponded to four equally spaced rotations (7◦) of the
foot platform: in the REF position the foot platform was orthogonal to the leg,
in DF7 it was rotated by 7◦ in the dorsiflexion range, in PF7 and PF14 it was
rotated respectively of 7◦ and 14◦ in the plantar-flexion range. Each trial started
with both feet on a baseline resting position (baseline, BAS). The range spanned
between the BAS position and the furthest position in the dorsi-flexion range
(DF7) was 35◦.
Behavioral analysis of the matching performance. As an indicator of
the matching performance we computed the constant error (CE) that is the differ-
ence between the position reached by the matching foot and the target position,
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both measured in terms of angular rotations of the foot platforms. The values
computed for each trial were averaged across repetitions and across targets, ob-
taining a single measure of the overall performance to correlate with the fMRI
data in each task (IMA-R and CMA-R), with the structural damage of the cor-
pus callosum as well as with the parameter assessing the balance performance.
This measure indicates a systematic error: a negative value corresponds to an
undershoot of the target positions, a positive value to an overshoot; if the CE is
zero, there is no systematic error.
Assessment of the upright standing ability of eRR MS patients. The
WII balance board is a low cost instrument used in several studies to measure the
variation of the centre of pressure during quite standing with different subjects
populations [231; 232; 233], for a review, see [234] including Multiple Sclerosis
[235; 236; 237].
In this experiment all subjects were assessed with the same WBB device,
following the recommendations of [233]. During the neurological examination,
all eRR MS patients underwent also a test aiming at evaluating their standing
balance. They stand upright and barefoot on a Nintendo WII Balance Board
(WBB, Nintendo, Kyoto, Japan), with the arms relaxed along the sides of the
body, the heels separated by about 2 cm, and the feet abducted at 20◦ [238] (see
Figure 4.1 E-F). They were asked to remain as still as possible for three trials,
each lasting 40 s. We asked subjects to keep their eyes closed during the three
testing trials to increase reliance on proprioception and to eliminate visual cues
[80; 222].
Data acquired from the four load cells of the WBB were transferred via Blue-
tooth to a laptop using a custom modification of the software (1 (Figure 4.1 E,
F). The signals from the four load cells of the WBB were sampled at 40 Hz.
1https://www.colorado.edu/neuromechanics/research/wii-balance-board-project
85
4. BEHAVIORAL AND NEURAL CORRELATES OF POSITION
SENSE AT THE LOWER LIMBS IN EARLY MULTIPLE
SCLEROSIS
The offset recorded during unloaded condition was subtracted to the signal of
each load cell [235] before computing the two components of the CoP trajectory
[233]. The CoP coordinates were low-pass filtered with a 5th order Butterworth
filter with cut-off frequency 10 Hz and the mean value from both signals was
subtracted [239]. Then, for each trial we estimated the Root Mean Square of the
Antero Posterior oscillations of the center of pressure (RMSAP [mm]). We chose
this parameter because it is influenced by the responses of the muscle spindle
and thus, it is strictly related to proprioceptive information; an increment of this
parameter reflects poor balance performance [80]. Moreover, RMSAP has been
indicated among the most reliable parameters when using a WBB in HS and
patients with MS [235]. No learning effects were observed across the three trials,
as already described in a previous study [238], thus we averaged the obtained
values.
MRI acquisition and image processing. All subjects underwent MRI
at 1.5 T Signa Excite (Signa Excite General Electric Healthcare, WI, USA)
with 8-channels phased-array head coil. The protocol included: High resolu-
tion Fast Spoiled Gradient Echo (FGPR) 3D T1-weighted sequence: voxelsize =
1.2x1.2x1.2 mm3, repetition time (TR)/echo time (TE)/inversion time (TI)=
9.7/4.1/500 ms). Spin-echo dual-echo proton density-weighted and T2-weighted
sequence: voxel size= 0.94x0.94x0.94 mm3, TR/TE1/TE2 = 2120/38.2/102 ms
for lesions identification. Single-shot echo-planar imaging (EPI) sequence for task
fMRI: voxelsize = 3.75x3.75x4 mm3, TR/TE = 3000/60 ms. Axial single-shot
spin echo diffusion tensor imaging sequence: voxelsize = 0.94x0.94x2.5 mm3;
TR/TE = 14000/95.7 ms; flip angle= 90◦; with 30 non-collinear diffusion direc-
tions with b = 1000 s/mm2 and 5 b = 0 s/mm2.
fMRI preprocessing and first level analysis. fMRI data processing.
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Figure 4.1: Figure 1. (A) Custom-made MR compatible passive device employed
during the MRI experimental protocol. The numbers indicate (1) the adjustable
tight platform; (2) the foot platforms that allow for each foot independent one
degree-of-freedom movement in the sagittal plane; (3) the two rails (two per each
side) that allow the thigh platform and the foot platforms to slide relative to
one another to fit different subjects’ anthropometries; (4) the MR compatible
optical encoder was attached to each platform axis of rotation. (B) An overview
of a subject outside the MR environment. The thighs and the feet were firmly
strapped to the corresponding platform with velcro straps. (C) The four presented
platform positions (PF14, PF7, REF, and DF7) that the subjects were required
to match during each matching tasks. The angle values on the right show the
rotation values of the platform with respect to the BAS position from which each
trial started. (D) Task-fMRI protocols during motor and matching tasks. Rest
and block duration were 30 s each. Tasks were randomized across subjects. (E-F)
Overview of the subject and of the feet position during balance control task.
Firstly, the T1-weighted images of eRR MS patients underwent a lesion in-
painting procedure prior to the brain extraction and anatomical structures’ seg-
mentation. The in-painting procedure was needed to avoid failure of the segmen-
tation procedure since, without it, the white matter (WM) lesions would have
been considered as gray matter by FAST (part of FSL) [202]. These T1 and T2
WM lesions were identified by neurologists on the T2/Proton Density-weighted
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and T1-weighted, using a semi-automated technique based on user-supervised lo-
cal thresholding (Jim version 6; Xinapse Systems, 1. Initial pre-processing step
of despiking (detection and reduction of extreme time series outliers by fitting a
smooth curve insensitive to extreme outliers to the data) were performer in AFNI
2 [240]. Non-brain removal was performed with FreeSurfer skull stripping [241].
All other pre-processing steps were performed using FSL (FMRIB’s Software Li-
brary, 3) [242; 243] as implemented in FEAT [244; 245], including: removal of the
first 3 volumes, motion correction using MCFLIRT 4 [242], slice-timing correction
for regular ascending acquisition (using Fourier-space time series phase-shifting),
spatial smoothing (Gaussian kernel, FWHM=6 mm), grand-mean intensity nor-
malization of all volumes by a single multiplicative factor, and high-pass tem-
poral filtering (Gaussian-weighted least-squares straight line fitting, sigma = 30
s). Nuisance signal from white matter (WM) and cerebrospinal fluid (CSF) was
calculated by segmenting T1-weighted images with FAST [246], then register-
ing the resulting WM and CSF masks to functional space and averaging the
raw time series within each mask. To detect task-related activity, one explana-
tory variable (EV) was defined to model the On-Off periods of the task for each
run (ACTIVE-UNILAT and ACTIVE-BILAT motor tasks, IMA-R, and CMA-R
tasks) and convolved with the hemodynamic response function. The 24 motion
parameters calculated during motion correction were added as confound EVs.
Mean CSF and WM signals were added to the general linear model as covariates
of no interest. Boundary-based registration BBR [247] was used to register each
individual functional data to the corresponding T1-weighted brain image. Then,
linear affine with twelve degree of freedom registration was performed to register
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voxel size: 2x2x2 mm3) [242].
In order to model mean activation per group, one-sample t-test was used per
each task (4 group mean activation in total, one per each of the task performed,
2 motor and 2 matching tasks). To investigate differences in the neural correlates
of the matching tasks within the same group, the IMA-R and CMA-R tasks
performed with the right foot using two-sample paired t-tests (IMA-R vs CMA-R)
were compared. Anatomical localization of the peaks of activation were computed
with the SPM anatomical toolbox [248].
DTI processing. Data were processed using FMRIB’s Diffusion Toolbox
(part of FSL). First, we corrected for motion and eddy currents artifacts and
then standard DTI metrics of fractional anisotropy (FA) and mean diffusivity
(MD) were computed. The region of interest (ROI) of the CC was extracted
from the JHU DTI based white matter atlas (ICBM-DTI-81 white-matter labels
[249] and co-registered to the diffusion images of each subject using a combination
of linear and non-linear registration (FLIRT 1 and FNIRT 2 [242; 250]. Mean FA
and MD values were extracted from the ROI of CC in both eRR MS patients and
HS groups.
Statistical analysis. The statistical analysis was performed with SPSS (Ver-
sion 20.0), except for the fMRI section, performed with FSL. Prior to all statisti-
cal testing, we tested (Kolmogorov-Smirnov test) the hypothesis that the demo-
graphic, behavioral and DTI data were normally distributed. We used Levene’s
and Mauchly’ tests to verify, respectively, the homogeneity of variances for all
the above-mentioned independent measures and the sphericity assumption for
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Demographic and clinical data. Differences in age and gender between
the two groups were assessed with the unpaired t-test and chi-square tests, re-
spectively.
Proprioceptive matching performance. To investigate significant dif-
ference during matching tasks we performed a repeated measures ANOVA with
one between-subjects factor ‘group’ (eRR MS vs HS) and two within-subject fac-
tors i.e. ‘task’ (CMA-R and IMA-R) and ‘positions’ (DF7, REF, PF7 and PF14).
When the sphericity assumption was rejected, we applied the Greenhouse-Geisser
correction. Then, based on the ANOVA results, we used a Tukey’s HSD post-hoc
test to further investigate significant differences among the four target positions
and an unpaired t-test to investigate specific difference between the two groups
of HS and eRR MS subjects in each task. A Pearson correlation coefficient was
used to assess the relationship between CE during CMA-R and RMSAP within
the eRR MS group.
fMRI. To strictly investigate position sense related activity, we chose to con-
trast the matching tasks neural response with the purely active motor neural
response, using two sample paired t-tests (IMA-R>ACTIVE-UNILAT, CMA-
R>ACTIVE-BILAT), as performed in a previous study [230]. Results were con-
verted to Z-values and then a threshold of Z ≥ 3.1 for cluster formation was
applied, followed by with a significance threshold of p = 0.0001 (cluster corrected
using Gaussian Random Field Theory (GRFT)). In all the different group level
analyses, we added age and gender as covariates for the HS group while age,
gender and disease duration for the eRR MS group. To compare the activity
during IMA-R and CMA-R between the HS and eRR MS group, we used un-
paired t-test. A threshold of Z ≥ 2.3 for cluster formation and a significance
threshold of p = 0.01 (cluster corrected using GRFT). The correlations between
brain activations of eRR MS patients (IMA-R and CMA-R) and the behavioral
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measure CE during the two matching tasks were modeled separately with age,
gender and disease duration as covariates. A threshold of Z ≥ 2.3 for cluster for-
mation was applied, followed by with a significance threshold of p = 0.01 (cluster
corrected using GRFT). We performed the same correlation analysis for the HS
group, using age and gender as covariates. In addition, to test the a-priori hy-
pothesis that there is a correlation between the balance parameter during quiet
standing (RMSAP) and the proprioceptive-related brain activity in the eRR MS
group, we used the same correlation analysis as above (for the CE). We selected
the brain activity measured during CMA-R, since for both fulfilling this task and
maintaining balance during quiet standing, the proprioceptive representation of
both legs is needed.
DTI metrics and behavioral parameters. Unpaired t-test was used to
assess differences in Fractional anisotropy (FA) and mean diffusivity (MD) values
of the CC between HS and eRR MS. Moreover, partial correlation between the
DTI metrics and CE during CMA-R was assessed in the two groups separately and
in the HS+eRR MS group, adding age and gender as covariates, using Pearson
correlation coefficient. The latter test was used also to assess the relationship
between diffusion metrics and the quiet standing parameter (RMSAP), in eRR
MS group.
4.3 Results
Participants. Demographic and clinical characteristics of all subjects included
in the analysis are reported in Table 4.1. The median sensory functional system
score (s-FSS) in eRR MS group was 0 (range: 0-2). The demographic data as
well as the behavioral and DTI parameters were normally distributed (p > 0.05
in all cases). Age and gender did not significantly differ between the two groups:
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t(46)= -1.05, p=0.298 and χ(1)=0.375 , p=0.540, for age and gender, respectively.
Patients (N=24) HS (N=24)
Age 32.50± 6.76 30.75± 4.54
Gender 17 females; 7 males 15 females; 9 males
Waterloo scale score 7.5± 7.9 11.82± 4.91
Disease Duration (months) 38.17± 24.77 -
EDSS (median; range) 1 (0-3.5) -
s-FSS (median; range) 0 (0-2) -
CE CMA-R (◦) 10.89± 4.56 8.38± 2.96
CE IMA-R (◦) 6.33± 2.53 6.59± 2.69
RMSAP (mm) 4.96± 1.73 -
T2-LV (mL) 2.43± 2.65 -
T1-LV (mL) 1.89± 1.85 -
CC FA 0.64± 0.03 0.66± 0.03
CC MD (×10− 3mm2s−1) 0.77± 0.02 0.75± 0.02
Table 4.1: Demographic, clinical and behavioral data.
Mean± standard deviation are reported if not otherwise specified. Abbreviations:
s-FSS: sensory functional system score; EDSS: expanded disability status scale;
CE: constant error; CMA-R: contralateral matching task executed with the right
foot; IMA-R: ipsilateral matching task executed with the right foot; RMSAP:
root mean square of the antero-posterior direction; T2-LV: lesion volume in T2-
weighted sequence; T1-LV: lesion volume in T1-weighted sequence.
Behavioral performance during matching tasks and during quiet
standing. The sphericity assumption was verified for both the group and task
factors (p > 0.05), but not for the positions factor (χ2(2) = 66.78, p < 0.001).
Thus, for the latter case, we adopted the Greenhouse-Geisser correction (η =
0.54). Both populations systematically overshot the target position. eRR MS pa-
tients had a greater CE than HS during the CMA-R task while, during the IMA-R
task, the two groups showed similar performance (Figure 4.2): group× task effect,
F(1,46)=7.26, p=0.010, group effect F(1,46)=1.98, p=0.170. Mean and standard
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deviation CE values during CMA-R were 10.89± 4.56◦ and 8.38± 2.96◦ for eRR
MS and HS respectively, with the unpaired t-test highlighting a significant differ-
ence (t=2.26, p=0.029). Mean and standard deviation CE values during IMA-R
were 6.33±2.53◦ and 6.59±2.69◦ for eRR MS and HS respectively (unpaired t-
test t=-0.35, p=0.730). The CE in CMA-R was greater than IMA-R for both
populations (task effect: F(1,46)=38.31, p < 0.001). The ANOVA highlighted
also a position effect (F(1.61,73.96)=9.79; p < 0.001; η = 0.54, Greenhouse-
Geisser corrected). Specifically, as revealed by the post-hoc analysis, the error
was greater in plantarflexion than in dorsiflexion or in the REF position (post-
hoc analysis: p < 0.002 for all comparisons among positions with the exception
of the comparison between DF7 and REF (p > 0.05)). In addition, we found an
interaction group × task × position (F(3,138)=2.96; p=0.035) due to the fact
that for eRR MS patients the CE in the CMA-R task had a monotonic increase
from dorsi-flexion to plantar-flexion, while this effect was not present neither in
the IMA-R for both population nor in the CMA-R for the HS subjects. The
performance of eRR MS related to postural control during quiet standing, i.e.
the root mean square of the antero-posterior direction (RMSAP), is reported in
Table 4.1. RMSAP significantly correlated with CE during CMA-R (r=0.510,
p=0.015).
Brain activations during matching and motor tasks in eRR MS pa-
tients and HS.
Single-group analysis: brain activity for both eRR MS patients and HS
groups is reported in Table 4.2 and Table 4.3 for matching and motor tasks,
respectively.
IMA-R. eRR MS patients activated at the level of left paracentral lobule,
postero-medial frontal cortex (PMFC), right supramarginal gyrus (SMG) and
bilateral cerebellum. The same areas were involved also in HS group with addi-
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Figure 4.2: On the left: Constant Error for the four target angular positions
(DF7, REF; PF14, and PF7) presented during the matching tasks. Error bars
represent the standard error (mean± SE). On the right: Mean group differences
(eRR MS vs HS, black and gray lines, respectively) in constant error for the two
matching tasks (CMA-R and IMA-R). Filled circles and bars indicate mean and
standard errors.
tional activity at the level of right inferior and bilateral middle frontal gyrus, and
the right inferior and superior parietal lobule (IPL and SPL, respectively).
CMA-R. eRR MS patients activated at the level of the bilateral paracentral
lobule, right middle frontal gyrus and PMFC, left inferior frontal gyrus, right
postcentral gyrus and SMG and bilateral cerebellum. HS presented additional
activation at the level of the right insula, left superior temporal gyrus, IPL and
SMG.
ACTIVE-UNILAT. eRR MS group activated at the level of the bilateral pre-
motor and left primary motor cortex, bilateral IPL, bilateral parietal operculum,
left putamen and right cerebellum. Instead, HS activated at the level of left
paracentral and posterior medial frontal cortex, left parietal operculum, bilateral
rolandic operculum, bilateral cerebellum, bilateral putamen and right IPL.
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ACTIVE-BILAT. eRR MS patients’ group activations were found at the level
of bilateral primary motor, cerebellum, supramarginal gyrus, rolandic operculum
and putamen and right IPL. HS activations were detected at the level of the right
primary motor cortex, bilateral IPL, bilateral cerebellum and right putamen.
Location Cytoarchitetonic MNI coordinates Z Side
location X Y Z score
eRR MS IMA-R
Paracentral Lobule Area 6 -4 -18 68 7.85 L
Paracentral Lobule Area 4a -6 -34 68 7.45 L
Posterior-Medial Frontal Area 6 8 -2 70 7.29 R
Cerebellum (III) Lobule I IV 10 -42 -18 6.59 R
Cerebellum (VIII) Lobule VIIb -30 -64 -54 6.51 L
Cerebellum (VII) Lobule VIIa -22 -72 -46 6.2 L
Cerebellum (VI) Lobule VI 28 -58 -22 6.13 R
Vermis (4/5) Lobule I IV 4 -46 -12 6.02
Vermis (4/5) Lobule V 2 -56 -4 5.79
SupraMarginal Gyrus Area PFop 56 -22 28 7.31 R
SupraMarginal Gyrus Area PF 64 -32 26 6.66 R
SupraMarginal Gyrus Area PFcm 54 -34 26 6.45 R
SupraMarginal Gyrus Area PFt 56 -30 36 6.07 R
eRR MS CMA-R
Paracentral Lobule Area 4a 6 -38 66 7.92 R
Paracentral Lobule Area 6 -2 -22 70 7.6 L
Postcentral Gyrus Area 3b 12 -40 68 7.41 R
Middle Frontal Gyrus 34 -2 54 7.26 R
SupraMarginal Gyrus Area PFcm 60 -28 30 7.23 R
Posterior-Medial Frontal Area 6 10 2 58 6.88 R
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Cerebellar Vermis (4/5) Lobule I IV -2 -48 -12 6.19
Cerebellum (IV-V) Lobule V -18 -38 -24 6.04 L
Cerebellum (IV-V) Lobule I IV -4 -46 -8 5.76 L
Cerebellum (III) Lobule I IV 14 -38 -24 5.71 R
Cerebellum (VI) Lobule VI -32 -56 -26 5.5 L
Cerebellum (VII) Lobule VIIb -12 -74 -44 5.5 L
Precentral Gyrus Area 44 -54 6 14 5.37 L
Inferior frontal gyrus Area 44 -46 12 0 5.06 L
HS IMA-R
Paracentral Lobule Area 4a -6 -32 64 7.48 L
Inferior frontal gyrus Area 44 48 10 12 7.23 R
Paracentral Lobule Area 6 -6 -18 70 7 L
Posterior-Medial Frontal Area 6 -10 -12 66 6.91 L
Cerebellum (IV-V) Lobule V 16 -38 -22 6.77 R
Middle Frontal Gyrus -26 -8 52 6.72 L
SupraMarginal Gyrus 56 -30 38 6.42 R
SupraMarginal Gyrus Area PF 58 -32 42 6.38 R
SupraMarginal Gyrus Area PFcm 56 -34 26 6.35 R
SupraMarginal Gyrus 48 -26 24 5.76 R
SupraMarginal Gyrus Area Pfop 62 -24 24 5.76 R
Inferior Parietal Lobule Area PF 56 -30 52 5.7 R
Cerebellum (VI) Lobule VI -34 -64 -24 5.88 L
Cerebellum (VIII) Lobule VIIIa -28 -64 -54 5.54 L
Cerebellum (VIII) Lobule VIIb -40 -48 -56 4.49 L
Middle Frontal Gyrus 36 48 24 5 R
Cerebellum (VIII) Lobule VIIIb 20 -48 -52 5.27 R
Cerebellum (VIII) Lobule VIIIa 22 -62 -50 4.32 R
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Cerebellum (IX) Lobule VIIIb 12 -52 -60 4.23 R
Cerebellum (IX) Lobule IX 10 -58 -56 4.05 R
Cerebellum (IX) Lobule IX 10 -58 -52 3.9 R
Vermis 8 Lobule VIIIb 0 -68 -44 3.85
Superior parietal lobule Area 5L 18 -50 74 4.5 R
Superior parietal lobule Area 7A 18 -68 64 4.18 R
Superior parietal lobule Area 7P 16 -68 54 3.7 R
HS CMA-R
Paracentral Lobule Area 4a 6 -30 70 7.11 R
Paracentral Lobule Area 4a -4 -24 72 6.38 L
Paracentral Lobule Area 4a 8 -38 72 6.29 R
Insula Lobe 42 20 2 6.18 R
Vermis (4/5) Lobule I IV 0 -48 -12 6.6
Cerebellum (IV-V) Lobule I IV -4 -48 -16 6.32 L
Cerebellum (VI) Lobule VI -28 -66 -26 6.1 L
Cerebellum (III) Lobule I IV 16 -36 -24 5.87 R
Cerebellum (VIII) Lobule VIIIb -20 -54 -52 5.65 L
Superior Temporal Gyrus Area OP1 -52 -30 18 5.8 L
SupraMarginal Gyrus Area PFcm -52 -36 24 4.89 L
Superior Temporal Gyrus Area PFcm -56 -36 22 4.88 L
Inferior Parietal Lobule AreahIP2 -48 -36 36 4.69 L
SupraMarginal Gyrus -46 -34 32 4.55 L
Inferior Parietal Lobule Area hIP3 -42 -42 42 4.51 L
Middle Frontal Gyrus 36 46 30 5.33 R
Table 4.2: Brain activations during matching tasks in eRR MS patients and HS
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Location Cytoarchitetonic MNI coordinates Z Side
location X Y Z score
eRR MS ACTIVE-UNILAT
Paracentral Lobule Area 6 -4 -22 68 7.11 L
Paracentral Lobule Area 4a -8 -34 68 6.66 L
Rolandic Operculum Area OP2 -36 -28 16 6.41 L
Superior temporal Gyrus Area PFcm -48 -32 20 6.38 L
SupraMarginal Gyrus Area OP1 -46 -30 24 6.34 L
Putamen -28 -8 12 5.98 L
Vermis (4/5) Lobule I IV 0 -50 -6 6.31
Vermis (4/5) Lobule V 4 -54 -12 6.22
Cerebellum (III) Lobule I IV 14 -36 -22 5.89 R
Cerebellum (IV-V) Lobule V 22 -30 -26 5.13 R
Cerebellum (VI) Lobule VI 28 -56 -24 4.7 R
Superior temporal Gyrus Area PFcm 56 -34 22 6.05 R
Superior temporal Gyrus Area PF 66 -30 22 5.35 R
SupraMarginal Gyrus Area OP1 64 -18 18 5.08 R
Postcentral gyrus Area PFop 58 -12 26 4.73 R
Precentral Gyrus Area 6 54 0 48 5.91 R
Precentral Gyrus Area 44 58 6 26 4.13 R
Postcentral Gyrus -50 -8 54 5.81 L
Precentral Gyrus Area 6 -40 -14 56 4.76 L
Cerebellum (IX) Lobule VIIIb 16 -48 -52 4.65 R
Cerebellum (VIII) Lobule VIIIa 28 -58 -52 4.64 R




Paracentral Lobule Area 4a -6 -36 70 7.37 L
Cerebellar Vermis (4/5) Lobule V 4 -52 -8 6.87
Cerebellum (IV-V) Lobule V -20 -36 -22 6.54 L
Cerebellum (VI) Lobule VI 28 -58 -20 5.94 R
Cerebellum (IV-V) Lobule I IV -8 -44 -18 5.86 L
Rolandic Operculum 44 -30 22 5.82 R
Superior Temporal Gyrus Area PFcm 54 -34 20 5.21 R
Putamen 30 -8 6 5.15 R
SupraMarginal Gyrus 50 -32 32 5.14 R
Rolandic Operculum Area OP1 -48 -28 20 6.72 L
SupraMarginal Gyrus -44 -36 24 6.18 L
Putamen -28 2 6 5.64 L
Precentral Gyrus Area 6 40 -6 50 4.9 R
HS ACTIVE-UNILAT
Paracentral lobule -8 -36 66 7.41 L
Posterior-Medial frontal 0 -4 64 6.24 L
Postcentral gyrus Area 5L -20 -42 70 5.94 L
Putamen -28 -4 12 6.26 L
SupraMarginal gyrus Area OP1 -54 -26 20 6.12 L
Rolandic operculum Area OP2 -36 -28 18 5.35 L
Cerebellum (III) Lobule I IV 10 -40 -22 7 R
Vermis (4/5) Lobule I IV -2 -50 -6 6.39
Cerebellum (VI) Lobule VI 28 -60 -20 5.82 R
Putamen 28 0 12 5.59 R
Insula lobe 44 4 4 5.25 R
Rolandic operculum Area PFcm 48 -30 20 5.46 R
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SupraMarginal gyrus Area Pfop 56 -24 26 5.28 R
Rolandic operculum Area TE 1.1 40 -30 16 5.22 R
Cerebellum (VI) Lobule VI -30 -56 -26 6.06 L
Cerebellum (IV-V) Lobule V -28 -38 -30 4.15 L
Fusiform gyrus Area FG4 -42 -54 -24 3.91 L
Cerebellum crus 1 Area FG2 -40 -64 -22 3.83 L
Cerebellum (VIII) Lobule VIIIa 24 -58 -54 5.23 R
Cerebellum (IX) Lobule IX 12 -52 -52 4.64 R
Cerebellum (VIII) Lobule VIIIb 18 -50 -54 4.36 R
HS ACTIVE-BILAT
Precuneus Area 3a -10 -40 68 7.84 L
Paracentral Lobule Area 4a 8 -28 66 7.45 R
Posterior-Medial Frontal 8 -18 70 6.99 R
Superior Temporal gyrus Area Pfop -52 -32 22 6.32 L
Rolandic operculum Area Pfop 56 -24 22 6.31 R
Rolandic operculum Area OP1 50 -26 22 6.27 R
SupraMarginal gyrus -54 -32 26 5.81 L
Putamen 30 -2 12 5.73 R
Vermis (4/5) Lobule I IV -2 -50 -12 7.67
Cerebellum (III) Lobule I IV 14 -38 -22 6.77 R
Cerebellum (IV-V) Lobule V -20 -38 -22 6.64 L
Cerebellum (IV-V) Lobule I IV -20 -34 -26 6.27 L
Cerebellum (VIII) Lobule VIIIb 20 -58 -54 5.11 R
Cerebellum (VIII) Lobule VIIIb -22 -50 -56 4.8 L
Cerebellum (VIII) Lobule VIIIa -22 -64 -54 4.53 L
Table 4.3: Brain activations during motor tasks in eRR MS patients and HS
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Within-group analysis in eRR MS patients:
1) IMA-R > ACTIVE-UNILAT: the activation clusters involved the bilateral
frontal areas, superior and inferior parietal lobule (SPL and IPL, respectively),
primary somatosensory cortex (S1), right supramarginal gyrus (SMG), and left
precuneus (Figure 4.3, Table 4.4); 2) CMA-R > ACTIVE-BILAT: the contrast
revealed several clusters covering parietal and frontal areas, in particular the
bilateral postero-medial frontal cortex, right SPL, SMG and S1, while the pre-
cuneus was activated bilaterally (Figure 4.3, Table 4.4); 3) IMA-R > CMA-R:
cortical activations of the left paracentral lobule and of IPL were observed; 4)
CMA-R > IMA-R: a cluster of greater activation was observed at the level of the
right paracentral lobule (Table 4.5).
Location Cytoarchitetonic MNI coordinates Z Side
location X Y Z score
IMA-R>ACTIVE-UNILAT
Superior parietal lobule Area 7A 18 -70 62 6.23 R
Inferior parietal lobule Area hIP2 42 -40 48 5.34 R
Inferior parietal lobule Area PFt 54 -34 50 5.12 R
Superior parietal lobule Area 5L 20 -54 68 4.84 R
SupraMarginal gyrus Area PFm 54 -36 44 4.82 R
Postcentral gyrus Area 1 40 -44 66 4.75 R
Superior parietal lobule Area 7A -20 -64 54 5.72 L
Inferior parietal lobule Area hIP3 -38 -46 46 5.1 L
Inferior parietal lobule Area 2 -42 -42 54 5 L
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Precuneus -14 -52 58 4.99 L
Postcentral gyrus Area 2 -40 -42 58 4.89 L
Middle frontal gyrus 32 0 56 5.89 R
Mid-cingulate cortex 8 16 44 5.11 R
Inferior frontal gyrus Area 44 52 8 16 4.64 R
Middle frontal gyrus -24 -6 48 5.82 L
Superior frontal gyrus -24 -2 56 5.03 L
Posterior-Medial frontal -16 -4 62 4.74 L
CMA-R>ACTIVE-BILAT
Precuneus 8 -56 56 6.2 R
Precuneus Area 7A 8 -64 58 5.94 R
Superior Parietal lobule Area 5L 20 -52 60 5.44 R
Precuneus Area 5L 6 -58 62 5.37 R
Precuneus Area 5M -10 -54 56 5.25 L
Superior frontal gyrus 28 -2 60 5.46 R
Precentral Gyrus Area 6 34 -2 50 4.74 R
Posterior-Medial frontal Area 6 14 14 60 3.52 R
Posterior-Medial frontal Area 6 -24 -4 62 5.12 L
SupraMarginal gyrus Area PFm 60 -42 34 4.99 R
SupraMarginal gyrus Area PF 60 -36 36 4.49 R
Postcentral gyrus Area 1 56 -24 52 4.07 R
Postcentral gyrus Area 2 46 -24 42 3.64 R
SupraMarginal gyrus Area PFt 56 -28 42 3.61 R
Table 4.4: Brain activations during matching tasks vs motor tasks in eRR MS
Between-group analysis for matching tasks. Motor tasks: no dif-
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Figure 4.3: Clusters of activations resulting from the contrasts IMA-R>ACTIVE-
UNILAT (top) and CMA-R>ACTIVE-BILAT (bottom), thus reflecting position
sense neural correlates without the motor component of the task, in eRR MS
group. The results are cluster corrected for multiple comparisons (Z ≥ 3.1,
p < 0.0001) and are shown in MNI space. Note the cortical activity in the bilateral
fronto-parietal areas, more widespread during IMA-R>ACTIVE-UNILAT.
ferences were detected between eRR MS patients and HS during bilateral motor
task; on the contrary, when performing motor task with the right foot, eRR MS
patients had a greater activation, compared to HS, in the left MTG and SMG
(Table 4.6). Matching tasks: differences between eRR MS patients and HS were
detected between cortical activations during IMA-R but not CMA-R. (Table 4.7,
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Location Cytoarchitetonic MNI coordinates Z Side
location X Y Z score
IMA-R>CMA-R
Paracentral Lobule Area 4a -8 -30 74 5.68 L
Precentral gyrus -36 -2 64 4.83 L
IPL Area hIP3 -34 -48 48 4.33 L
IPL Area 7A -40 -56 60 3.91 L
CMA-R>IMA-R
Paracentral Lobule Area 4a 8 -30 68 6.85 R
Postcentral gyrus Area 5L 14 -40 70 6.36 R
Table 4.5: Contrast IMA-R vs CMA-R and CMA-R vs IMA-R in eRR MS patients
Figure 4.4).
Location Cytoarchitetonic MNI coordinates Z Side
location X Y Z score
eRR MS patients>HS
Middle temporal gyrus Area PGp -54 -62 16 4.56 L
Supramarginal gyrus Area PFm -56 -48 32 3.41 L
Table 4.6: Differences in brain activation during unilateral motor task (ACTIVE-
UNILAT) between eRR MS and HS
Brain-behavior correlations. In eRR MS, during IMA-R, CE negatively
correlated with brain activity at the level of the right S1 and SPL, while it
positively correlated with brain activity at the level of the right frontal areas
(Table 4.8, Figure 4.5 A-B). Instead, the CE during CMA-R positively correlated
with an activation cluster at the level of the left motor and premotor area and
S1 (Table 4.8, Figure 4.5 C). Moreover, the RMSAP inversely correlated with
cortical activation during CMA-R, in particular with activity at the level of the
right SPL and IPL and primary motor cortex (Table 4.8, Figure 4.5 D). No
cortical or subcortical activation related to CE was found during either IMA-R
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Location Cytoarchitetonic MNI coordinates Z Side
location X Y Z score
eRR MS patients>HS
IPL AreahIP3 -38 -50 56 3.94 L
IPL Area hIP2 -50 -38 42 3.35 L
PostCg Area 1 -30 -42 66 3.2 L
HS>eRR MS patients
MCC -4 -40 38 4.67 L
MCC 2 -30 44 3.51 R
Table 4.7: Differences in brain activation during IMA-R between eRR MS and
HS
Abbreviations: IPL: inferior parietal lobule; PostCg: Postcentral gyrus; MCC:
mid-cingulate cortex.
or CMA-R in HS group.
Location Cytoarchitetonic MNI coordinates Z Side
location X Y Z score
IMA-R(Negative)
Superior parietal lobule Area 5L 20 -46 72 5.26 R
Postcentral gyrus Area 5L 16 -46 70 4.76 R
Superior parietal lobule Area 7PC 22 -50 58 4.13 R
Postcentral gyrus Area 2 28 -42 62 3.56 R
IMA-R (Positive)
Middle frontal gyrus 36 36 48 4.52 R
Superior frontal gyrus 26 40 34 3.81 R
Inferior frontal gyrus 40 16 36 2.82 R
CMA-R (Positive)
Postcentral gyrus Area 4p -44 -14 40 3.66 L
Postcentral gyrus Area OP4 -64 -8 14 3.6 L
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Precentral gyrus Area 6 -28 -14 58 3.59 L
Postcentral gyrus Area 3a -44 -14 32 3.38 L
Postcentral gyrus Area 3b -52 -14 40 3.31 L
RMSAP (Negative)
Inferior Parietal Lobule Area hIP1 36 -50 40 4.17 R
Superior Parietal Lobule Area 7PC 26 -46 46 3.95 R
Superior Parietal Lobule Area 5L 18 -46 70 3.89 R
Superior Parietal Lobule Area 7A 24 -66 52 3.72 R
Paracentral Lobule Area 4a 6 -44 70 3.68 R
Table 4.8: Correlations between CE and the relative matching task activations;
correlations between the behavioral parameter during quiet standing (RMSAP )
and brain activations during CMA-R
CC diffusion tensor metrics and relationship with behavioral per-
formance during CMA-R and during quiet standing. Mean FA and MD
values extracted from CC (reported in Table 4.1) resulted significantly different
between eRR MS and HS (unpaired t-test, t(46)=3.015, p=0.004 and t(46)=-
3.522, p=0.001, respectively). Moreover, when considering both eRR MS patients
and HS, the FA and MD of CC correlated with behavioral performance in terms
of CE during CMA-R (r=-0.298, p=0.044 and r=0.335, p=0.023, respectively),
but no significant correlation was found when the two groups were considered
separately. No significant correlations were found between FA or MD of the CC
and RMSAP for the eRR MS group.
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Figure 4.4: Clusters resulting from the comparison between eRR MS patients and
HS brain activity during IMA-R. The results are cluster corrected for multiple
comparisons (Z ≥ 2.3, p<0.01) and are shown in MNI space. Note the greater
activation in the mid-cingulate cortex in HS vs eRR MS and in the left parietal
cortex in eRR MS vs HS.
4.4 Discussion
In this work, we describe the behavioral and neural correlates of the lower limbs
position sense in eRR MS patients, as well as their relationship with balance per-
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Figure 4.5: Clusters resulting from the correlation between BOLD signal and be-
havioral parameters during matching tasks (CMA-R and IMA-R CE) and during
quiet standing (RMSAP) in eRR MS patients group. The results are cluster cor-
rected for multiple comparisons (Z ≥ 2.3, p < 0.01) and are shown in MNI space.
Brain activity during IMA-R presented both negative and positive correlations
with the CE (A and B, respectively) while during CMA-R only a negative cor-




formance during quiet standing. In summary, eRR MS patients presented a worse
systematic matching error than controls during contralateral but not during ip-
silateral task. However, compared to HS, eRR MS patients showed a functional
reorganization involving the parietal areas during the ipsilateral matching task,
while no differences between the two groups were found during CMA-R. More-
over, both the behavioral metrics and the neural activity during CMA-R corre-
lated with the performance during quiet standing. Lastly, the worse performance
during the contralateral task correlated with the damage at the level of the CC.
Position sense deficits and their neural correlates during lower limb matching
tasks. In our study, both groups had a greater error during the contralateral
than during the ipsilateral matching tasks and this may be explained by the
greater complexity of the former, that is associated to a higher likelihood of error
[66; 230]. Moreover, eRR MS patients had worse proprioceptive performance
than HS during the contralateral but not during the ipsilateral matching task.
This latter finding is relevant from a clinical point of view since it indicates
that contralateral matching tasks can reveal subtle position sense deficits that
are below the sensitivity of the standard clinical examination, as shown by the
normal median s-FSS in our population of eRR MS patients. Moreover, this
result highlights the limits of the most used rating scale for assessing disability
in MS, the EDSS, in properly evaluating deep sensation deficits. In fact, in the
EDSS, position sense is scored together with other somatosensory modalities,
thus making its impact on disability not easy to estimate. The introduction of
a quantitative measure of proprioceptive deficits in the clinical practice could
help overcome this limit. Although an indirect quantitative characterization of
the proprioceptive impairment in patients with MS, employing posturographic
or electrophysiological measurements, has been suggested by previous studies
[251; 252], matching tasks allow for a direct assessment of position sense and a
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quantification of the related deficits [66].
As for the neural correlates of position sense, a predominant fronto-parietal
activity was detected in eRR MS patients when the contrasts between matching
tasks and pure motor tasks (IMA-R>ACTIVE-UNILAT and CMA-R>ACTIVE-
BILAT) were examined. Frontal areas play a role in sensory attentional and
spatially oriented processing but also in working memory processing [253; 254]
while parietal regions are involved in the processing of proprioceptive informa-
tion [255], reorienting,[256] recognition of a matching position during visually
guided tasks [257] and with the modulation of spinal motor output during move-
ment preparation [258]. Another relevant and novel finding of our study is the
observation of a significant increase of brain activity in patients, compared to
HS, during the ipsilateral matching task. This result, in combination with the
absence of significant differences in behavioral performance between the two pop-
ulations for this task, suggests an efficient supplying functional reorganization
occurring during the execution of a simpler task such as the ipsilateral matching
task. Conversely, during the contralateral matching task, the modulation of func-
tional activity was not accomplished or not sufficient, resulting in a compromised
behavioral performance. We found further evidence in support of the occurring
functional reorganization. In fact, in eRR MS we found a negative correlation
between CE during IMA-R and activity in the right parietal areas, but a positive
correlation with right frontal areas. This result could further support a fronto-
parietal functional reorganization, at the level of the right hemisphere, underlying
the lower rate of proprioceptive errors. Moreover, the positive correlation between
CE during IMA-R and the right frontal cortex activation could imply the role of
the spatial attention [259] in the execution of the task. On the contrary, we could
speculate that the positive correlation found between post and precentral gyrus
activation and CE during CMA-R represents an inefficient attempt to improve
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the task performance. No correlations were found in the HS group between brain
functional activity and behavioral parameters during the matching tasks, further
suggesting that the findings in eRR MS group are indicative of mechanisms of
functional plasticity.
Correlations with behavioral parameters during quiet standing. In eRR MS
patients, the amplitude of the antero-posterior oscillations of the center of pres-
sure (RMSAP) during quiet standing correlated positively with the errors (CE)
during CMA-R, suggesting that the position sense deficits, measured with match-
ing tasks, affect balance during quiet standing. The amplitude of the postural
sway displayed also an inverse correlation with activations in different brain areas,
and specifically at the level of the right parietal lobe, suggesting that a deterio-
ration of balance performance due to proprioceptive deficits is associated with an
increased activity in the brain area processing position sense.
Behavioral performance during matching tasks and CC diffusion tensor met-
rics. The behavioral performance during CMA-R was significantly associated
with the mean FA and MD values of the CC, leading us to speculate that during
a bilateral task, such as the contralateral matching task, structural damage at
the level of the CC prevents an efficient interhemispheric transfer of information
as well as a functional cortical reorganization to compensate and guarantee a
normal behavioral performance. Interestingly, results from previous studies seem
to support this interpretation. In fact, a correlation between sensori-motor cortex
functional connectivity and structural alterations of the CC, measured by means
of DTI parameters, has already been reported in patients with eRR MS [260].
Likewise, in a DTI study on HS, bimanual task performance in absence of aug-
mented visual feedback was significantly correlated with CC structural properties
[261].
This study has a few limitations. First of all, the relatively small sample size
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of our patients’ group that included only subjects in the early stage of the disease.
Although our approach and our findings are novel, they will have to be confirmed
in larger populations of patients and at different stages of the disease. Admittedly,
the lack of availability of postural control parameters in our controls’ group limits
the interpretation of the relationship observed between quiet standing behavioral
measures and brain activity during matching tasks. However, the measurement of
patients’ postural control parameters has been instrumental to the assessment of
the impact of our findings on balance. Moreover, our MRI protocol did not include
sequences for the structural and functional assessment of spinal cord integrity
thus precluding the investigation of the contribution of spinal cord abnormalities
to proprioception processing. Lastly, although we performed this analysis on
patients with low disability, the assessment of position sense by matching tasks
on a sample of patients with moderate or severe disability could be influenced by
their cognitive abilities, in particular in terms of attention. Therefore, cognitive
assessment would be useful to exclude patients with attention impairment or
to correct the results accordingly. At moderate or severe stages of the disease,
other methods of proprioception assessment, such as the active movement extent








Here are presented the rationale and methods of the study of the functional
connectivity in patients with progressive multiple sclerosis, the results and their
interpretation.
5.1 Introduction
Progressive multiple sclerosis is characterized by a compartmentalised and a lower
burden of inflammation associated to neurodegeneration, with axonal and neu-
ronal loss. However, a brain adaptation and reactive changes to damage occur
even at this stage and could account, at least in part, for the gap between conven-
tional imaging features and clinical disability. In fact, it’s still debated whether
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changes detected with both structural and functional imaging reflect an adaptive
or a maladaptive response. Nonetheless, both a compensatory and a maladaptive
modulation could occur at the same time.
Previous studies on patients with progressive MS revealed reduced functional
activation within the default mode network (DMN) in both PP MS and SP MS
compared to healthy controls, although the reduction was observed in different
areas [262]. During task fMRI, cognitively impaired PP MS patients revealed an
increased functional activity during the performance of a cognitive task, which
inversely correlated with the cognitive status and increased activity within the
motor network during a motor task [140; 263]. A recent study showed in pa-
tients with progressive MS increased FC after a rehabilitation training of the
upper limbs, which correlated with the motor improvement [264]. Although task
fMRI could reveal changes related to a specific treatment, is more influenced by
the task itself since the performance would be more affected in more clinically
impaired patients. rs-fMRI analysis doesn’t suffer from this disadvantage and
could offer a more straightforward insight on the mechanisms subtending the
clinico-radiological gap observed also in the advanced stages of the disease.
While resting state functional reorganization has been largely investigated
in patients with CIS and RR MS, by means of connectivity and graph metrics,
studies on the global functional remodulation occurring at the progressive stage
of the disease are still missing.
5.2 Materials and methods
Participants.
Forty-seven patients with either PP or SP MS and 27 healthy controls (HC)
were recruited. Diagnosis of PP or SP MS was made according to McDonald’s
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criteria 2010 [201]. All subjects underwent MRI and, on the same day, patients
with MS underwent clinical and neuropsychological evaluation. The study was
approved by the institutional review board of the Icahn School of Medicine at
Mount Sinai and all the subjects gave written informed consent to participate.
Clinical and neuropsychological assessment. Patients with PP or SP MS
underwent neurological examination including expanded disability status scale
(EDSS), timed 25-foot walking (T25FW) test, 9-hole peg test (9HPT) and neu-
ropsychological assessment including symbol digit modalities test (SDMT), Cal-
ifornia verbal learning test second edition (CVLT-II, considering the first five
recall trials) and the brief visuospatial memory test revised (BVMT-R, consider-
ing the first three recall trials [265]). Raw scores were transformed into z-scores
according to [266].
MRI acquisition. All the participants underwent MRI on a 3.0 T scanner
(Siemens Magnetom Skyra, Erlangen, Germany) with a protocol including the
following sequences: a) T2-weighted sequence: voxel size 0.5x0.5x3 mm3, repe-
tition time (TR) 8000 ms, echo time (TE) 95ms; b) 3D T1-weighted sequence:
voxel size:0.8x0.8x0.8 mm3, TR 3000 ms, TE 2.47 ms, flip angle 7◦, inversion
time 1000 ms); c) echo planar imaging (EPI) sequence for the resting state: voxel
size: 2.1x2.1x2.1 mm3, TR 1000 ms, TE 35 ms, multi-band acceleration factor
7, flip angle 60◦, 400 volumes. During resting state fMRI subjects were asked to
rest with their eyes closed.
Structural MRI analysis. T2 and T1 lesion load were computed on the T2-
weighted and the 3D-T1-weighted images respectively, using a semi-automated
technique (Jim version 7; Xinapse Systems, http://www.xinapse.com). A lesion
mask obtained on the 3D-T1-weighted images was obtained for each patient and
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used to fill-in the T1-hypointense lesions [202].
Functional resting state MRI analysis. RS fMRI data were preprocessed
using custom made MATLAB scripts and SPM8 (FIL, UCL, UK). Preprocessing
steps included: realignment and discarding of the first 10 volumes, resulting in 390
time points. T1 images were co-registered to the individual functional space and
segmented into white matter (WM), grey matter (GM) and cerebrospinal fluid
(CSF). The average WM and CSF signals were obtained from standard WM and
ventricular masks mapped to the subject’s space and masked with the subjects’
WM and CSF masks. Regression of the nuisance variables, including WM and
CSF signals and the six motion parameters, was then performed using DPARSF
toolbox. Framewise displacement according to Power et al. [267] was computed
and subjects with a FDPower >0.5 mm in more than 25% of the volumes were dis-
carded from the analysis [268]. In all other subjects, scrubbing was applied with
contaminated volumes (FDPower>0.5mm) censored and replaced with average
of the surrounding volumes. Lastly, despiking and band-pass filtering (0.01-0.15)
were applied. From the initial sample of 74 subjects, 4 were excluded for issues
in the structural/functional co-registration and 13 (1 HC, 8 SP MS patients and
4 PP MS patients) were excluded after motion scrubbing because more than 25%
of volumes in their scans had a framewise displacement above the threshold of
0.5 mm. T1 images were processed using FreeSurfer software to obtain cortical
surphace for each subject [269; 270] and registered to a the Schaefer atlas using
the 100 parcels and 17 networks atlas [271]. The parcellation using FreeSurfer
was preferred to a co-registration of the atlas to the individual space since the
representation of the cortical thickness was more reliable.
Functional connectivity. The FC was assessed using a non parametric
estimator called ”accordance” e.g. a measure, range 0-1, that reflects coupling
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between two ROIs. The co-activations and co-deactivations between regions are
obtained by thresholding the normalized fMRI signal at positive and negative
thresholds, respectively. The threshold used was the 80% quantile of the normal
distribution [272]. Therefore, for each subject two matrices based on the accor-
dance (including co-activations and co-deactivations) and discordance (reflecting
the activation-disactivation between timecourses) were obtained. A Fisher’s Z-
transformation was further applied to the accordance and discordance matrices
to improve the normality of the measure.
Graph properties. The brain connectivity toolbox (1) [22] was used to com-
pute the graph measures on accordance matrices. For each region were obtained
the following metrics:
• nodal strength for weighted undirected graphs
• eigenvector centrality for weighted unndirected graphs [273]
• clustering coefficient for weightes undirected graphs according to [274]
• local efficiency for weighted graphs according to [275]
• betweenness centrality for weighted graphs [276]
Statistical analysis. Chi-square test and analysis of variance (ANOVA)
were used to assess differences among the three groups in gender and age, re-
spectively. Two sempled t-test or non-parametric Mann Whitney U test were
used to compare the clinical parameters between the two groups, if the condition
of normality of the single variable per group was or not satisfied, respectively.
Analysis of covariance (ANCOVA) was used to test differences in accordance and
1http:/www.brain-connectivity-toolbox.net
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discordance and in graph metrics between HS, PP MS and SP MS patients, with
age and gender as covariates. The false discovery rate (FDR) method was applied
to correct for multiple comparisons across regions. To verify relationship between
functional connectivity and clinical measures a partial least squares correlation
(PLSC) analysis was performed [277]. Two analysis were performed: i) for the
first PLSC analysis EDSS score and the pyramidal, sensory and mental func-
tional system scores were included, ii) in the second one the T25FW test and the
9HPT (using the averaged score between the dominant and non dominant hand);
were included as measures of motor disability, iii) in the third one the SDMT,
BVMT T1-3 and CVLT T1-5 as measures of cognitive disability. The correlation
components obtained with singular value decomposition underwent permutation
testing (300 permutations) and bootstrapping (300 bootstrap samples) to assess,
respectively, the significance and stability of behavior and brain weights. Only
the accordance measure of FC was tested as brain variable. We discarded the
cerebellar, visual, bladder/bowel and brainstem functional system scores of the
EDSS since these score can be considerably affected by damage at the level of
the spinal cord, the cerebellum or the brainstem.
5.3 Results
Demographic and clinical characteristics. Demographic data for the three
groups and clinical data for the patients with MS are reported in Table 1. HC, SP
MS and PP MS patients did not show significant differences in gender (χ(1)=2.882,
p=.237) or age (F(2,27)=1.462, p=.241). See Table 5.1
Functional connectivity. ANCOVA analysis among the three groups re-
vealed differences in functional coupling, defined by the accordance metric, be-
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HS(N=25) PPMS(N=18) SPMS(N=14) p
Age 47.28± 8.74 49.39± 10.42 52.64± 9.16 0.241
Gender 10 F; 15 M 11 F; 7 M 9 F; 5 M 0.237
Disease duration (years) - 9.17± 4.76 23.36± 13.83 <0.001
EDSS◦ (median; range) - 5.0; 1.0-6.5 6.0; 3.0-6.5 0.565
SDMT◦ - 45.47± 16.62 49.71± 11.49 0.462
BVMT-R T1-3 - 17.24± 8.98 16.92± 8.18 0.922
CVLT-II T1-5 - 58.78± 13.52 49.64± 11.29 0.051
T25FW◦ - 7.28± 2.24 9.78± 4.96 0.320
9HPT-Avg◦ - 30.99± 10.17 31.56± 8.62 0.578
9HPT-D◦ - 27.64± 9.15 29.52± 6.18 0.295
9HPT-ND◦ - 32.11± 10.55 33.61± 12.82 0.721
years of education - 16.61± 2.64 16.57± 2.14 0.964
Table 5.1: Demographic and clinical data. ◦: tested with non parametric Mann-
Whitney U test. Abbreviationa: EDSS: expanded disability status scale; SDMT:
symbol digit modalities test; CVLT-II: California verbal learning test second
edition; BVMT: brief visuospatial memory test revised; T25FW: timed 25 foot
walking test; 9HPT-Avg: average of the 9-hole peg test of the dominant and
non dominant hand; 9HPT-D: 9-hole peg test of the dominand hand; 9HPT-ND:
9-hole peg test for the non dominant hand
tween regions of the visual network, salience, default mode, dorsal attention,
control and temporo-parietal networks. However, no connections survived after
correction for multiple comparison. Instead, discordance showed anticoupling be-
tween regions of the default, control, salience and temporoparietal networks. The
anticoupling between precuneus and parahippocampal cortex survided multiple
comparison correction, with a posthoc comparison revealing a reduced discor-
dance in SP MS patients. No significant differences were found between PP MS
and SP MS patients (Figure 5.1).
Graph Properties. No differences were in graph metrics survived multiple
comparison correction.
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Figure 5.1: Differences between HS and MS patients in nodal strength and ac-
cordance (left) and in discordance (right) measures. Both nodal strength and
coupling/anticoupling are thresholded at p<0.01 for visualization purposes.
Correlations with clinical disability. The PLSC analysis revealed two
significant association between FC, expressed with accordance and clinical pa-
rameters: the first with EDSS (p=0.003), and the second one (p=0.033) with
motor disability, expressed by both TF25TW and 9HPT scores. The third PLSC
did not show any significant correlations between FC and cognitive test scores.
In the significant correlation component of the first PLSC analysis a FC pattern
including connections mainly between areas of the DMN (in particular the pos-
terior cingulate cortex (PCC) and the temporal and retrosplenial cortices) and
the precuneus with regions of the dorsal attention, salience end sensorimotor net-
works correlated with the global EDSS for both PP and SP MS groups. This
FC pattern correlated also with EDSS functional system scores: with the sensory
functional system score for the PP MS patients and with the pyramidal functional
system score for both groups but in opposite directions (a direct weak correlation
for SP MS group and a stronger negative correlation for PP MS group) (Figure
5.2). Regarding the second PLSC analysis, the correlation was driven mainly
by the T25FW scores of SP MS patients and mainly involved connections of the
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prefrontal regions of the DMN with sensori-motor network regions (positive cor-
relation) and between sensori-motor regions, post central and fronto-medial areas
and of the postcentral areas (negative correlation). The results in the first PLSC
analysis were mainly driven by the PP MS group, while in the second by SP MS
group (Figure 5.3).
5.4 Discussion
The first novelty of this work is the analysis of the functional connectivity ex-
pressed by both a coupling and anticoupling between timecourses in patients with
progressive Multiple Sclerosis. The results indicate that patients with progressive
MS, compared to HS, showed a different functional coupling and anti-coupling
among multiple network but the greatest difference was captured by anti-coupling,
suggesting this could be a novel measure to include in further studies.
The study of the functional reorganization in progressive MS is quite intrigu-
ing: the motor task fMRI studies have consistently showed an increased acti-
vation in SP and PP MS patients compared to controls and RR MS patients
[142; 263; 278]. Cognitive task fMRI studies revealed a greater activity in the
cognitively impaired group of patients [140] and in SP MS group compared to
patients with clinically isolated syndrome [143]. On the contrary, there is a rela-
tive lack of resting state fMRI studies, with the few available focusing on specific
networks [141; 262].
Resting state fMRI in the inflammatory phase of the disease has instead re-
ceived a larger attention, with most of the studies on patients with RR MS or
CIS, showing an increase in functional connectivity. Previous studies also indicate
that the functional reorganization is related to white matter structural general
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Figure 5.2: a) bootstrap ratio results, indicating pattern of ROIs positively and
negatively correlated with disability score (global EDSS score, pyramidal, sensory
and mental functional system scores); networks are indicating on x axis and the
ROIs number on y axis; b) correlation between behavior and brain scores as
resulting from the significant latent variable; c) design saliences, showing the
strong effect of the PP MS subgroup; d) nodal strength of positive weights in
the 100 ROIs with edges representing the bootstrap scores, indicating positive
correlation and corresponding to positive values in A; e) nodal strength of negative
weights in the 100 ROIs with edges representing the bootstrap scores, indicating
negative correlation and corresponding to negative values in A). lV: left visual
network, lSM: left somatomotor network, lDA: left dorsal attention network, lS:
left salience network, lL: left limbic network, lC: left executive control network,
lDM: left default mode network, lTP: left temporo-parietal network, rV: right
visual network, rSM: right somatomotor network, rDA: right dorsal attention
network, rS: right salience network, rL: right limbic network, rC: right executive




Figure 5.3: a) bootstrap ratio results, indicating pattern of ROIs positively and
negatively correlated with motor disability score (T25FW and 9HPT); networks
are indicating on x axis and the ROIs number on y axis; b) correlation between
behavior and brain scores as resulting from the significant latent variable; c)
design saliences, showing the strong effect of the SP MS subgroup; d) nodal
strength of positive weights in the 100 ROIs with edges representing the bootstrap
scores, indicating positive correlation and corresponding to positive values in A;
e) nodal strength of negative weights in the 100 ROIs with edges representing the
bootstrap scores, indicating negative correlation and corresponding to negative
values in A). lV: left visual network, lSM: left somatomotor network, lDA: left
dorsal attention network, lS: left salience network, lL: left limbic network, lC: left
executive control network, lDM: left default mode network, lTP: left temporo-
parietal network, rV: right visual network, rSM: right somatomotor network,
rDA: right dorsal attention network, rS: right salience network, rL: right limbic
network, rC: right executive control network, rDM: right default mode network,
rTP: right temporo-parietal network.
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dysruption [122; 123] and to focal lesions [279]. However, in the progressive
stages of the disease focal inflammation phenomena are more rare while diffuse
neurodegenerative processes become predominant. Observing the course of func-
tional modulation occurring in other neurological diseases resulting in focal and
acute damage could help in the interpretation. A longitudinal study on patients
with stroke showed that the asymmetry in resting state FC between ipsi- and
contra-lesional motor area was larger in patients compared to healthy controls at
onset and one month after the stroke but no differences were found after 3 and 6
months [280].
We could speculate that during the inflammatory stages of MS the acute dam-
age in the white matter would result in a more evident modulation of FC while in
the progressive stages changes are more subtle. Recently a novel definition of the
clinical course in patients with MS has been proposed, implying a subdivision of
clinical phenotypes based on disease activity and disease progression based on the
assumption that they reflect an ongoing inflammatory or neurodegenerative pro-
cess, respectively, with a different impact on the prognosis, therapeutic decisions
and trials outcome [90]. A future direction for the study of functional connec-
tivity in patients at the progressive stage would be the exploration of differences
between patients with active disease, expressed in terms of both clinical relapses
and the detection of new lesions on MR imaging.
Nonetheless, in this work we found that functional connectivity explains mo-
tor and global disability. In particular, the global EDSS score in PP and SP MS
groups and the sensory functional score in PP MS were associated to a stronger
spread connectivity between regions of the posterior DMN, mainly the PCC, and
of the precuneus with other networks such as the dorsal attention, salience and
sensori-motor networks. A greater functional connectivity between regions of the
DMN and sensori-motor regions explained also the worse score of the T25WT in
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patients with SP MS. Altogether these results indicate that a stronger coupling
between regions of the DMN and other networks associates with a greater disabil-
ity in patients with progressive MS. Previous studies focused on the relationship
between FC and cognitive tests, revealing a positive association between cingu-
late and medial prefrontal cortex functional activity and a better cognitive per-
formance [262] or a decreased FC between the executive control and attentional
networks [141]. While in our study we did not find any significant association
between cognitive tests and functional connectivity, we could hypothesize that a
resilience in the FC of the DMN and a less fluid and dynamic could explain at
least in part the clinical disability occurring at a more chronic stage of the disease.
The investigation of the dynamic functional connectivity and of the relationship
with the structural damage could help clarifying and extend these results.
Graph metrics did not showed significant differences between patients and con-
trols. However, brain graph analysis present a large statistical variability [281]
and in previous studies differences in functional graph metrics did not survive
multiple comparison correction [118] or different methods other than FDR were
used [134]. Limitations of this work include the small sample size, the lack of
measures of subcortical functional connectivity and of structural damage. Alto-
gether, the results of this work suggest that more subtle changes in resting state
functional connectivity occur at the late and chronic stage of MS. Further investi-
gation including longitudinal measures and markers of white matter damage are
needed.
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Neural correlates of action
observation in patients with
Parkinson Disease
Summary
Here are presented the rationale and methods of the study of the neural correlates
of action observation in patients with Parkinson disease with or without freezing
of gait, the results and their interpretation.
6.1 Introduction
The observation of someone performing an action recruits brain areas that are
activated also during the action execution. The physiological bases of this phe-
nomenon rely on the mirror neuron system (MNS), firstly discovered in the ventral
premotor cortex of monkeys (area F5)[179]. Further neurophysiological and brain
imaging studies confirmed a mirror mechanism is also present in humans [180],
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thus providing a first potential localization of the MNS.
MNS has been identified as the neural substrate for action observation (AO)
training, observation plus repetition of actions, which has been proposed as a re-
habilitation strategy in neurological disorders, including Parkinson’s disease [282].
However, whether the MNS, and thus the efficacy of AO, is preserved or altered
in patients with PD is still controversial [178] Indeed, voluntary movement imi-
tation seems to be preserved [283] and movement observation is accompanied by
bilateral beta reduction in subthalamic power and cortico-subthalamic coherence
[284; 285]. On the contrary, the modulation of motor evoked potentials [286]
as well as the event-related mu-rhythm desynchronization [287] during AO have
been showed to be impaired in PD.
Gait disorders are frequent in PD patients but, in spite of their major effects
on disability, their neural correlates remain quite unknown. Most of studies
exploring the neural correlates of gait in PD patients have been performed with
fMRI using a task of motor imagery, and some discrepancies have been reported
when comparing patients with and without freezing of gait (FOG) [192; 288].
It has been demonstrated that AO training is effective in improving levodopa-
resistant gait disturbances such as FOG [181]. In a recent study, Agosta and co-
workers [289] showed that PD patients with FOG, after a 4-week training based
on observation plus execution of gait, exhibited a clinical improvement and an
increased recruitment of cortical areas involved in motor and attentional control.
However, in this study, the Authors focused only on patients with FOG and used
a specific task to emphasize FOG, while there are no data in the literature about
the neural correlates of AO of gait in patients with or without FOG.
In addition, it should be considered that most previous studies have explored
brain activity during gait in patients with PD in the “off” state [289; 290]. Al-
though this may unveil the functional reorganization and reflect more accurately
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the physiopathological substrate of the disease, it prevents the comprehension
of the neural functional mechanisms underlying behavioral performance in the
every-day life of PD patients. This prompted us to design a functional MRI
(fMRI) study in order to evaluate the neural structures recruited during the ob-
servation of human-gait in PD patients with (FOG+) or without FOG (FOG-)
while in the “on” state, and to investigate the relationship between AO-induced
brain activation and gait performance.
6.2 Materials and methods
Subjects. A total of 54 subjects (33 PD subjects and 21 healthy adults) were
prospectively enrolled in the study. Participants with idiopathic PD (according
to the UK Brain Bank criteria [291], were recruited at the outpatient Move-
ment Disorders clinic (Department of Neuroscience) of the University of Genova
(Italy). Healthy subjects (HS) were recruited from local community groups and
from caregivers and relatives of PD patients. The study was approved by the
regional ethical committee and was performed according to the principles of the
Declaration of Helsinki. Written informed consent was obtained from each par-
ticipant prior to study entry. Participants were excluded if they had an history
of neurologic disorders other than PD, if they scored ¡25/30 at the Mini-Mental
State Examination (MMSE) [292], if they had visual impairments that could hin-
der task-fMRI acquisition and any musculoskeletal disorders that could hamper
gait task, or if they needed assistance during walking. In PD subjects, severity
and stage of the disease were evaluated with the MDS–Unified Parkinson Dis-
ease Rating Scale [293] and the Hoehn and Yahr stage respectively [294] . The
presence of FOG was assessed according to the new FOG questionnaire [295].
Study design and procedures The study consisted of two separate experi-
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mental sessions (gait evaluation and AO fMRI) performed by each participant in
two different days. The first day, demographic and clinical characteristics were
collected, then participants were randomly assigned and underwent to either gait
assessment evaluations or AO fMRI. The second day subjects performed the other
part of the study protocol. Each session was scheduled at the same time for each
participant. The sessions were scheduled over a period of 7 days. All PD patients
were under treatment with dopaminergic therapy and clinical and instrumental
evaluations took place during the “on” state (≈ 1 hour after taking antiparkin-
sonian medications).
Gait evaluation Participants were required to walk at their comfortable
speed (labeled as Normal Walking - NW); on a sensorized mat (GaitRite R©, CIR
Systems Inc. Clifton, US) for 1 minute. The GaitRITE (≈ 7 m long) was
positioned in the center of the room so that there was a minimum of 3 m of open
space at either end and a minimum of 2.5 m at either side. This arrangement
provided sufficient open space to minimize gait acceleration and deceleration while
walking on the walkway. The Proto-Kinetics movement analysis software was use
for analyzing the spatiotemporal gait parameters. Cadence (i.e. number of steps x
minutes), gait velocity (GV), stride length (SL) and their coefficients of variability
(CV; Standard deviation/Mean *100) were then determined. Kinematic data of
gait were determined from all steps recorded during the entire task.
Action observation and fMRI Task The MRI protocol aimed to assess
the functional activity during AO; we chose a block fMRI design with 30 seconds
of rest (one block) followed by 30 seconds of task, 8 blocks total. After standard-
ized verbal instructions, subjects were required to carefully watch a third-person
videoclip representing human gait, inside the magnetic resonance scanner. The
walker proceeded from the left to the right of the screen, on a neutral background,
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so that participants watched the human gait on a sagittal plane. Participants
watched the videoclip by looking at the mirror positioned on the head coil. The
mirror reflected the human gait video displayed on a screen placed inside the mag-
net room, located ≈ 1 m far from the bottom of the scan. A video-projector was
connected with a computer and placed outside the magnet room. A custom-made
Matlab Software (Mathworks, Massachusetts, USA) synchronized videoclip onset
with fMRI acquisition. Cushions were used to avoid head motion and the mirror
on the head coil was carefully adjusted to ensure a clear vision of the screen to
each participant.
Functional MRI image acquisition and preprocessing. Images were ac-
quired on Signa Excite 1.5 MRI (Signa Excite General Electric Healthcare, WI,
USA) with 8-channels phased array head coil. The MRI protocol included a T2-
weighted sequence (TR/TE= 2340/102 ms, voxel size: 0.94x0.94x4 mm3), Fast
Spoiled Gradient Echo (FSPGR) 3-D T1-weighted sequence (TR/TE= 11.70/5.12,
voxel size: 1x1x1 mm3) and a single-shot echo-planar imaging (EPI) sequence
(TR/TE = 3000/60 ms, slice thickness = 4 mm, pixel size = 3.75 mm2) for fMRI
task during action observation of gait. Initial pre-processing step included the
despiking (detection and reduction of extreme time series outliers by fitting a
smooth curve insensitive to extreme outliers to the data), performed in AFNI
(https://afni.nimh.nih.gov) (Cox, 1996). Brain extraction was performed
with FreeSurfer skull stripping on the T1-weighted anatomical sequence [241].
The other pre-processing steps were performed using FSL (FMRIB’s Software Li-
brary, https://fsl.fmrib.ox.ac.uk/fsl/fslwiki) [243; 296] as implemented
in FEAT [244; 245], including: removal of the first 3 volumes, motion correc-
tion using MCFLIRT (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/MCFLIRT)
[242], slice-timing correction for regular ascending acquisition (using Fourier-
space time series phase-shifting), spatial smoothing (Gaussian kernel, FWHM=6
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mm), grand-mean intensity normalization of all volumes by a single multiplicative
factor, and high-pass temporal filtering (Gaussian-weighted least-squares straight
line fitting, sigma=30 sec). T1-weighted brain images were segmented into white
matter (WM), grey matter (GM) and cerebrospinal fluid (CSF) using FAST [246];
then the WM and CSF masks were registered to the functional space and the av-
erage of the raw time-series within each mask was derived in order to obtain the
nuisance signal from WM and CSF.
Statistical analysis
Demographics, clinical data and gait assessment. Analyses were
performed using Statistical Package for the Social Sciences (SPSS) version 22
and means and standard deviations (SD) were calculated for all dependent vari-
ables. Gender differences among groups (PD FOG+, PD FOG- and HS) were
assessed using the Chi-square procedure. For age and education group differences
were assessed by the non-parametric Kruskal-Wallis test because data were not
normally distributed (according to the Kolmogorov Smirnov statistical test) and
group to group comparison was performed using Mann-Whitney U-test. For gait
kinematic parameters, that were normally distributed, a one-way ANOVA was
used to perform groups comparison. For clinical data the comparison between
PD FOG+ and PD FOG- groups was done using an unpaired t-test. P values
< 0.05 was considered significant.
Functional MRI. One explanatory variable (EV) was defined to model
the On-Off periods of the task (action observation, AO) and convolved with the
hemodynamic response function (HRF), to detect task-related activity. The 24
motion parameters calculated during motion correction were added as confound
EVs together with the mean CSF and WM signals. Boundary-based registration
BBR (Greve and Fischl, 2009) was used to register each individual functional
data to the corresponding T1-weighted brain image. Then, linear affine 12 de-
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gree of freedom registration was performed to register each subject’s T1-weighted
brain to the standard space (MNI152 brain template, voxel size: 2 mm3) [242].
A one-sample t-test was used to model group mean activation for both PD pa-
tients and healthy controls. Differences between the two groups (HS and PD)
were investigated using a two-sample unpaired t-test, adding age and gender as
covariates. Moreover, to test for significant differences among FOG+, FOG- and
HS groups, ANCOVA, with age and gender as covariates, was used. Results were
converted to Z-values and then thresholded at Z = 2.3 for cluster formation and
significance threshold corrected for multiple comparisons (p < 0.05). The corre-
lations between brain activations of HS or PD patients (both FOG- and FOG+
groups) and the behavioral measures, in particular GV, SL and their CV (i.e.
GV − CV and SL − CV ), were modeled separately with age and gender as co-
variates. Z−maps were thresholded at Z ≥ 2.3 for cluster formation, followed by
with a significance threshold of p = 0.05 (cluster corrected using Gaussian Ran-
dom Field Theory). Brain functional activations were labeled using the Eickhoff
atlas (SPM Anatomy toolbox) [248].
6.3 Results
Demographics and clinical data. Two PD subjects could not complete the
MRI examination. Moreover, two subjects were excluded from the analysis be-
cause they resulted outliers at the behavioural performance (i.e. needed assis-
tance during gait task). Thus, results were obtained from 50 participants (29
PD and 21 HS). HS (13 females) had a mean age of 64.62 years (range 22-84
years). PD patients (8 females, mean age = 70.10 years, range 60-83 years) had
mild-to-moderate symptoms as indicated by a mean Hoehn & Yahr stage of 2.02
(SD ± 0.56; range 1 – 3). Motor symptoms severity (i.e. MDS-UPDRS section
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III) ranged from 8 to 46 and the patients’ mean score (±SD) was of 22.28±11.95.
Twelve PD participants were confirmed to experience Freezing of Gait (FOG+),
whereas the rest (n = 17) were classified as PD without FOG (FOG-). At the
end of the recruitment phase, age sex and education levels were similar among
the three groups (PD FOG+, PD FOG- HS; palways > 0.05). As expected, one
way ANOVA revealed that MoCA score was different among groups (p < 0.01).
Post hoc analysis showed that PD subjects had a lower score compared to HS
participants (PD FOG+ vs HS and PD FOG- vs HS p always < 0.001), whereas
no difference were seen between FOG+ and FOG- patients (p = 0.131). When
clinical data were compared between FOG+ and FOG- PD patients, no differ-
ences emerged for Hoehn and Yahr stage, UPDRS-III motor (p > 0.05 for all
these variables). The statistics for demographic and clinical data are reported in
Table 6.1.
HS (n=21) PD (n=29) p value
Demographic and clinical characteristics
Age (years) 64.62±13.52. 70.10 ± 5.16 .08
Education (years 11.16 ± 6.37 9.22±5.17 .19
MoCA score 28.81± 1.01 25.62±2.08 <.01
Disease duration(years) - 10.55 ± 4.79 -
H&Y (stage) - 2.02 ± 0.56 -
MDS-UPDRS (motor score) - 22.18 ± 11.95 -
Gait Parameters
Gait velocity (cm/s) 132.27 ± 11.84 113.89 ± 20.56 <.01
Gait velocity CV 4.40 ± 1.81 3.46 ± 0.90 .03
Stride Length (cm) 135.78 ± 11.46 122.76 ± 15.86 <.01
Stride Length CV 2.20 ± 0.61 3.21 ± 1.18 <.01
Cadence (n steps x minD) 114.51 ± 9.17 110.98 ±12.59 .29
Table 6.1: Demographic, clinical and gait parameters of participants. Reported
as mean ± SD.
Abbreviations: HS, Healthy Subjects; PD, Parkinson’s disease; n, number; SD,
Standard Deviation; MoCA, Montreal Cognitive Assessment; H&Y, Hoehn and
Yahr; MDS–UPDRS, Movement Disorders Society - Unified Parkinson Disease
Rating Scale; CV, coefficient of variability.
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Gait Performance. As expected, statistical analysis revealed significant
differences between the two groups (PD vs HS) for most of the kinematic param-
eters obtained during gait task. One-way ANOVA revealed that GV and SL were
different among groups (p = 0.023 and p = 0.038, respectively). Post-hoc anal-
ysis showed that both FOG+ and FOG- participants had a reduced gait speed
(p = 0.10 and p = 0.48 respectively) and shorter steps (p = 0.47 and p = 0.35 re-
spectively) compared to HS. For GV −CV and SL−CV statistical analysis were
significantly higher (i.e., worse) in patients with PD compared to HS participants
(GV − CV p = 0.048; SL− CV p = 0.003). Post-hoc analysis revealed a higher
variability in FOG+ and FOG- patients compared to HS (GV − CV : FOG+ vs
HS, p = 0.44 and FOG- vs HS, p = 0.039; SL−CV : FOG+ vs HS, p = 0.03 and
FOG- vs HS, p = 0.006). No significant differences were found between FOG+
and FOG- subjects related to gait parameters. Finally, statistical analysis did
show any significant difference between HS and PD groups for cadence (p = 0.56)
Action Observation (AO) fMRI task.
PD and HS single groups activations. During the AO task, the whole
PD group showed several clusters of activation at the level of the occipital and
temporal regions, inferior and superior parietal lobule (IPL and SPL, respectively)
and precentral gyrus, in both hemispheres. HS activated at the level of the
temporal and occipital regions bilaterally, bilateral SPL and intraparietal sulcus
(IPS), left pre- and post-central gyrus and superior frontal gyrus (Figure 6.1,
Table 6.2).
FOG- and FOG+ single group activations. When FOG- and FOG+
groups were investigated separately, the former showed activity at the level of
right temporal and frontal regions and bilateral occipito-parietal areas, while the
latter activated only at the level of the occipital regions (Figure 6.1).
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Figure 6.1: Cortical activity during AO of gait in the whole group of PD patients
(top,left), in the HS group (top,right), in FOG- (bottom,left) and FOG+ (bot-
tom,right) patients. The results are cluster corrected for multiple comparisons
(Z ≥ 2.3, p < 0.05) and are shown in MNI space.
PD vs HS. When the PD and the HS groups were compared, HS showed
a significantly greater activation at the level of the cingulate cortex, posterior
medial frontal cortex (PMFC), occipital regions and the precuneus (Table 6.3).
Subgroups comparisons. ANCOVA analysis revealed a significant differ-
ence among the three groups at the level of the left posterior-medial frontal cortex
and cingulate cortex. Both FOG- and HS showed an increased activity in the bi-
lateral PMFC, in the left IPL and in the postcentral gyrus compared to FOG+
participants. Moreover, HS showed two clusters of greater activation, compared
to FOG-, at the level of the left occipital regions, right precuneus, left cingulate
cortex and right pre- and post-central gyrus (Figure 6.2, Table 6.4 and Table 6.5).
Brain-behavioral correlations. When brain activations were correlated
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Figure 6.2: Results of the ANOVA analysis (top) and comparison between sub-
groups. The results are cluster corrected for multiple comparisons (Z ≥ 2.3,
p < 0.05) and are shown in MNI space.
with kinematic parameters obtained during normal walking task, significant cor-
relations were found in the FOG+ group. Specifically, increased activity at the
level of the precuneus cortex was associated with higher SL−CV and GV −CV
values (Figure 6.3, Table 6.6). No significant relationships between brain activa-
tions and gait parameters were found for FOG- or HS group.
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Figure 6.3: Brain-behavioral correlations, in particular correlations of brain ac-
tivity during AO of gait and SL−CV (left) or GV −CV (right) during normal
walking. The results are cluster corrected for multiple comparisons (Z ≥ 2.3,
p < 0.05) and are shown in MNI space
6.4 Discussion
In this study, we investigated the neural mechanisms underlying AO of gait and
the possible association between brain activity and walking performance in PD
patients, with and without FOG and in HS. There are two main findings: first,
patients with PD present a modulation of brain activation during AO of nor-
mal walking, and that this functional reorganization occurs in both FOG- and
FOG+ patients; second, in PD FOG+ participants, activity in the precuneus is
associated with spatio-temporal parameters of gait.
Although AO is emerging as a tool for rehabilitation of PD symptoms, includ-
ing FOG, the neural correlates of AO of gait remain unknown. Previous studies
explored brain activity during real walking task [48] and imagined gait task [297]
which showed a similar pattern of neural activity. One study of gait observation
in HS revealed activations mainly at the level of frontal areas, particularly of
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the the supplementary motor area and the dorsal premotor cortex, but also of
parietal, occipital regions and parahippocampal gyrus, mostly overlapping with
the activity elicited during virtual walking [298]. The similarity of activation pat-
terns between real, imagined and observed gait and the improvement of motor
performance after AO training in PD patients corroborate the hypothesis that AO
could enhance motor learning and motor performance in a varied rehabilitative
protocols.
In this framework, the results of this study add some novel information about
the response of PD patients to AO of gait, with potential consequences on the
practical application of AO in the rehabilitation training. We showed, in both
HS and PD groups, a cortical activation at the level of the occipital, parietal
and frontal areas during the observation of walking. In particular, the pattern
of activity we found in HS is similar to the one found by [298] However, cortical
activation was significantly reduced in PD patients, when compared to HS at the
level of the PMFC and of regions in the posterior parietal cortex. Interestingly,
both the occipital areas and the precuneus have been found to be active in HS
during observation of gait [298] with precuneus being involved in spatial control
of motor behavior and perspective taking of actions [299] and both areas being
hypoactivated during real gait in patients with PD, compared to HS [190]. Be-
sides, PMFC is one of the brain areas most consistently observed in studies on
gait [48; 190; 298] and affected in patients with PD [190]. Thus, our results con-
firm the impaired functionality of fronto-parietal areas related to gait in patients
with PD, even during AO of gait.
When FOG+ and FOG- patients were considered separately, the more striking
result was found in the FOG+ group, showing brain activation only at the level
of occipital lobes and, compared to both FOG- and HS, presenting a reduced
activity at the level of association regions such as PMFC and IPL, while the main
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differences between HS and FOG- was at the level occipital and primary sensori-
motor cortices. Previous studies found a reduced activity in FOG+ patients,
compared to FOG- [288], in particular at the level of the supplementary motor
area and parietal regions [192] during imaging of gait. Similarly, the previous
study on AO in PD patients with FOG [289] revealed a reduced activity in the
precentral and SMA areas, in comparison with HS.
The preserved activation of PMFC we found in FOG- but not FOG+ patients
adds a missing piece, confirming the involvement of this area in the functional
reorganization subtending FOG [222], and suggesting that this could be a tar-
get of AO training. On the other hand, the IPL has been described to play a
role in the representation of actions from sensory stimuli, including the visual
input [282]. Therefore, a dysfunction in this area, resulting in an altered sen-
sory input integration and a misrepresentation of the action could contribute to
the occurrence of FOG. This could be also one of the mechanisms underlying
the effectiveness of AO training in improving FOG [181]. Although L-dopa has
been found to modulate brain activity during imaging of gait in FOG+ patients
restoring the cortico-subcortical connectivity, in their PET study, Maillet et al.
did not directly compare HS and patients with PD under the effect of medication
[191]. Overall, our results confirm an impaired cortical activation in PD patients,
compared to HS, even under the effects of anti-parkinsonian medication. Both
PD patients with and without FOG undergo a change in the functional connec-
tivity subtending the AO of gait, but a wider modification occurs in PD patients
presenting FOG. The knowledge of the pattern of brain activity during AO of gait
in their most frequent condition, i.e. under the effect of medications, could help
in understanding the functional modulation shaped by AO training and therefore
in designing the most appropriate rehabilitation protocols. Finally, in FOG+ pa-
tients we found a significant association between brain activity during AO of gait
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and the kinematic parameters recorded during normal walking task. Precisely,
the activity at the level of the precuneus correlated with a worse performance in
terms of SL and GV variability during normal walking, This association was not
significant both in patients PD FOG- and in healthy controls.
This current finding appear to fit with findings in HS were the activations of
the precuneus was associated with the imagination of complex locomotor func-
tions such as walking with obstacles [297], attention shift and the processing of
visuo-spatial stimulus [299]. Therefore, we could speculate that the activity at
the level of the precuneus is crucial in the covert action of walking, in those sub-
jects presenting walking difficulties, such as PD patients with FOG. It would be
interesting to investigate whether activity at this level might change with AO
training.
This study is not without limitations, including the relatively small sample
size of the FOG-/FOG+ sub-groups of patients and the lack of a control condition
in the “off” state. However, this is the first study investigating neural correlates
of AO of gait in a population of both FOG+ and FOG- PD patients, revealing
that a functional reorganization occurs in PD patients and in particular in those
presenting with FOG, which could be linked to a fronto-parietal dysfunction.
Furthermore, in the latter patients, the behavioral performance during gait is
associated with activity at parietal level (in particular, the precuneus) suggesting
that these regions could have a role in AO rehabilitation of gait in FOG+ patients.
Exploring the neural correlates of AO of gait and the differences between FOG+
and FOG- patients, this study would be helpful in designing and assessing the
efficacy of rehabilitation protocols including AO training as a potential resource
for improving the motor performance.
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Side Location Cytoarchitetonic PD patients HS
location
MNI coord Z
(x y z) score
MNI coord Z
(x y z) score
R MTG - 46 -60 0 6.35 -
R ITG Area FG2 44 -64 -12 5.93 44 -70 -10 5.82
L STG Area PFcm -48 -34 22 5.1 -
R IOG Area h0c4v 36 -80 -8 4.73 -
R IOG Area h0c4lp - 36 -84 -4 5.75
L IOG Area h0c4lp - -36 -96 -4 5.26
L IOG Area h0c5 -44 -72 -6 4.94 -
R MOG/V5 Area h0c5 - 46 -68 4 6.41
L MOG/V5 Area h0c5 -44 -74 2 6.57 -
R MOG Area h0c3d 30 -92 12 4.95 30 -98 12 5.19
L MOG Area h0c4la -42 -86 0 5.5 -46 -76 2 5.38
L MOG Area h0c4d -22 -90 10 4.21 -
L MOG Area h0c4lp -44 -86 16 4.06 -40 -88 -6 4.58
L MOG Area h0c3d - -22 -98 0 5.02
L FG Area FG2 -40 -72 -18 4.09 -
R IPL Area 2 40 -38 54 4.79 32 -42 46 3.58
R IPL Area hIP3 38 -44 54 4.79 36 -44 52 4.16
R SPL Area 7A 32 -56 58 4.1 -
R SPL Area 7PC - 36 -46 58 4.13
R SPL Area 5L - 16 -56 74 3.65
L SPL Area hIP3 -22 -60 52 3.61 -40 -50 60 4.17
L SPL Area 7A -26 -68 64 2.8 -24 -64 62 3.46
L SPL Area 5L - -18 -56 72 3.34
R SMG Area 2 32 -40 46 3.55 -
R SMG Area PF - 64 -26 28 4.31
L SMG - -50 -40 28 4.21 -
R MFG - 48 2 52 4.82 -
R PrecG Area 44 56 4 40 3.4 -
L PrecG - -44 -8 54 3.24 -52 -6 52 4.54
L PostG - -52 -8 54 3.44 -62 -6 36 3.38
L SFG - - -34 -4 66 3.41
Table 6.2: Clusters of brain activation in PD patients (whole group) and HS.
Abbreviations: R: right; L: left; MTG: middle temporal gyrus; ITG: inferior
temporal gyrus; STG: superior temporal gyrus; IOG: inferior occipital gyrus;
MOG: middle occipital gyrus; FG: fusiform gyrus; IPL: inferior parietal lobule;
SPL: superior parietal lobule; SMG: supramarginal gyrus; MFG: middle frontal




Side Location Cytoarchitetonic MNI coordinates Z
location X Y Z score
L SOG - -14 -72 28 4.41
L CG - -16 -66 14 3.95
R Prec - 12 -68 30 4.16
L Prec - -4 -46 28 4.66
R MCC Area 5Ci 6 -38 46 3.54
L MCC Area 5M -4 -36 50 3.97
R PMFC - 10 -8 50 3.34
Table 6.3: Comparison between HS and PD patients.
Abbreviations: R: right; L: left; SOG: superior occipital gyrus; CG: calcarine
gyrus; Prec: precuneus; MCC: midcingulate cortex; PMFC: posteromedial frontal
cortex;
Side Location Cytoarchitetonic HS > FOG− HS > FOG+
location
MNI coord Z
(x y z) score
MNI coord Z
(x y z) score
L SOG - -14 -72 28 4.69 -
L Cuneus - -4 -76 28 4.56 -
L CG - -16 -66 16 4 -
R Prec - 12 -68 30 3.99 -
L IPL Area PFt - -56 -30 42 3.7
L IPL Area PF - -54 -40 44 3.28
L MCC - -8 -22 40 3.47
L ParaG Area 5M -4 -38 50 3.69 -4 -32 50 3.4
R PMFC - - 6 -12 68 3.45
L PMFC - - -4 -18 50 4.28
R PrecG - 50 -12 46 3.14 -
R PostG Area 3a 44 -12 32 3.16 -
R PostG Area4p 50 -12 32 3.08 -
L PostG Area 1 - -34 -40 64 3.75
Table 6.4: Comparison between HS versus FOG+ and FOG- patients.
Abbreviations: R: right; L: left; SOG: superior occipital gyrus; CG: calcarine
gyrus; Prec: precuneus; IPL: inferior parietal lobule; MCC: midcingulate cor-
tex; PMFC: posteromedial frontal cortex; MFG: middle frontal gyrus; PrecG:
precentral gyrus; PostG: postcentral gyrus; ParaG: paracentral gyrus.
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PATIENTS WITH PARKINSON DISEASE
Side Location Cytoarchitetonic MNI coordinates Z
location X Y Z score
L IPL Area PFt -54 -32 42 3.48
L IPL Area hIP2 -50 -46 38 3.35
L IPL Area hIP1 -46 -50 44 3.31
R PMFC - 6 -12 68 3.92
L PMFC - -2 4 54 3.7
L PrecG - -44 -16 60 3.72
L PostG Area 1 -46 -30 60 3.42
Table 6.5: Comparison between FOG+ and FOG- patients.
Abbreviations: R: right; L: left; IPL: inferior parietal lobule; PMFC: postero-
medial frontal cortex; PrecG: precentral gyrus; PostG: postcentral gyrus.
Side Location Cytoarchitetonic MNI coordinates Z
location X Y Z score
GV − CV during normal walking
L Prec Area 7P -2 -78 50 3.46
L SOG - -14 -78 44 3.18
L Prec Area 7A -6 -64 48 3.13
SL− CV during normal walking
L Prec Area 7P -2 -78 50 3.52
L Prec Area 7A -6 -64 48 3.14
L SOG - -14 -78 44 3.07




Functional magnetic resonance imaging is a powerful tool in investigating plastic-
ity occurring in brain and, when applied to patients with neurological disease, in
understanding how the functional changes are related to clinical disability. The
work of these three years aimed at moving few steps forward in the process of
understanding the functional reorganization occurring in multiple sclerosis and
Parkinson’s disease, with a focus, for the two diseases, on topics useful to design
strategies for the rehabilitation of gait, in particular position sense at the lower
limbs and action observation training.
Within this frame, studies were performed, using both resting state fMRI and
task fMRI in patients with multiple sclerosis and in patients with Parkinson’s
disease. We aimed at i) exploring the pattern of BOLD signal variability, a mea-
sure reflecting the brain functional flexibility, in patients with multiple sclerosis
at the early stage of the disease, ii) investigating the deficits of position sense
at the lower limbs and the underlying brain functional patterns, considering the
major role position sense plays in balance and gait, in patients with early multiple
sclerosis, iii) characterizing the functional connectivity in patients with multiple
sclerosis at the late stages of the disease, since functional changes in this phase
have received less attention so far, despite the relative lack of disease modifying
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drugs for these patients and thus the increased importance of rehabilitation, iv)
identifying the neural correlates of action observation of gait in patients with
Parkinson’s disease, which would be the starting point for the comprehension of
plasticity changes occurring during action observation training.
Patients with clinically isolated syndrome and RR MS presented with an in-
creased variability which was related to a better clinical performance. A possible
interpretation of this finding is a compensatory response, revealing functional
variability as a measure related to plastic changes occurring in the brain. More-
over, patients with early MS presented also deficits of position sense, which were
not detectable with the standard neurological examination, and that were asso-
ciated to changes in brain functional connectivity, mainly interesting the fronto-
parietal regions, and to altered diffusion metrics of the corpus callosum. The
position sense deficits affected balance at the early stages of the disease and
this would provide a main contribution for further therapeutic rehabilitative ap-
proaches in these patients. A future development of this study would be the
definition of the role of position sense during gait, in the same population of sub-
jects. This work also showed that changes of resting state functional connectivity
were more subtle in the late stages of multiple sclerosis, but still reflecting clinical
disability. A more integrated approach to the study of functional changes in the
chronic phase of multiple sclerosis is needed and would be a topic for further in-
vestigations. Lastly, patients with Parkinson’s disease presented with a different
functional pattern underlying action observation compared to controls, with these
changes becoming more prominent when freezing of gait was present. The knowl-
edge of such differences would allow a better insight in planning the inclusion of
action observation training in rehabilitative protocols for gait disorders.
Altogether, there results offer an better insight into the pathophysiological
functional mechanisms underlying disability in patients with multiple sclerosis
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both a the early and late stages and provide evidence for a reorganization of the
neural network underlying action observation in patients with PD. This work is
intended to be a basis for a better understanding of the brain plasticity that occurs
during rehabilitation. In fact, the characterization of the ”baseline” changes in
response to brain injury would lay the groundwork to properly select the best
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